FedInvent™ Patents

Patent Details for Tuesday, October 09, 2018 

This page was updated on Monday, March 27, 2023 at 05:38 AM GMT

Department of Health and Human Services (HHS) 

US 10091985 Tempelman et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Small Business Administration (SBA)
Small Business Innovation Research (SBIR)
APPLICANT(S) Linda A. Tempelman (Lincoln, Massachusetts);  Klearchos K. Papas (Maple Grove, Minnesota);  Simon G. Stone (Arlington, Massachusetts);  William Earl Scott, III (Saint Paul, Minnesota);  Thomas M. Suszynski (Maple Plain, Minnesota);  Shuichiro Matsumoto (Uwajima Ehime, Japan);  Joana Ferrer Fabrega (Girona, Spain);  Michael D. Rizzari (Saint Paul, Minnesota)
ASSIGNEE(S) GINER, INC. (Newton, Massachusetts)
INVENTOR(S) Linda A. Tempelman (Lincoln, Massachusetts);  Klearchos K. Papas (Maple Grove, Minnesota);  Simon G. Stone (Arlington, Massachusetts);  William Earl Scott, III (Saint Paul, Minnesota);  Thomas M. Suszynski (Maple Plain, Minnesota);  Shuichiro Matsumoto (Uwajima Ehime, Japan);  Joana Ferrer Fabrega (Girona, Spain);  Michael D. Rizzari (Saint Paul, Minnesota)
ABSTRACT Method and system for organ preservation. According to one aspect, an organ may be preserved by being perfused with an in situ generated preserving gas. The organ may be, for example, a human or porcine pancreas, and perfusion of the pancreas may be anterograde, retrograde, ductal, anterograde/ductal, or retrograde/ductal. The preserving gas used to perfuse the organ may be dissolved in a liquid and then administered to the organ as a gas/liquid solution or may be mixed with one or more other gases and then administered to the organ as a gas/gas mixture. The preserving gas may be, for example, oxygen gas generated in situ using an electrochemical oxygen concentrator. According to another aspect, an organ preservation system may include an electrochemical oxygen concentrator having a water vapor feed, as well as auxiliary equipment to control and measure delivery pressure, flow, temperature and humidity.
FILED Friday, June 18, 2010
APPL NO 12/803083
ART UNIT 1657 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Preservation of Bodies of Humans or Animals or Plants or Parts Thereof; Biocides, e.g as Disinfectants, as Pesticides or as Herbicides; Pest Repellants or Attractants; Plant Growth Regulators
A01N 1/0226 (20130101)
A01N 1/0247 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10092180 Hart et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Eye Institute (NEI)
APPLICANT(S) Bioptigen, Inc. (Morrisville, North Carolina)
ASSIGNEE(S) Bioptigen, Inc. (Morrisville, North Carolina)
INVENTOR(S) Robert H. Hart (Cary, North Carolina);  Eric L. Buckland (Hickory, North Carolina);  Glenn A. Myers (Durham, North Carolina);  Joseph A. Izatt (Raleigh, North Carolina);  Joseph Elliott Vance (Durham, North Carolina)
ABSTRACT OCT imaging systems are provided for imaging a spherical-type eye including a source having an associated source arm path and a reference arm having an associated reference arm path coupled to the source path. The reference arm path has an associated reference arm path length. A sample is also provided having an associated sample arm path coupled to the source arm and reference arm paths. A lens having a focal power optimized for a diameter of the spherical-type eye is provided along with a reference arm path length adjustment module coupled to the reference arm. The reference arm path length adjustment module is configured to automatically adjust the reference arm path length such that the reference arm path length is based on an eye diameter of the subject.
FILED Monday, November 13, 2017
APPL NO 15/810939
ART UNIT 2872 — Optics
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 3/102 (20130101) Original (OR) Class
A61B 5/0066 (20130101)
A61B 5/0073 (20130101)

Optical Elements, Systems, or Apparatus
G02B 26/105 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10092181 Yang et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Eye Institute (NEI)
APPLICANT(S) Qiang Yang (Rochester, New York);  Ethan Andrew Rossi (Rochester, New York)
ASSIGNEE(S) University of Rochester (Rochester, New York)
INVENTOR(S) Qiang Yang (Rochester, New York);  Ethan Andrew Rossi (Rochester, New York)
ABSTRACT Methods and apparatus for imaging multiple retinal structures and montaging of multiple retinal images are provided. The method involves cross-correlating images from different imaging channels to compensate for intra-frame distortion due to retinal movement during image acquisition, and conducting a second cross-correlation to filter out any motion artifacts in the images. The resultant images are combined to generate a composite image. The method also involves controlling light directed on the retina spatially and temporally.
FILED Tuesday, April 12, 2016
APPL NO 15/097040
ART UNIT 2872 — Optics
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 3/12 (20130101) Original (OR) Class
A61B 3/13 (20130101)
A61B 3/14 (20130101)
A61B 3/0025 (20130101)
A61B 3/0058 (20130101)
A61B 3/1015 (20130101)
A61B 3/1025 (20130101)

Optical Elements, Systems, or Apparatus
G02B 27/0031 (20130101)
G02B 27/0068 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10092196 Narayan et al.
FUNDED BY
Department of Veterans Affairs (DVA)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (Oakland, California)
ASSIGNEE(S) The Regents of the University of California (Oakland, California);  The United States of America as Represented by the Department of Veterans Affairs (Washington, District of Columbia)
INVENTOR(S) Sanjiv M. Narayan (La Jolla, California);  Wouter-Jan Rappel (San Diego, California)
ABSTRACT A method of analyzing a complex rhythm disorder in a human heart includes accessing signals from a plurality of sensors disposed spatially in relation to the heart, where the signals are associated with activations of the heart, and identifying a region of the heart having an activation trail that is rotational or radially emanating, where the activation trail is indicative of the complex rhythm disorder and is based on activation times associated with the activations of the heart.
FILED Friday, September 09, 2016
APPL NO 15/261013
ART UNIT 3762 — Refrigeration, Vaporization, Ventilation, and Combustion
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/02 (20130101)
A61B 5/04 (20130101)
A61B 5/042 (20130101)
A61B 5/044 (20130101)
A61B 5/046 (20130101)
A61B 5/0245 (20130101)
A61B 5/0402 (20130101)
A61B 5/0422 (20130101)
A61B 5/0452 (20130101)
A61B 5/0464 (20130101)
A61B 5/726 (20130101)
A61B 5/02405 (20130101) Original (OR) Class
A61B 5/02416 (20130101)
A61B 5/04007 (20130101)
A61B 5/04011 (20130101)
A61B 5/04012 (20130101)
A61B 5/04525 (20130101)
A61B 5/4836 (20130101)
A61B 5/6857 (20130101)
A61B 5/6858 (20130101)
A61B 5/6859 (20130101)
A61B 5/7203 (20130101)
A61B 5/7405 (20130101)
A61B 7/04 (20130101)
A61B 8/0883 (20130101)
A61B 18/1206 (20130101)
A61B 18/1492 (20130101)
A61B 2018/00214 (20130101)
A61B 2018/00351 (20130101)
A61B 2018/00357 (20130101)
A61B 2018/00375 (20130101)
A61B 2018/00839 (20130101)
A61B 2018/1435 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10092199 Heberlein et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Center for Research Resources (NCRR)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
National Institute of Child Health and Human Development (NICHD)
National Institute on Drug Abuse (NIDA)
National Institute of Mental Health (NIMH)
APPLICANT(S) Siemens Healthcare GmbH (Erlangen OT, Germany);  The General Hospital Corporation (Boston, Massachusetts)
ASSIGNEE(S) Siemens Healthcare GmbH (Erlangen, Germany);  The General Hospital Corporation (Boston, Massachusetts)
INVENTOR(S) Keith Aaron Heberlein (Charlestown, Massachusetts);  Himanshu Bhat (Cambridge, Massachusetts);  Matthew Dylan Tisdell (Somerville, Massachusetts);  Andre Jan Willem Van Der Kouwe (Woburn, Massachusetts)
ABSTRACT A magnetic resonance method and system are provided for generating real-time motion-corrected perfusion images based on pulsed arterial spin labeling (PASL) with a readout sequence such as a 3D gradient and spin echo (GRASE) image data acquisition block. The real-time motion correction is achieved by using a volumetric 3D EPI navigator that is provided during an intrinsic delay in the PASL sequence, which corrects for motion prospectively and does not extend the image data acquisition time as compared to a similar non-motion-corrected imaging procedure.
FILED Wednesday, April 01, 2015
APPL NO 14/676011
ART UNIT 2867 — Printing/Measuring and Testing
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/055 (20130101)
A61B 5/0263 (20130101) Original (OR) Class
A61B 5/7207 (20130101)

Measuring Electric Variables; Measuring Magnetic Variables
G01R 33/5616 (20130101)
G01R 33/5618 (20130101)
G01R 33/5676 (20130101)
G01R 33/56366 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10092205 Contreras-Vidal et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
APPLICANT(S) Jose L. Contreras-Vidal (Houston, Texas);  Saurabh Prasad (Houston, Texas);  Atilla Kilicarslan (Houston, Texas);  Nikunj Bhagat (Houston, Texas)
ASSIGNEE(S) UNIVERSITY OF HOUSTON SYSTEM (Houston, Texas)
INVENTOR(S) Jose L. Contreras-Vidal (Houston, Texas);  Saurabh Prasad (Houston, Texas);  Atilla Kilicarslan (Houston, Texas);  Nikunj Bhagat (Houston, Texas)
ABSTRACT Brain-Machine Interface (BMI) systems or movement-assist systems may be utilized to aid users with paraplegia or tetraplegia in ambulation or other movement or in rehabilitation of motor function after brain injury or neurological disease, such as stroke, Parkinson's disease or cerebral palsy. The BMI may translate one or more neural signals into a movement type, a discrete movement or gesture or a series of movements, performed by an actuator. System and methods of decoding a locomotion-impaired and/or an upper-arm impaired subject's intent with the BMI may utilize non-invasive methods to provide the subject the ability to make the desired motion using an actuator or command a virtual avatar.
FILED Thursday, July 03, 2014
APPL NO 14/323320
ART UNIT 3735 — Sheet Container Making, Package Making, Receptacles, Shoes, Apparel, and Tool Driving or Impacting
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/0476 (20130101) Original (OR) Class
A61B 5/4851 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10092508 Gower et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) UNIVERSITY OF SOUTH CAROLINA (Columbia, South Carolina)
ASSIGNEE(S) University of South Carolina (Columbia, South Carolina)
INVENTOR(S) Robert Gower (Columbia, South Carolina);  Michael Hendley (Columbia, South Carolina)
ABSTRACT Implantable devices including a biocompatible matrix configured for long term location in adipose tissue and a biologically active agent that can be carried by the matrix and delivered to the adipose tissue following implant therein. The biologically active agent can include a modulator or a precursor thereof that can directly or indirectly modify the gene expression of adipose cells, e.g., adipocytes, and thereby modify the presence or quantity of one or more expression products of the adipose tissue that may act locally on distant from the implant site in an endocrine fashion. Modulators can include small molecules (e.g., resveratrol), polynucleotides (e.g., RNAi), or polypeptides (e.g., antibodies or functional fragments thereof).
FILED Tuesday, June 27, 2017
APPL NO 15/634093
ART UNIT 1625 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/0024 (20130101) Original (OR) Class
A61K 9/5031 (20130101)
A61K 31/05 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10092509 Maisel et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) The Johns Hopkins University (Baltimore, Maryland)
ASSIGNEE(S) The Johns Hopkins University (Baltimore, Maryland)
INVENTOR(S) Katharina Maisel (Troy, Michigan);  Craig W. Hendrix (Ellicott City, Maryland);  Laura Ensign (Towson, Maryland);  Edward Fuchs (Westminster, Maryland);  Richard Cone (Baltimore, Maryland);  Justin Hanes (Baltimore, Maryland)
ABSTRACT Hypotonic microbicidal compositions including an antimicrobial, such as an antiviral compound, and a pharmaceutically acceptable carrier in a solution formulation having hypotonic osmolarity have been developed for administration rectally to the gastrointestinal mucosa. In a preferred embodiment for use in preventing or decreasing HIV infection, the microbiocidal is tenofovir, or a prodrug or derivative thereof. The formulations may include additional agents such as surfactants to enhance cleansing, buffers, or preservatives. Polymers may be included for osmolarity as well as comfort.
FILED Thursday, August 27, 2015
APPL NO 15/120852
ART UNIT 1655 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/0031 (20130101) Original (OR) Class
A61K 31/52 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10092515 Tam et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) Vincent Tam (Bellaire, Texas);  Diana Chow (Houston, Texas);  Jie Gohlke (Houston, Texas)
ASSIGNEE(S) University of Houston System (Houston, Texas)
INVENTOR(S) Vincent Tam (Bellaire, Texas);  Diana Chow (Houston, Texas);  Jie Gohlke (Houston, Texas)
ABSTRACT The present invention provides an intravenous liposomal formulation of a low dose polymyxin B or a pharmaceutical composition thereof. The present invention also provides methods utilizing the intravenous liposomal formulation or its pharmaceutical composition for increasing the therapeutic efficacy during treatment of a bacterial infection in a subject, for decreasing exposure of renal tissue to the polymyxin B during a course of polymyxin B treatment and for lowering exposure to polymyxin B in renal tissues in a subject receiving polymyxin B treatment.
FILED Monday, November 20, 2017
APPL NO 15/817800
ART UNIT 1612 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/0019 (20130101)
A61K 9/127 (20130101) Original (OR) Class
A61K 38/12 (20130101)
A61K 47/24 (20130101)
A61K 47/28 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10092526 Chen et al.
FUNDED BY
Department of Veterans Affairs (DVA)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) University of Pittsburgh Of the Commonwealth System of Higher Education (Pittsburgh, Pennsylvania);  The United States of America as represented by the Department of Veterans Affairs (Washington, District of Columbia)
ASSIGNEE(S) University of Pittsburgh Of the Commonwealth System of Higher Education (Pittsburgh, Pennsylvania);  The United States of America as represented by the Department of Veterans Affairs (Washington, District of Columbia)
INVENTOR(S) Beibei Chen (Wexford, Pennsylvania);  Rama Mallampalli (Sewickley, Pennsylvania)
ABSTRACT A method for treating a respiratory injury or disease comprising: administering to a patient in need of treatment a pharmaceutical composition comprising a compound of general Formula I: or salt, ester, solvate, hydrate, or prodrug thereof; wherein: x is an integer from 1 to 10; A and B are each, independently, C3-7cycloalkyl, C3-7cycloalkyl-C1-6alkyl, C3-7heterocycloalkyl, C3-7heterocycloalkyl-C1-6alkyl, C6-10aryl, C6-10aryl-C1-6alkyl, C3-9heteroaryl, or C3-9heteroaryl-C1-6alkyl; and n and p are each, independently, integers from 1 to 10; and a pharmaceutically acceptable carrier, excipient, or diluent.
FILED Friday, November 17, 2017
APPL NO 15/816963
ART UNIT 1629 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/007 (20130101)
A61K 31/137 (20130101) Original (OR) Class
A61K 31/341 (20130101)
A61K 31/381 (20130101)
A61K 31/427 (20130101)
A61K 31/444 (20130101)
A61K 31/506 (20130101)
A61K 31/4025 (20130101)
A61K 31/4155 (20130101)
A61K 31/4178 (20130101)
A61K 31/4545 (20130101)
A61K 31/5377 (20130101)
A61K 45/06 (20130101)

Acyclic or Carbocyclic Compounds
C07C 211/27 (20130101)

Heterocyclic Compounds
C07D 295/135 (20130101)
C07D 401/12 (20130101)
C07D 403/12 (20130101)
C07D 407/12 (20130101)
C07D 409/12 (20130101)
C07D 417/12 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10092543 Zhang et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) Indiana University Research and Technology Corporation (Indianapolis, Indiana);  Beth Israel Deaconess Medical Center, Inc. (Boston, Massachusetts)
ASSIGNEE(S) Indiana University Research and Technology Corporation (Indianapolis, Indiana)
INVENTOR(S) Zhong-Yin Zhang (Carmel, Indiana);  Maria Kontaridis (Auburndale, Massachusetts);  Li-Fan Zeng (Indianapolis, Indiana);  Jianxun Wang (Cambridge, Massachusetts)
ABSTRACT Methods are disclosed herein for administering a oncogenic Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2) inhibitor for treating autoimmune and/or glomerulonephritis-associated diseases, and in particular, Systemic Lupus Erythematosus (SLE).
FILED Wednesday, November 15, 2017
APPL NO 15/813729
ART UNIT 1621 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/404 (20130101) Original (OR) Class
A61K 31/427 (20130101)
A61K 31/428 (20130101)
A61K 31/433 (20130101)
A61K 31/4025 (20130101)
A61K 31/4178 (20130101)
A61K 31/4184 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10092591 Drew et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
APPLICANT(S) University of Alaska Fairbanks (Fairbanks, Alaska)
ASSIGNEE(S) University of Alaska Fairbanks (Fairbanks, Alaska)
INVENTOR(S) Kelly Drew (Fairbanks, Alaska);  Tulasi Jinka (Ann Arbor, Michigan);  Lori Bogren (North Pole, Alaska);  Isaac Bailey (Fairbanks, Alaska);  Zachary Carlson (Fairbanks, Alaska);  Jasmine Olson (Shoreline, Washington)
ABSTRACT Disclosed are compositions and methods for inducing therapeutic hypothermia in a subject.
FILED Thursday, February 27, 2014
APPL NO 14/191515
ART UNIT 1649 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/00 (20130101)
A61K 31/166 (20130101)
A61K 31/366 (20130101)
A61K 31/522 (20130101)
A61K 31/661 (20130101)
A61K 31/4439 (20130101)
A61K 31/7076 (20130101) Original (OR) Class
A61K 38/57 (20130101)
A61K 45/06 (20130101)

Heterocyclic Compounds
C07D 473/06 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10092596 Baumler et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (Oakland, California)
ASSIGNEE(S) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (Oakland, California)
INVENTOR(S) Andreas J. Baumler (Davis, California);  Sebastian E. Winter (Dallas, Texas)
ABSTRACT The present invention provides compositions of therapeutic agents and methods of use for reducing and/or treating gastrointestinal inflammation. In particular aspects, the tungstate salts described herein and pharmaceutical compositions thereof inhibit the activity of one or a plurality of anaerobic respiratory enzymes in facultative anaerobic bacteria such as, for example, Enterobacteriaceae, that can exacerbate inflammation. In particular embodiments, the present invention provides compositions of therapeutic agents for treating gastrointestinal inflammation, as well as methods for treating or preventing gut microbial imbalance due to an increase in the abundance of intestinal Enterobacteriaceae.
FILED Wednesday, December 09, 2015
APPL NO 14/964487
ART UNIT 1617 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 33/24 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10092620 Ghadiri et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) THE SCRIPPS RESEARCH INSTITUTE (La Jolla, California)
ASSIGNEE(S) The Scripps Research Institute (La Jolla, California)
INVENTOR(S) M. Reza Ghadiri (San Diego, California);  Luke J. Leman (Encinitas, California);  Yannan Zhao (La Jolla, California);  Bruce E. Maryanoff (Holicong, Pennsylvania)
ABSTRACT The present invention provides cyclic compounds that are useful in preventing or treating atherosclerosis or related disorders. The invention also provides therapeutic methods for treating or preventing various diseases or disorders associated with or mediated by atherosclerosis. Further provided in the invention are methods of screening for anti-atherosclerotic cyclic peptides with improved properties.
FILED Wednesday, April 02, 2014
APPL NO 14/781859
ART UNIT 1675 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/12 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10092623 Polk et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
APPLICANT(S) Vanderbilt University (Nashville, Tennessee)
ASSIGNEE(S) VANDERBILT UNIVERSITY (Nashville, Tennessee)
INVENTOR(S) D. Brent Polk (Los Angeles, California);  Fang Yan (Franklin, Tennessee)
ABSTRACT The present invention provides therapeutic and prophylactic compositions for use in treating and preventing disorders involved epithelial cell apoptosis, such as gastrointestinal disorders (e.g., inflammatory bowel disease, Crohn's disease or ulcerative colitis) in a subject, such as a human patient.
FILED Friday, May 26, 2017
APPL NO 15/606699
ART UNIT 1645 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/00 (20130101)
A61K 38/164 (20130101) Original (OR) Class

Peptides
C07K 14/195 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10092624 Gourdie et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
National Institute of Dental and Craniofacial Research (NIDCR)
APPLICANT(S) MUSC FOUNDATION FOR RESEARCH DEVELOPMENT (Charleston, South Carolina);  UNIVERSITY OF SOUTH CAROLINA (Columbia, South Carolina)
ASSIGNEE(S) MUSC Foundation for Research Development (Charleston, South Carolina);  University of South Carolina (Columbia, South Carolina)
INVENTOR(S) Robert G. Gourdie (Roanoke, Virginia);  Edie C. Goldsmith (Columbia, South Carolina);  L. Jane Jourdan (Roanoke, Virginia);  Joshua Matthew Rhett (Charleston, South Carolina);  Michael J. Yost (Charleston, South Carolina)
ABSTRACT Provided are peptides that can inhibit collagen synthesis, processing and/or secretion. In some aspects, the therapeutic peptides may be used to treat a cancer such as, e.g., a pancreatic cancer or a glioblastoma.
FILED Friday, April 22, 2016
APPL NO 15/135780
ART UNIT 1611 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/0048 (20130101)
A61K 38/00 (20130101)
A61K 38/08 (20130101)
A61K 38/10 (20130101)
A61K 38/1703 (20130101) Original (OR) Class
A61K 45/06 (20130101)
A61K 47/10 (20130101)

Methods or Apparatus for Sterilising Materials or Objects in General; Disinfection, Sterilisation, or Deodorisation of Air; Chemical Aspects of Bandages, Dressings, Absorbent Pads, or Surgical Articles; Materials for Bandages, Dressings, Absorbent Pads, or Surgical Articles
A61L 15/32 (20130101)
A61L 15/44 (20130101)
A61L 17/005 (20130101)
A61L 27/22 (20130101)
A61L 27/34 (20130101)
A61L 27/34 (20130101)
A61L 27/54 (20130101)
A61L 31/10 (20130101)
A61L 31/10 (20130101)
A61L 31/16 (20130101)
A61L 31/047 (20130101)
A61L 2300/25 (20130101)
A61L 2300/252 (20130101)
A61L 2300/412 (20130101)
A61L 2430/16 (20130101)

Peptides
C07K 7/06 (20130101)
C07K 7/08 (20130101)
C07K 14/46 (20130101)
C07K 14/47 (20130101)
C07K 14/4703 (20130101)
C07K 2319/035 (20130101)

Compositions of Macromolecular Compounds
C08L 77/04 (20130101)
C08L 77/04 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10092626 Fikrig et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) Yale University (New Haven, Connecticut)
ASSIGNEE(S) Yale University (New Haven, Connecticut);  Howard Hughes Medical Institute (Chevy Chase, Maryland)
INVENTOR(S) Erol Fikrig (Guilford, Connecticut);  Martin Heisig (Marburg, Germany);  Nabil Abraham (New Haven, Connecticut);  Girish Neelakanta (Norfolk, Virginia)
ABSTRACT As microbial drug-resistance increases, there is a critical need for new classes of compounds to combat infectious diseases. The Ixodes scapularis tick antifreeze glycoprotein, IAFGP, functions as an anti-infective agent against diverse bacteria including methicillin-resistant Staphylococcus aureus. Recombinant IAFGP and a peptide, PI, described herein and derived from this protein, bind to microbes and alter biofilm formation. Transgenic iafgp-expressing flies and mice challenged with bacteria, as well as wild-type animals administered IAFGP or PI, were resistant to infection, septic shock, or biofilm development on implanted biomaterials. Antifreeze protein controls bacterial infection and present new therapeutic strategies to counter pathogens.
FILED Wednesday, December 17, 2014
APPL NO 15/104719
ART UNIT 1675 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/51 (20130101)
A61K 31/43 (20130101)
A61K 31/43 (20130101)
A61K 31/7036 (20130101)
A61K 31/7036 (20130101)
A61K 31/7048 (20130101)
A61K 31/7048 (20130101)
A61K 38/14 (20130101)
A61K 38/14 (20130101)
A61K 38/1767 (20130101) Original (OR) Class
A61K 38/1767 (20130101)
A61K 45/06 (20130101)
A61K 2300/00 (20130101)
A61K 2300/00 (20130101)
A61K 2300/00 (20130101)
A61K 2300/00 (20130101)
A61K 2300/00 (20130101)

Methods or Apparatus for Sterilising Materials or Objects in General; Disinfection, Sterilisation, or Deodorisation of Air; Chemical Aspects of Bandages, Dressings, Absorbent Pads, or Surgical Articles; Materials for Bandages, Dressings, Absorbent Pads, or Surgical Articles
A61L 2/18 (20130101)
A61L 15/32 (20130101)
A61L 15/44 (20130101)
A61L 27/34 (20130101)
A61L 27/54 (20130101)
A61L 29/16 (20130101)
A61L 29/085 (20130101)
A61L 31/10 (20130101)
A61L 31/16 (20130101)
A61L 2202/24 (20130101)
A61L 2300/404 (20130101)
A61L 2300/606 (20130101)
A61L 2420/02 (20130101)

Compositions of Macromolecular Compounds
C08L 89/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10092627 Wagers et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
National Institute on Aging (NIA)
APPLICANT(S) President and Fellows of Harvard College (Cambridge, Massachusetts);  THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (Boston, Massachusetts)
ASSIGNEE(S) President and Fellows of Harvard College (Cambridge, Massachusetts);  The Brigham and Womens's Hospital, Inc. (Boston, Massachusetts)
INVENTOR(S) Amy J. Wagers (Cambridge, Massachusetts);  Richard T. Lee (Weston, Massachusetts)
ABSTRACT Methods and compositions for rejuvenating skeletal muscle stem cells are disclosed.
FILED Tuesday, April 08, 2014
APPL NO 14/783426
ART UNIT 1676 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/1875 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10092628 Ikeda et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) Mayo Foundation for Medical Education and Research (Rochester, Minnesota)
ASSIGNEE(S) Mayo Foundation for Medical Education and Research (Rochester, Minnesota)
INVENTOR(S) Yasuhiro Ikeda (Rochester, Minnesota);  Stephen James Russell (Rochester, Minnesota);  Alessandro Cataliotti (Rochester, Minnesota);  John C. Burnett, Jr. (Rochester, Minnesota);  Jason M. Tonne (Rochester, Minnesota)
ABSTRACT This document provides methods and materials for treating cardiovascular and/or renal diseases. For example, AAV9 vectors designed to express natriuretic polypeptides, nucleic acid molecules encoding natriuretic polypeptides, methods for making AAV9 vectors, and methods for using such vectors or molecules to treat cardiovascular and/or renal diseases are provided.
FILED Monday, April 30, 2018
APPL NO 15/966288
ART UNIT 1636 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/2242 (20130101) Original (OR) Class

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 7/00 (20130101)
C12N 2750/14143 (20130101)
C12N 2750/14171 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10092632 Lodge et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) Washington University (Saint Louis, Missouri)
ASSIGNEE(S) Washington University (Saint Louis, Missouri)
INVENTOR(S) Jennifer Lodge (Saint Louis, Missouri);  Woei Lam (Saint Louis, Missouri);  Rajendra Upadhya (Saint Louis, Missouri)
ABSTRACT Vaccines and methods of inoculation for conferring immunity to Cryptococcus infection are disclosed. Strains of Cryptococcus fungi, including Cryptococcus neoformans and Cryptococcus gattii, can be administered to a human or animal subject via inhalation. Cryptococcus fungi that can be used to confer immunity can comprise one or more mutations in genes that contribute to chitosan production, such as genes encoding a chitin deacetylase (cda), a chitin synthase (chs) and/or a regulator of chitin synthase (csr). Inhalation administration of heat-killed Cryptococcus harboring deletions in cda1, cda2 and cda3 genes can confer immunity. In a murine model system, inhalation administration of Cryptococcus neoformans harboring deletions in cda1, cda2 and cda3 genes conferred immunity against subsequent exposure to wild type Cryptococcus neoformans in 100% of test animals. Inhalation administration of heat-killed Cryptococcus grown under conditions leading to reduced chitosan production can also confer immunity.
FILED Thursday, May 14, 2015
APPL NO 14/712567
ART UNIT 1645 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/08 (20130101)
A61K 9/0043 (20130101)
A61K 9/0073 (20130101)
A61K 39/0002 (20130101) Original (OR) Class
A61K 2039/543 (20130101)
A61K 2039/544 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10092637 Chang et al.
FUNDED BY
Department of Health and Human Services (HHS)
APPLICANT(S) The United States of America as rep. by the Secretary of the Department of Health and Human Services (Washington, District of Columbia)
ASSIGNEE(S) The United States of America as represented by the Secretary of the Department of Health and Human Services (Washington, District of Columbia)
INVENTOR(S) Gwong-Jen J. Chang (Fort Collins, Colorado);  Wayne D. Crill (Fort Collins, Colorado);  Holly R. Hughes (Fort Collins, Colorado);  Brent S. Davis (Fort Collins, Colorado)
ABSTRACT Described herein are dengue virus E-glycoprotein polypeptides containing mutations that eliminate immunodominant cross-reactive epitopes associated with immune enhancement. The disclosed dengue virus E-glycoproteins optionally further include mutations that introduce a strong CD4 T cell epitope. The disclosed E-glycoprotein polypeptides, or nucleic acid molecules encoding the polypeptides, can be used, for example, in monovalent or tetravalent vaccines against dengue virus.
FILED Monday, September 12, 2016
APPL NO 15/262268
ART UNIT 1648 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 39/12 (20130101) Original (OR) Class
A61K 2039/53 (20130101)
A61K 2039/57 (20130101)
A61K 2039/70 (20130101)
A61K 2039/575 (20130101)
A61K 2039/5258 (20130101)
A61K 2039/6031 (20130101)
A61K 2039/6075 (20130101)

Peptides
C07K 14/005 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 7/00 (20130101)
C12N 2770/24122 (20130101)
C12N 2770/24123 (20130101)
C12N 2770/24134 (20130101)
C12N 2770/24151 (20130101)
C12N 2770/24171 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10092654 Alsberg et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Institute of Dental and Craniofacial Research (NIDCR)
APPLICANT(S) Case Western Reserve University (Cleveland, Ohio)
ASSIGNEE(S) Case Western Reserve University (Cleveland, Ohio)
INVENTOR(S) Eben Alsberg (Cleveland, Ohio);  Oju Jeon (Cleveland, Ohio);  David Wolfson (Cleveland, Ohio)
ABSTRACT A composition includes a plurality of coacervate micro and/or nanodroplets of oxidized alginate and a methacrylated gelatin.
FILED Thursday, July 09, 2015
APPL NO 14/795569
ART UNIT 1653 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/00 (20130101)
A61K 31/727 (20130101)
A61K 35/28 (20130101)
A61K 38/1875 (20130101)
A61K 47/00 (20130101)
A61K 47/36 (20130101) Original (OR) Class
A61K 47/42 (20130101)

Methods or Apparatus for Sterilising Materials or Objects in General; Disinfection, Sterilisation, or Deodorisation of Air; Chemical Aspects of Bandages, Dressings, Absorbent Pads, or Surgical Articles; Materials for Bandages, Dressings, Absorbent Pads, or Surgical Articles
A61L 27/26 (20130101)
A61L 27/26 (20130101)
A61L 27/26 (20130101)
A61L 27/38 (20130101)
A61L 27/52 (20130101)
A61L 27/54 (20130101)
A61L 27/3834 (20130101)
A61L 2300/414 (20130101)
A61L 2430/02 (20130101)

Compositions of Macromolecular Compounds
C08L 5/04 (20130101)
C08L 89/06 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 5/0662 (20130101)
C12N 2533/54 (20130101)
C12N 2533/74 (20130101)
C12N 2537/00 (20130101)
C12N 2537/10 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10092662 Wang et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
APPLICANT(S) Dong Wang (Omaha, Nebraska);  Jindrich Kopecek (Salt Lake City, Utah);  Scott C. Miller (Salt Lake City, Utah);  Pavla Kopeckova (Salt Lake City, Utah)
ASSIGNEE(S) University of Utah Research Foundation (Salt Lake City, Utah)
INVENTOR(S) Dong Wang (Omaha, Nebraska);  Jindrich Kopecek (Salt Lake City, Utah);  Scott C. Miller (Salt Lake City, Utah);  Pavla Kopeckova (Salt Lake City, Utah)
ABSTRACT This invention relates to biotechnology, more particularly, to water-soluble polymeric delivery systems for the imaging, evaluation and/or treatment of rheumatoid arthritis and other inflammatory diseases. Using modern MR imaging techniques, the specific accumulation of macromolecules in arthritic joints in adjuvant-induced arthritis in rats is demonstrated. The strong correlation between the uptake and retention of the MR contrast agent labeled polymer with histopathological features of inflammation and local tissue damage demonstrates the practical applications of the macromolecular delivery system of the invention.
FILED Wednesday, March 30, 2005
APPL NO 10/591258
ART UNIT 1619 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 47/58 (20170801)
A61K 49/0041 (20130101)
A61K 49/0054 (20130101) Original (OR) Class
A61K 49/128 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10093557 Messersmith et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Dental and Craniofacial Research (NIDCR)
APPLICANT(S) Northwestern University (Evanston, Illinois)
ASSIGNEE(S) NORTHWESTERN UNIVERSITY (Evanston, Illinois)
INVENTOR(S) Phillip B. Messersmith (Clarendon Hills, Illinois);  Haeshin Lee (Daejeon, South Korea)
ABSTRACT A bio-inspired method for detoxifying contaminated water is disclosed. In the method, polydopamine, a mussel-inspired adhesive catecholamine was used as an adsorbent to effectively remove from contaminated water three major classes of toxic agents: heavy metal ions (e.g., Cr, Hg, Pb, Cu, and Cd), toxic organic species (e.g., 4-aminopyridine), and radioisotopes (e.g., Lutetium-177). Furthermore, the polydopamine adsorbent was regenerated by treatment with acid or hydrogen peroxide.
FILED Monday, April 04, 2016
APPL NO 15/090222
ART UNIT 1773 — Chemical Apparatus, Separation and Purification, Liquid and Gas Contact Apparatus
CURRENT CPC
Chemical or Physical Processes, e.g Catalysis or Colloid Chemistry; Their Relevant Apparatus
B01J 20/262 (20130101)
B01J 20/345 (20130101)
B01J 20/3204 (20130101)
B01J 20/3206 (20130101)
B01J 20/3208 (20130101)
B01J 20/3272 (20130101)
B01J 20/3293 (20130101)
B01J 20/3475 (20130101)
B01J 20/28016 (20130101)
B01J 20/28019 (20130101)

Treatment of Water, Waste Water, Sewage, or Sludge
C02F 1/285 (20130101)
C02F 1/286 (20130101)
C02F 1/288 (20130101) Original (OR) Class
C02F 2101/006 (20130101)
C02F 2101/20 (20130101)
C02F 2101/22 (20130101)
C02F 2101/30 (20130101)
C02F 2101/38 (20130101)
C02F 2303/16 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10093609 Davies et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Emory University (Atlanta, Georgia)
ASSIGNEE(S) Emory University (Atlanta, Georgia)
INVENTOR(S) Huw M. L. Davies (Duluth, Georgia);  Spandan Chennamadhavuni (Natick, Massachusetts);  Andrei Bakin (Buffalo, New York)
ABSTRACT The disclosure relates to TAK1 inhibitors, compositions, and uses related thereto. In certain embodiments, the disclosure relates to compounds of formula I, pharmaceutical compositions having a compound of formula I, and methods of treating or preventing cancer by administering an effective amount of a pharmaceutical composition having a compound of formula I to a subject in need thereof.
FILED Monday, September 04, 2017
APPL NO 15/694982
ART UNIT 1626 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/36 (20130101)
A61K 31/194 (20130101)
A61K 31/216 (20130101)
A61K 31/343 (20130101)
A61K 31/357 (20130101)
A61K 31/405 (20130101)

Acyclic or Carbocyclic Compounds
C07C 51/00 (20130101)
C07C 57/42 (20130101)
C07C 67/31 (20130101)
C07C 69/65 (20130101)
C07C 69/73 (20130101) Original (OR) Class
C07C 69/604 (20130101)
C07C 69/618 (20130101)
C07C 69/732 (20130101)
C07C 69/734 (20130101)
C07C 69/736 (20130101)
C07C 69/738 (20130101)
C07C 201/12 (20130101)
C07C 205/56 (20130101)
C07C 259/06 (20130101)

Heterocyclic Compounds
C07D 209/24 (20130101)
C07D 209/26 (20130101)
C07D 209/34 (20130101)
C07D 307/79 (20130101)
C07D 307/80 (20130101)
C07D 317/60 (20130101)
C07D 317/68 (20130101)
C07D 319/18 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10093640 Lee et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) VANDERBILT UNIVERSITY (Nashville, Tennessee)
ASSIGNEE(S) Vanderbilt University (Nashville, Tennessee)
INVENTOR(S) Taekyu Lee (Brentwood, Tennessee);  Nicholas F. Pelz (Nashville, Tennessee);  Johannes Belmar (Nashville, Tennessee);  Zhiguo Bian (Nashville, Tennessee);  Edward T. Olejniczak (Nashville, Tennessee);  Stephen W. Fesik (Nashville, Tennessee);  Brian A. Chauder (Smyrna, Tennessee)
ABSTRACT The present invention provides for compounds that inhibit the activity of an anti-apoptotic Bcl-2 family member Myeloid cell leukemia-1 (Mcl-1) protein. The present invention also provides for pharmaceutical compositions as well as methods for using compounds for treatment of diseases and conditions (e.g., cancer) characterized by the over-expression or dysregulation of Mcl-1 protein.
FILED Friday, September 20, 2013
APPL NO 14/429799
ART UNIT 1626 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/343 (20130101)
A61K 31/381 (20130101)
A61K 31/404 (20130101)
A61K 31/422 (20130101)
A61K 31/496 (20130101)
A61K 31/4155 (20130101)
A61K 31/4439 (20130101)
A61K 31/4709 (20130101)
A61K 31/5377 (20130101)
A61K 45/06 (20130101)

Heterocyclic Compounds
C07D 209/42 (20130101)
C07D 307/85 (20130101) Original (OR) Class
C07D 333/70 (20130101)
C07D 401/04 (20130101)
C07D 401/06 (20130101)
C07D 401/10 (20130101)
C07D 401/12 (20130101)
C07D 401/14 (20130101)
C07D 403/04 (20130101)
C07D 403/12 (20130101)
C07D 403/14 (20130101)
C07D 405/04 (20130101)
C07D 405/10 (20130101)
C07D 405/12 (20130101)
C07D 405/14 (20130101)
C07D 409/04 (20130101)
C07D 413/04 (20130101)
C07D 413/10 (20130101)
C07D 413/12 (20130101)
C07D 471/04 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10093674 Xu
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Materials Research (DMR)
APPLICANT(S) Brandeis University (Waltham, Massachusetts)
ASSIGNEE(S) Brandeis University (Waltham, Massachusetts)
INVENTOR(S) Bing Xu (Newton, Massachusetts)
ABSTRACT Disclosed are nucleopeptide compounds that include a nucleobase, and an amino acid. Certain compounds further comprise a glycoside. The compounds may self-assemble to form supramolecular hydrogels. Also, the compounds may be used as a platform to examine specific biological functions (e.g., binding to DNA and RNA) of a dynamic supramolecular system that is able to interact with both proteins and nucleic acids. Other uses include: methods of growing cells and methods of delivering a substance to a cell.
FILED Monday, December 02, 2013
APPL NO 14/093974
ART UNIT 1675 — Organic Chemistry
CURRENT CPC
Heterocyclic Compounds
C07D 239/54 (20130101)
C07D 473/18 (20130101)
C07D 473/34 (20130101) Original (OR) Class

Acyclic, Carbocyclic or Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium or Tellurium
C07F 9/65121 (20130101)
C07F 9/65616 (20130101)

Sugars; Derivatives Thereof; Nucleosides; Nucleotides; Nucleic Acids
C07H 13/04 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10093685 Burns et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) VenatoRx Pharmaceuticals, Inc. (Malvern, Pennsylvania)
ASSIGNEE(S) VENATORX PHARMACEUTICALS, INC. (Malvern, Pennsylvania)
INVENTOR(S) Christopher J. Burns (Malvern, Pennsylvania);  Denis Daigle (Street, Maryland);  Bin Liu (Plainsboro, New Jersey);  Daniel McGarry (Malvern, Pennsylvania);  Daniel C. Pevear (Downingtown, Pennsylvania);  Robert E. Lee Trout (Collegeville, Pennsylvania);  Randy W. Jackson (Livingston, Montana)
ABSTRACT Described herein are compounds and compositions that modulate the activity of beta-lactamases. In some embodiments, the compounds described herein inhibit beta-lactamase. In certain embodiments, the compounds described herein are useful in the treatment of bacterial infections.
FILED Friday, August 11, 2017
APPL NO 15/675262
ART UNIT 1625 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/69 (20130101)
A61K 31/407 (20130101)
A61K 31/496 (20130101)
A61K 31/546 (20130101)
A61K 45/06 (20130101)

Acyclic, Carbocyclic or Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium or Tellurium
C07F 5/025 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10093686 Gurney et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Mental Health (NIMH)
National Institute of Neurological Disorders and Stroke (NINDS)
APPLICANT(S) Tetra Discovery Partners, LLC (Grand Rapids, Michigan)
ASSIGNEE(S) Tetra Discovery Partners, LLC (Grand Rapids, Michigan)
INVENTOR(S) Mark E. Gurney (Grand Rapids, Michigan);  Timothy J. Hagen (Lisle, Illinois);  Xuesheng Mo (Naperville, Illinois);  A. Samuel Vellekoop (Altamont, New York);  Donna L. Romero (Chesterfield, Missouri);  Robert F. Campbell (Niskayuna, New York);  Joel R. Walker (Schenectady, New York);  Lei Zhu (Schenectady, New York)
ABSTRACT The present invention relates to compounds and methods useful as inhibitors of phosphodiesterase 4 (PDE4) for the treatment or prevention of inflammatory diseases and other diseases involving elevated levels of cytokines and proinflammatory mediators.
FILED Friday, August 18, 2017
APPL NO 15/680842
ART UNIT 1624 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/44 (20130101)
A61K 31/53 (20130101)
A61K 31/69 (20130101)
A61K 31/435 (20130101)
A61K 31/496 (20130101)
A61K 31/505 (20130101)
A61K 31/506 (20130101)
A61K 31/517 (20130101)
A61K 31/519 (20130101)
A61K 31/4418 (20130101)
A61K 31/5377 (20130101)
A61K 45/06 (20130101)

Heterocyclic Compounds
C07D 213/56 (20130101)
C07D 213/72 (20130101)
C07D 213/74 (20130101)
C07D 221/04 (20130101)
C07D 239/26 (20130101)
C07D 239/70 (20130101)
C07D 251/22 (20130101)
C07D 251/30 (20130101)
C07D 251/42 (20130101)
C07D 401/04 (20130101)
C07D 401/12 (20130101)
C07D 403/12 (20130101)
C07D 405/04 (20130101)
C07D 409/04 (20130101)
C07D 409/14 (20130101)
C07D 413/12 (20130101)
C07D 413/14 (20130101)
C07D 495/04 (20130101)

Acyclic, Carbocyclic or Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium or Tellurium
C07F 5/025 (20130101)
C07F 5/027 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10093700 Ly et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Chemistry (CHE)
APPLICANT(S) CARNEGIE MELLON UNIVERSITY (Pittsburgh, Pennsylvania)
ASSIGNEE(S) CARNEGIE MELLON UNIVERSITY (Pittsburgh, Pennsylvania)
INVENTOR(S) Danith H. Ly (Pittsburgh, Pennsylvania);  Srinivas Rapireddy (Pittsburgh, Pennsylvania);  Bichismita Sahu (Pittsburgh, Pennsylvania)
ABSTRACT The present invention relates to γ-PNA monomers according to Formula I where substituent groups R1, R2, R3, R4, R5, R6, B and P are defined as set forth in the specification. The invention also provides methodology for synthesizing compounds according to Formula I and methodology for synthesizing PNA oligomers that incorporate one or more Formula I monomers.
FILED Friday, October 23, 2015
APPL NO 14/921755
ART UNIT 1637 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 47/60 (20170801)

Acyclic or Carbocyclic Compounds
C07C 229/12 (20130101)
C07C 271/20 (20130101)

Heterocyclic Compounds
C07D 239/47 (20130101)
C07D 239/54 (20130101)
C07D 473/18 (20130101)
C07D 473/34 (20130101)

Peptides
C07K 1/04 (20130101)
C07K 1/08 (20130101)
C07K 14/003 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10093705 Spiegelman et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
APPLICANT(S) Bruce M. Spiegelman (Waban, Massachusetts);  Pontus Bostrom (Boston, Massachusetts)
ASSIGNEE(S) Dana-Farber Cancer Institute, Inc. (Boston, Massachusetts)
INVENTOR(S) Bruce M. Spiegelman (Waban, Massachusetts);  Pontus Bostrom (Boston, Massachusetts)
ABSTRACT The invention provides compositions and methods for brown fat induction and activity through modulation of Fndc5 activity and/or expression. Also provided are methods for preventing or treating metabolic disorders in a subject through modulation of Fndc5 activity and/or expression. Further provided are methods for identifying compounds that are capable of modulating Fndc5 activity and/or expression.
FILED Wednesday, September 12, 2012
APPL NO 14/344460
ART UNIT 1647 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Peptides
C07K 14/47 (20130101) Original (OR) Class
C07K 14/78 (20130101)
C07K 14/435 (20130101)
C07K 14/575 (20130101)
C07K 16/18 (20130101)
C07K 19/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10093706 Antony et al.
FUNDED BY
Department of Veterans Affairs (DVA)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
National Institute of Child Health and Human Development (NICHD)
APPLICANT(S) Indiana University Research and Technology Corporation (Indianapolis, Indiana)
ASSIGNEE(S) Indiana University Research and Technology Corporation (Indianapolis, Indiana)
INVENTOR(S) Asok C. Antony (Indianapolis, Indiana);  Ying-Sheng Tang (Zionsville, Indiana)
ABSTRACT Described herein are compositions relating to engineered hnRNP-E1 variant polypeptides, nucleic acids encoding such polypeptides, engineered hnRNP-E1 compositions, and methods of use thereof. In some embodiments, the engineered hnRNP-E1 polypeptide contains a C293S substitution and retains the ability to bind to a poly(rC)- and poly(U)-rich 5′-UTR element in its cognate mRNA targets in the absence of homocysteine. In some cases, the engineered hnRNP-E1 compositions provided herein are useful to increase the translation of a subset of mRNAs or to treat certain health conditions as described herein.
FILED Monday, January 30, 2017
APPL NO 15/419655
ART UNIT 1636 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/00 (20130101)

Peptides
C07K 14/47 (20130101) Original (OR) Class
C07K 2319/85 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 7/00 (20130101)
C12N 15/11 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10093710 Pavlakis et al.
FUNDED BY
Department of Health and Human Services (HHS)
APPLICANT(S) THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (Washington, District of Columbia)
ASSIGNEE(S) THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (Washington, District of Columbia)
INVENTOR(S) George N. Pavlakis (Rockville, Maryland);  Barbara K. Felber (Rockville, Maryland);  Antonio Valentin (Frederick, Maryland);  Cristina Bergamaschi (Frederick, Maryland)
ABSTRACT The present invention provides method for promoting the maturation and export of T cells from thymic tissue by contacting the thymic tissue with supraphysiological levels of interleukin (IL)-15. The present invention also provides methods for preventing, alleviating, reducing, and/or inhibiting lymphopenia or peripheral depletion of lymphocytes in a patient in need thereof by administering to the patient IL-15.
FILED Tuesday, April 11, 2017
APPL NO 15/485093
ART UNIT 1647 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/00 (20130101)

Peptides
C07K 14/5443 (20130101) Original (OR) Class
C07K 14/7155 (20130101)
C07K 2319/30 (20130101)
C07K 2319/70 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 5/06 (20130101)
C12N 15/09 (20130101)
C12N 15/62 (20130101)
C12N 15/1138 (20130101)

Fermentation or Enzyme-using Processes to Synthesise a Desired Chemical Compound or Composition or to Separate Optical Isomers From a Racemic Mixture
C12P 21/02 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10093720 Burton et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
U.S. Agency for International Development (USAID)
APPLICANT(S) International AIDS Vaccine Initiative (New York, New York);  The Scripps Research Institute (La Jolla, California);  Cornell University (Ithaca, New York)
ASSIGNEE(S) INTERNATIONAL AIDS VACCINE INITIATIVE (New York, New York);  THE SCRIPPS RESEARCH INSTITUTE (La Jolla, California);  CORNELL UNIVERSITY (Ithaca, New York)
INVENTOR(S) Dennis R. Burton (La Jolla, California);  Marit J. van Gils (La Jolla, California);  Wayne Koff (New York, New York);  Pascal R. G. Poignard (New York, New York);  Rogier W. Sanders (Ithaca, New York);  Melissa D. J. S. Simek-Lemos (New York, New York);  Devin Sok (La Jolla, California)
ABSTRACT The present invention relates to an exceptionally broad and potent neutralizing antibody which may comprise cross-clade neutralizing coverage of 83% at a median IC50 of 0.003 μg/ml, compositions containing the same and uses thereof.
FILED Friday, June 05, 2015
APPL NO 14/731621
ART UNIT 1648 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Peptides
C07K 16/1063 (20130101) Original (OR) Class
C07K 2317/21 (20130101)
C07K 2317/55 (20130101)
C07K 2317/76 (20130101)
C07K 2317/565 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10093737 Zang
FUNDED BY
Department of Defense (DOD)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
APPLICANT(S) ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY (Bronx, New York)
ASSIGNEE(S) Albert Einstein College of Medicine, Inc. (Bronx, New York)
INVENTOR(S) Xingxing Zang (New York, New York)
ABSTRACT Provided are methods of treating an autoimmune disease in a subject, or of suppressing transplant rejection in a subject, or of treating a cancer in a subject, as well as compositions therefor.
FILED Friday, February 07, 2014
APPL NO 14/770120
ART UNIT 1642 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Peptides
C07K 16/2827 (20130101) Original (OR) Class
C07K 2317/21 (20130101)
C07K 2317/24 (20130101)
C07K 2319/30 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10093746 Kaplan
FUNDED BY
Department of Veterans Affairs (DVA)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) THE TRUSTEES OF THE UNIVERSiTY OF PENNSYLVANIA (Philadelphia, Pennsylvania);  The United States of America as represented by the Department of Veterans Affairs (Washington, District of Columbia)
ASSIGNEE(S) The Trustees of the University of Pennsylvania (Philadelphia, Pennsylvania);  The United States of America as represented by the Department of Veterans Affairs (Washington, District of Columbia)
INVENTOR(S) David Kaplan (Media, Pennsylvania)
ABSTRACT The present invention relates to compositions and methods of isolated polynucleotides that encode or polypeptides comprising glypican-3 (GPC3). The invention also includes a chimeric antigen receptor (CAR) wherein the CAR is able to target GPC3. The invention further includes methods of treating a subject or diagnosing and treating diseases, disorders or conditions associated with dysregulated glypican-3.
FILED Thursday, September 03, 2015
APPL NO 15/508317
ART UNIT 1643 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 35/17 (20130101)
A61K 2035/124 (20130101)

Peptides
C07K 14/7051 (20130101)
C07K 16/303 (20130101) Original (OR) Class
C07K 2317/21 (20130101)
C07K 2317/24 (20130101)
C07K 2317/54 (20130101)
C07K 2317/55 (20130101)
C07K 2317/569 (20130101)
C07K 2317/622 (20130101)
C07K 2319/02 (20130101)
C07K 2319/03 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/57438 (20130101)
G01N 2333/705 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10093898 Zhang et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Mental Health (NIMH)
National Institute of Neurological Disorders and Stroke (NINDS)
APPLICANT(S) The Board of Trustees of the Leland Stanford Junior University (Stanford, California)
ASSIGNEE(S) The Board of Trustees of the Leland Stanford Junior University (Stanford, California)
INVENTOR(S) Ye Zhang (Menlo Park, California);  Steven Sloan (Palo Alto, California);  Ben A. Barres (Palo Alto, California)
ABSTRACT Compositions and methods are provided for the purification of astrocytes from biological samples or from in vitro cultures. An advantage of the methods of the invention is the ability to isolate astrocytes in a quiescent state, which allows analysis of the cells in a more natural state.
FILED Wednesday, May 18, 2016
APPL NO 15/158404
ART UNIT 1649 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 35/30 (20130101)
A61K 39/39541 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 5/0622 (20130101) Original (OR) Class
C12N 2501/50 (20130101)
C12N 2506/08 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10093901 Scott et al.
FUNDED BY
Department of Defense (DOD)
Uniformed Services University of the Health Sciences (USUHS)
Henry M Jackson Foundation for the Advancement of Military Medicine, Inc (HJF)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. (Bethesda, Maryland)
ASSIGNEE(S) THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. (Bethesda, Maryland)
INVENTOR(S) David W. Scott (Bethesda, Maryland);  Yong Chan Kim (Rockville, Maryland)
ABSTRACT The present invention generally relates to the production of antigen-specific T regulatory cells (Tregs). Such cells can be used in therapy to minimize undesirable immune responses such as those observed in autoimmunity and hemophilia and other diseases as well as in the response to protein therapy for genetic diseases. Methods for producing antigen specific Tregs and conditions for preferential expansion of functionally stable, specific Tregs are also provided.
FILED Friday, May 09, 2014
APPL NO 14/889962
ART UNIT 1644 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 35/17 (20130101)
A61K 39/0008 (20130101)
A61K 2039/57 (20130101)
A61K 2039/572 (20130101)
A61K 2039/5156 (20130101)
A61K 2039/5158 (20130101)

Peptides
C07K 14/7051 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 5/0637 (20130101) Original (OR) Class
C12N 2502/11 (20130101)
C12N 2510/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10093902 Corvera
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
APPLICANT(S) University of Massachusetts (Boston, Massachusetts)
ASSIGNEE(S) University of Massachusetts (Boston, Massachusetts)
INVENTOR(S) Silvia Corvera (Westborough, Massachusetts)
ABSTRACT Methods for preparation of prospectively identified human adipose stem cells enriched populations thereof, e.g., for therapy.
FILED Tuesday, March 17, 2015
APPL NO 14/660381
ART UNIT 1653 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 35/28 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 5/0653 (20130101) Original (OR) Class
C12N 5/0692 (20130101)
C12N 2501/11 (20130101)
C12N 2501/105 (20130101)
C12N 2501/115 (20130101)
C12N 2501/119 (20130101)
C12N 2501/165 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10093904 Jaenisch et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Whitehead Institute for Biomedical Research (Cambridge, Massachusetts)
ASSIGNEE(S) Whitehead Institute for Biomedical Research (Cambridge, Massachusetts)
INVENTOR(S) Rudolf Jaenisch (Brookline, Massachusetts);  Yaqub Hanna (Boston, Massachusetts);  Marius Wernig (Woodside, California);  Christopher J. Lengner (Wellesley, Massachusetts);  Alexander Meissner (Cambridge, Massachusetts);  Oliver Tobias Brambrink (Cambridge, Massachusetts);  G. Grant Welstead (Cambridge, Massachusetts);  Ruth Foreman (Somerville, Massachusetts)
ABSTRACT The disclosure relates to a method of reprogramming one or more somatic cells, e.g., partially differentiated or fully/terminally differentiated somatic cells, to a less differentiated state, e.g., a pluripotent or multipotent state. In further embodiments the invention also relates to reprogrammed somatic cells produced by methods of the invention, to uses of said cells, and to methods for identifying agents useful for reprogramming somatic cells.
FILED Friday, May 26, 2017
APPL NO 15/607028
ART UNIT 1632 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Animal Husbandry; Care of Birds, Fishes, Insects; Fishing; Rearing or Breeding Animals, Not Otherwise Provided For; New Breeds of Animals
A01K 67/0273 (20130101)
A01K 67/0275 (20130101)
A01K 2217/05 (20130101)
A01K 2227/105 (20130101)

Peptides
C07K 14/4702 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 5/0696 (20130101) Original (OR) Class
C12N 15/8509 (20130101)
C12N 15/8775 (20130101)
C12N 2501/602 (20130101)
C12N 2501/603 (20130101)
C12N 2501/604 (20130101)
C12N 2501/605 (20130101)
C12N 2501/606 (20130101)
C12N 2506/11 (20130101)
C12N 2506/13 (20130101)
C12N 2800/30 (20130101)
C12N 2830/003 (20130101)
C12N 2830/006 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/5023 (20130101)
G01N 2333/91011 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10093906 Kan et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Chemical, Bioengineering, Environmental and Transport Systems (CBET)
APPLICANT(S) California Institute of Technology (Pasadena, California)
ASSIGNEE(S) California Institute of Technology (Pasadena, California)
INVENTOR(S) Sek Bik Jennifer Kan (Pasadena, California);  Russell D. Lewis (Pasadena, California);  Kai Chen (Pasadena, California);  Frances H. Arnold (Pasadena, California)
ABSTRACT The present invention provides compositions and methods for catalyzing the formation of carbon-silicon bonds using heme proteins. In certain aspects, the present invention provides heme proteins, including variants and fragments thereof, that are capable of carrying out in vitro and in vivo carbene insertion reactions for the formation of carbon-silicon bonds. In other aspects, the present invention provides methods for producing an organosilicon product, the method comprising providing a silicon-containing reagent, a carbene precursor, and a heme protein; and combining the components under conditions sufficient to produce an organosilicon product. Host cells expressing the heme proteins are also provided by the present invention.
FILED Wednesday, February 01, 2017
APPL NO 15/422360
ART UNIT 1652 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Acyclic, Carbocyclic or Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium or Tellurium
C07F 7/0818 (20130101)
C07F 7/0829 (20130101)
C07F 7/0896 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 9/0042 (20130101) Original (OR) Class
C12N 9/0071 (20130101)

Enzymes
C12Y 106/02004 (20130101)
C12Y 114/14001 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10093910 Joung et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) The General Hospital Corporation (Boston, Massachusetts)
ASSIGNEE(S) The General Hospital Corporation (Boston, Massachusetts)
INVENTOR(S) J. Keith Joung (Winchester, Massachusetts);  Benjamin Kleinstiver (Medford, Massachusetts);  Vikram Pattanayak (Wellesley, Massachusetts)
ABSTRACT Engineered CRISPR-Cas9 nucleases with improved specificity and their use in genomic engineering, epigenomic engineering, genome targeting, and genome editing.
FILED Monday, December 05, 2016
APPL NO 15/369533
ART UNIT 1656 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 9/16 (20130101)
C12N 9/22 (20130101) Original (OR) Class
C12N 15/90 (20130101)
C12N 15/902 (20130101)
C12N 15/907 (20130101)

Enzymes
C12Y 301/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10093927 Davidson et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Child Health and Human Development (NICHD)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institute of Neurological Disorders and Stroke (NINDS)
APPLICANT(S) UNIVERSITY OF IOWA RESEARCH FOUNDATION (Iowa City, Iowa)
ASSIGNEE(S) University of Iowa Research Foundation (Iowa City, Iowa)
INVENTOR(S) Beverly L. Davidson (Iowa City, Iowa);  Alejandro Mas Monteys (Iowa City, Iowa);  Jodi McBride (Iowa City, Iowa);  Ryan Boudreau (Iowa City, Iowa)
ABSTRACT The present invention is directed to RNA interference (RNAi) molecules targeted against a nucleic acid sequence, and methods of using these RNAi molecules to reduce off-target toxicity.
FILED Friday, April 07, 2017
APPL NO 15/482284
ART UNIT 1674 — Plants
CURRENT CPC
Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/111 (20130101)
C12N 15/113 (20130101) Original (OR) Class
C12N 2310/14 (20130101)
C12N 2310/141 (20130101)
C12N 2310/531 (20130101)
C12N 2320/30 (20130101)
C12N 2320/53 (20130101)
C12N 2330/51 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10093930 Lou et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Mayo Foundation for Medical Education and Research (Rochester, Minnesota)
ASSIGNEE(S) Mayo Foundation for Medical Education and Research (Rochester, Minnesota)
INVENTOR(S) Zhenkun Lou (Rochester, Minnesota);  JungJin Kim (Rochester, Minnesota);  SeungBaek Lee (Rochester, Minnesota)
ABSTRACT Materials and methods for treating cancer (e.g., by reducing metastasis) are provided herein. For example, materials and methods for treating cancer by targeting WSB1 and/or pVHL are provided.
FILED Friday, May 06, 2016
APPL NO 15/148359
ART UNIT 1674 — Plants
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 48/00 (20130101)

Peptides
C07K 16/40 (20130101)
C07K 2317/75 (20130101)
C07K 2317/76 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 9/93 (20130101)
C12N 15/1135 (20130101)
C12N 15/1137 (20130101) Original (OR) Class
C12N 2310/14 (20130101)
C12N 2310/531 (20130101)

Enzymes
C12Y 603/02019 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10093947 Crystal et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute on Drug Abuse (NIDA)
APPLICANT(S) Cornell University (Ithaca, New York)
ASSIGNEE(S) CORNELL UNIVERSITY (Ithaca, New York)
INVENTOR(S) Ronald G. Crystal (New York, New York);  Martin J. Hicks (New York, New York);  Jonathan B. Rosenberg (Cranbury, New Jersey);  Bishnu P. De (New Hyde Park, New York);  Stephen M. Kaminsky (Bronx, New York);  Robin L. Davisson (Ithaca, New York)
ABSTRACT The invention is directed to an adeno-associated virus (AAV) vector which comprises a nucleic acid sequence encoding an antibody or antigen binding fragment that binds to nicotine or a nicotine analog. The invention also is directed to a composition comprising the AAV vector and methods of using the AAV vector to induce an immune response against nicotine in a mammal.
FILED Monday, February 25, 2013
APPL NO 14/381534
ART UNIT 1648 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/0019 (20130101)
A61K 35/76 (20130101)
A61K 39/00 (20130101)
A61K 39/12 (20130101)
A61K 39/0013 (20130101)
A61K 39/395 (20130101)
A61K 48/0083 (20130101)
A61K 2039/505 (20130101)
A61K 2039/5256 (20130101)

Peptides
C07K 14/005 (20130101)
C07K 14/005 (20130101)
C07K 16/16 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 7/00 (20130101)
C12N 15/79 (20130101)
C12N 15/86 (20130101) Original (OR) Class
C12N 15/86 (20130101)
C12N 15/8645 (20130101)
C12N 2710/10042 (20130101)
C12N 2750/14141 (20130101)
C12N 2750/14142 (20130101)
C12N 2750/14143 (20130101)
C12N 2750/14143 (20130101)
C12N 2750/14152 (20130101)
C12N 2750/14334 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10093967 Walter et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
Army Research Office (CCDC ARO)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) The Regents of The University of Michigan (Ann Arbor, Michigan)
ASSIGNEE(S) THE REGENTS OF THE UNIVERSITY OF MICHIGAN (Ann Arbor, Michigan)
INVENTOR(S) Nils Walter (Ann Arbor, Michigan);  Alexander Johnson-Buck (Brighton, Massachusetts);  Mario Blanco (Pasadena, California);  Arlie Rinaldi (Pasadena, California)
ABSTRACT Provided herein is technology relating to detecting and identifying nucleic acids and particularly, but not exclusively, to compositions, methods, kits, and systems for detecting, identifying, and quantifying target nucleic acids with high confidence at single-molecule resolution.
FILED Monday, January 05, 2015
APPL NO 14/589467
ART UNIT 1634 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6816 (20130101)
C12Q 1/6816 (20130101)
C12Q 1/6837 (20130101) Original (OR) Class
C12Q 1/6837 (20130101)
C12Q 2537/125 (20130101)
C12Q 2537/125 (20130101)
C12Q 2565/107 (20130101)
C12Q 2565/107 (20130101)
C12Q 2565/519 (20130101)
C12Q 2565/519 (20130101)
C12Q 2565/601 (20130101)
C12Q 2565/601 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10093970 Keefe et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Center for Research Resources (NCRR)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) New York University (New York, New York);  Yale University (New Haven, Connecticut)
ASSIGNEE(S) New York University (New York, New York);  Yale University (New Haven, Connecticut)
INVENTOR(S) David Keefe (New York, New York);  Sherman Weissman (New Haven, Connecticut);  Lin Liu (Tampa, Florida);  Fang Wang (Rego Park, New York);  Xinghua Pan (Hamden, Connecticut)
ABSTRACT The invention relates to a method for single cell analysis of relative telomere length using multiplex pre-PCR followed by a qPCR (SCT-pqPCR).
FILED Friday, March 14, 2014
APPL NO 14/776384
ART UNIT 1637 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/686 (20130101) Original (OR) Class
C12Q 1/6851 (20130101)
C12Q 1/6851 (20130101)
C12Q 1/6876 (20130101)
C12Q 2521/113 (20130101)
C12Q 2525/204 (20130101)
C12Q 2531/113 (20130101)
C12Q 2537/143 (20130101)
C12Q 2545/101 (20130101)
C12Q 2600/16 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10093979 Masli
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Eye Institute (NEI)
APPLICANT(S) TRUSTEES OF BOSTON UNIVERSITY (Boston, Massachusetts)
ASSIGNEE(S) Trustees of Boston University (Boston, Massachusetts)
INVENTOR(S) Sharmila Masli (Brookline, Massachusetts)
ABSTRACT Embodiments of the invention relate to single nucleotide polymorphisms (SNPs) in Thrombospondin 1 gene (THB-S1) that are herein linked to an increased risk for dry eye (also known as keratoconjunctivitis). The polymorphisms disclosed herein are directly useful for the diagnosis of an increased risk for dry eye, as well as for the determination of patient treatment pre- and post-surgery (e.g. pre and post refractive eye surgery) or in a patient having a condition associate with dry eye (e.g. diabetes, lupus, scleroderma, Sjogren's syndrome, thyroid disorders, vitamin A deficiency, and rheumatoid arthritis). Computer systems and medium are also enclosed. The SNPs can be present in unique combinations, or as specific haplotypes indicative of dry eye. The SNPs linked to an increased risk for dry eye include rs1478604, rs2228261, and rs2292305.
FILED Friday, March 14, 2014
APPL NO 14/774044
ART UNIT 1634 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6883 (20130101) Original (OR) Class
C12Q 2600/106 (20130101)
C12Q 2600/156 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10094764 Winkelman et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) Roche Diagnostics Hematology, Inc. (Westborough, Massachusetts)
ASSIGNEE(S) Roche Diagnostics Hematology, Inc. (Westborough, Massachusetts)
INVENTOR(S) James Winkelman (Chestnut Hill, Massachusetts);  Milenko Tanasijevic (West Newton, Massachusetts);  David Zahniser (Wellesley, Massachusetts)
ABSTRACT Systems and methods analyzing body fluids such as blood and bone marrow are disclosed. The systems and methods may utilize an improved technique for applying a monolayer of cells to a slide to generate a substantially uniform distribution of cells on the slide. Additionally aspects of the invention also relate to systems and methods for utilizing multi color microscopy for improving the quality of images captured by a light receiving device.
FILED Monday, April 27, 2015
APPL NO 14/697331
ART UNIT 1798 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry
CURRENT CPC
Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 1/312 (20130101)
G01N 1/2813 (20130101)
G01N 15/1475 (20130101) Original (OR) Class
G01N 21/255 (20130101)
G01N 33/49 (20130101)
G01N 35/00029 (20130101)
G01N 35/00871 (20130101)
G01N 35/1016 (20130101)
G01N 2015/008 (20130101)
G01N 2015/0073 (20130101)
G01N 2015/0084 (20130101)
G01N 2015/1006 (20130101)
G01N 2015/1472 (20130101)
G01N 2015/1486 (20130101)
G01N 2015/1497 (20130101)
G01N 2035/0091 (20130101)
G01N 2035/00138 (20130101)
G01N 2035/00465 (20130101)
G01N 2201/062 (20130101)
G01N 2201/126 (20130101)
G01N 2333/805 (20130101)

Recognition of Data; Presentation of Data; Record Carriers; Handling Record Carriers
G06K 9/4652 (20130101)
G06K 9/6267 (20130101)

Image Data Processing or Generation, in General
G06T 7/0012 (20130101)

Pictorial Communication, e.g Television
H04N 5/265 (20130101)
H04N 5/2256 (20130101)
H04N 5/23293 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10094820 Berthier et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Wisconsin Alumni Research Foundation (Madison, Wisconsin)
ASSIGNEE(S) Wisconsin Alumni Research Foundation (Madison, Wisconsin)
INVENTOR(S) Berwin Berthier (Madison, Wisconsin);  Peter Cavnar (Madison, Wisconsin);  John Guckenberger (Oconomowoc, Wisconsin);  David Beebe (Monona, Wisconsin)
ABSTRACT A microfluidic device and method is provided for handheld diagnostics and assays. A first substance is frozen in a cryopreservation fluid in a first well of a lid. The lid includes a first surface communicating with a first port of the first well and a second surface communicating with a second port of the first well. A porous membrane is affixed to the first surface so as to overlap the first port and a non-porous membrane is affixed to the second surface so as to overlap the second port. The first substance may be dialytically freed from the cryopreservation fluid at a user desired time. Thereafter, the lid may be moved from a first position wherein the lid is spaced from a base to a second position wherein the lid is adjacent the channel in the base such that the first substance communicates with the input of the channel.
FILED Wednesday, February 03, 2016
APPL NO 15/014146
ART UNIT 1799 — Optics
CURRENT CPC
Preservation of Bodies of Humans or Animals or Plants or Parts Thereof; Biocides, e.g as Disinfectants, as Pesticides or as Herbicides; Pest Repellants or Attractants; Plant Growth Regulators
A01N 1/0263 (20130101)
A01N 1/0268 (20130101)

Chemical or Physical Laboratory Apparatus for General Use
B01L 3/502715 (20130101)
B01L 7/50 (20130101)
B01L 2200/027 (20130101)
B01L 2300/044 (20130101)
B01L 2300/047 (20130101)
B01L 2300/0672 (20130101)
B01L 2300/0816 (20130101)
B01L 2300/0887 (20130101)
B01L 2400/086 (20130101)
B01L 2400/0406 (20130101)
B01L 2400/0481 (20130101)
B01L 2400/0677 (20130101)
B01L 2400/0683 (20130101)
B01L 2400/0694 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/5005 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10094825 Mesa et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) Annia Mesa (Miami, Florida);  Jason A. Somarelli (Durham, North Carolina)
ASSIGNEE(S) THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (Miami, Florida)
INVENTOR(S) Annia Mesa (Miami, Florida);  Jason A. Somarelli (Durham, North Carolina)
ABSTRACT The invention provides methods for identifying the presence of, or an increased risk of developing, organ damage in a subject having an autoimmune disease, for example, Systemic Lupus Erythematosus (SLE) or Mixed Connective Tissue Disease (MCTD), or other disease in which the lungs and/or kidneys are involved. In one embodiment, a significantly increased combined IgM reactivity against the peptides having the sequences of SEQ ID NOs: 4, 9, 12, and 15 in a sample obtained from a patient compared to a healthy control indicates lung damage or an increased risk of developing lung damage in the subject. In another embodiment, a significantly increased combined IgM reactivity against the peptides having the sequences of SEQ ID NOs: 2, 8, 12, 14, 15, and 17, in a sample from a patient compared to a healthy control indicates kidney damage or an increased risk of developing kidney damage in the subject.
FILED Monday, August 01, 2016
APPL NO 15/225395
ART UNIT 1647 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/564 (20130101) Original (OR) Class
G01N 33/6854 (20130101)
G01N 2800/50 (20130101)
G01N 2800/104 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10094836 Figg et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
APPLICANT(S) William D. Figg (Fairfax, Virginia);  Alex Sparreboom (Memphis, Tennessee);  Akinobu Hamada (Tokyo, Japan);  Douglas K. Price (Fairfax, Virginia);  Tristan M. Sissung (Annandale, Virginia)
ASSIGNEE(S) The United States of America, as represented by the Secretary, Department of Health and Human Services (Washington, District of Columbia)
INVENTOR(S) William D. Figg (Fairfax, Virginia);  Alex Sparreboom (Memphis, Tennessee);  Akinobu Hamada (Tokyo, Japan);  Douglas K. Price (Fairfax, Virginia);  Tristan M. Sissung (Annandale, Virginia)
ABSTRACT The invention relates methods of identifying and predicting inter-patient differences in prognostic prediction for survival in androgen independent prostate cancer. It further related to methods for determining and exploiting such differences to improve medical outcomes. Moreover, it provides methods for determining if a subject has prostate cancer.
FILED Tuesday, January 08, 2008
APPL NO 12/522480
ART UNIT 1637 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6886 (20130101)
C12Q 2600/106 (20130101)
C12Q 2600/118 (20130101)
C12Q 2600/136 (20130101)
C12Q 2600/172 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/57434 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10094840 Deisseroth et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute on Deafness and Other Communication Disorders (NIDCD)
National Institute of Mental Health (NIMH)
APPLICANT(S) The Board of Trustees of the Leland Stanford Junior University (Palo Alto, California)
ASSIGNEE(S) The Board of Trustees of the Leland Stanford Junior University (Stanford, California)
INVENTOR(S) Karl Deisseroth (Stanford, California);  Edward Stuart Boyden (Cambridge, Massachusetts)
ABSTRACT The present invention provides compositions and methods for light-activated cation channel proteins and their uses within cell membranes and subcellular regions. The invention provides for proteins, nucleic acids, vectors and methods for genetically targeted expression of light-activated cation channels to specific cells or defined cell populations. In particular the invention provides millisecond-timescale temporal control of cation channels using moderate light intensities in cells, cell lines, transgenic animals, and humans. The invention provides for optically generating electrical spikes in nerve cells and other excitable cells useful for driving neuronal networks, drug screening, and therapy.
FILED Monday, November 10, 2014
APPL NO 14/537290
ART UNIT 1632 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Animal Husbandry; Care of Birds, Fishes, Insects; Fishing; Rearing or Breeding Animals, Not Otherwise Provided For; New Breeds of Animals
A01K 2217/05 (20130101)
A01K 2227/40 (20130101)
A01K 2227/105 (20130101)
A01K 2227/703 (20130101)
A01K 2227/706 (20130101)

Filters Implantable into Blood Vessels; Prostheses; Devices Providing Patency To, or Preventing Collapsing Of, Tubular Structures of the Body, e.g Stents; Orthopaedic, Nursing or Contraceptive Devices; Fomentation; Treatment or Protection of Eyes or Ears; Bandages, Dressings or Absorbent Pads; First-aid Kits
A61F 2/18 (20130101)

Preparations for Medical, Dental, or Toilet Purposes
A61K 31/137 (20130101)
A61K 31/353 (20130101)
A61K 31/405 (20130101)
A61K 31/4172 (20130101)
A61K 35/30 (20130101)
A61K 35/30 (20130101)
A61K 38/00 (20130101)
A61K 48/00 (20130101)
A61K 2300/00 (20130101)

Methods or Apparatus for Sterilising Materials or Objects in General; Disinfection, Sterilisation, or Deodorisation of Air; Chemical Aspects of Bandages, Dressings, Absorbent Pads, or Surgical Articles; Materials for Bandages, Dressings, Absorbent Pads, or Surgical Articles
A61L 27/3604 (20130101)

Electrotherapy; Magnetotherapy; Radiation Therapy; Ultrasound Therapy
A61N 5/062 (20130101)
A61N 5/0601 (20130101)
A61N 5/0622 (20130101)

Peptides
C07K 14/405 (20130101)
C07K 14/705 (20130101)
C07K 2319/60 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 2740/15043 (20130101)
C12N 2740/15071 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/6872 (20130101) Original (OR) Class
G01N 2500/04 (20130101)
G01N 2500/10 (20130101)

Printed Circuits; Casings or Constructional Details of Electric Apparatus; Manufacture of Assemblages of Electrical Components
H05K 999/99 (20130101)

Technologies for Adaptation to Climate Change
Y02A 90/26 (20180101)

Technical Subjects Covered by Former USPC Cross-reference Art Collections [XRACs] and Digests
Y10S 530/82 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10094892 Hiller et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
APPLICANT(S) President and Fellows of Harvard College (Cambridge, Massachusetts)
ASSIGNEE(S) President and Fellows of Harvard College (Cambridge, Massachusetts)
INVENTOR(S) Sebastian Hiller (Zurich, Switzerland);  Gerhard Wagner (Brookline, Massachusetts)
ABSTRACT Described are methods and apparatus, referred to as “temperature-lock,” which can control and stabilize the sample temperature in an NMR spectrometer, in some instances with a precision and an accuracy of below about 0.1 K. In conventional setups, sample heating caused by experiments with high-power radio frequency pulses is not readily detected and is corrected by a cumbersome manual procedure. In contrast, the temperature-lock disclosed herein automatically maintains the sample at the same reference temperature over the course of different NMR experiments. The temperature-lock can work by continuous or non-continuous measurement of the resonance frequency of a suitable temperature-lock nucleus and simultaneous adaptation of a temperature control signal to stabilize the sample at a reference temperature value. Inter-scan periods with variable length can be used to maintain the sample at thermal equilibrium over the full length of an experiment.
FILED Friday, December 05, 2014
APPL NO 14/562028
ART UNIT 2866 — Printing/Measuring and Testing
CURRENT CPC
Measuring Electric Variables; Measuring Magnetic Variables
G01R 33/31 (20130101) Original (OR) Class
G01R 33/4608 (20130101)
G01R 33/4616 (20130101)
G01R 33/4625 (20130101)
G01R 33/34092 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10096110 Mouton et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Mental Health (NIMH)
APPLICANT(S) University of South Florida (Tampa, Florida);  Stereology Resource Center, Inc. (Chester, Maryland)
ASSIGNEE(S) University of South Florida (Tampa, Florida);  Stereology Resource Center, Inc. (Chester, Maryland)
INVENTOR(S) Peter Randolph Mouton (St. Petersburg, Florida);  Dmitry Goldgof (Lutz, Florida);  Lawrence O. Hall (Tampa, Florida);  Baishali Chaudhury (Tampa, Florida)
ABSTRACT This invention relates to a system and method for applying an ensemble of segmentations to microscopy images of a tissue sample to determine if the tissue sample is representative of cancerous tissue. The ensemble of segmentations is applied to a plurality of greyscale or color microscopy images to generate a final image level segmentation and a final blob level segmentation. The final image level segmentation and final blob level segmentation are used to calculate a mean nuclear volume to determine if the tissue sample is representative of cancerous tissue.
FILED Monday, August 24, 2015
APPL NO 15/503183
ART UNIT 2668 — Image Analysis; Applications; Pattern Recognition; Color and compression; Enhancement and Transformation
CURRENT CPC
Recognition of Data; Presentation of Data; Record Carriers; Handling Record Carriers
G06K 9/0014 (20130101)
G06K 9/38 (20130101)
G06K 9/629 (20130101)

Image Data Processing or Generation, in General
G06T 7/11 (20170101)
G06T 7/0012 (20130101) Original (OR) Class
G06T 7/136 (20170101)
G06T 7/155 (20170101)
G06T 2207/10056 (20130101)
G06T 2207/30024 (20130101)
G06T 2207/30096 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Defense (DOD) 

US 10092000 Whitten et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Defense Threat Reduction Agency (DTRA)
APPLICANT(S) David G. Whitten (Albuquerque, New Mexico);  Kirk S. Schanze (Gainesville, Florida);  Eunkyung Ji (Ervy le Chatel, France);  Thomas S. Corbitt (Albuquerque, New Mexico);  Zhijun Zhou (Albuquerque, New Mexico);  Dimitri Dascier (Ervy le Chatel, France);  Ying Wang (Albuquerque, New Mexico);  Linnea K. Ista (Albuquerque, New Mexico);  Anand Parthasarathy (Naperville, Illinois);  Eric H. Hill (Donostia, Spain);  Yanli Tang (Xi'an, China PRC)
ASSIGNEE(S) STC.UNM (Albuquerque, New Mexico);  University of Florida Research Foundation, Inc. (Gainesville, Florida)
INVENTOR(S) David G. Whitten (Albuquerque, New Mexico);  Kirk S. Schanze (Gainesville, Florida);  Eunkyung Ji (Ervy le Chatel, France);  Thomas S. Corbitt (Albuquerque, New Mexico);  Zhijun Zhou (Albuquerque, New Mexico);  Dimitri Dascier (Ervy le Chatel, France);  Ying Wang (Albuquerque, New Mexico);  Linnea K. Ista (Albuquerque, New Mexico);  Anand Parthasarathy (Naperville, Illinois);  Eric H. Hill (Donostia, Spain);  Yanli Tang (Xi'an, China PRC)
ABSTRACT The present disclosure provides novel oligo phenylene ethynylene (OPE) compounds, methods for synthesizing these compounds, and materials and substances incorporating these compounds. The various OPEs show antibacterial, antiviral and antifungal activity.
FILED Wednesday, July 13, 2011
APPL NO 13/809573
ART UNIT 1789 — Miscellaneous Articles, Stock Material
CURRENT CPC
Preservation of Bodies of Humans or Animals or Plants or Parts Thereof; Biocides, e.g as Disinfectants, as Pesticides or as Herbicides; Pest Repellants or Attractants; Plant Growth Regulators
A01N 25/08 (20130101)
A01N 25/10 (20130101)
A01N 25/10 (20130101)
A01N 33/10 (20130101)
A01N 33/12 (20130101)
A01N 33/12 (20130101)
A01N 41/04 (20130101)
A01N 41/04 (20130101)
A01N 43/10 (20130101)
A01N 43/10 (20130101)
A01N 43/90 (20130101) Original (OR) Class
A01N 43/90 (20130101)

Acyclic or Carbocyclic Compounds
C07C 217/20 (20130101)
C07C 309/11 (20130101)

Heterocyclic Compounds
C07D 333/16 (20130101)
C07D 409/14 (20130101)
C07D 487/08 (20130101)

Technical Subjects Covered by Former US Classification
Y10T 442/30 (20150401)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10092003 Widder et al.
FUNDED BY
Department of Defense (DOD)
Office of the Secretary of Defense (OSD)
Small Business Administration (SBA)
Small Business Innovation Research (SBIR)
APPLICANT(S) Novel Textiles and Treatments LLC (New York, New York)
ASSIGNEE(S) Novel Textiles and Treatments LLC (New York, New York)
INVENTOR(S) Laurie Widder (New York, New York);  Gary Innocenti, Sr. (Mahwah, New Jersey)
ABSTRACT Insect control devices and associated methods are generally described. In some embodiments, the insect control device includes one or more substrate materials impregnated or otherwise loaded with an active species (e.g., a pyrethroid). In some cases, the device may provide protection against insects over prolonged periods of time.
FILED Tuesday, May 19, 2015
APPL NO 14/716723
ART UNIT 1613 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Preservation of Bodies of Humans or Animals or Plants or Parts Thereof; Biocides, e.g as Disinfectants, as Pesticides or as Herbicides; Pest Repellants or Attractants; Plant Growth Regulators
A01N 25/18 (20130101)
A01N 25/34 (20130101)
A01N 53/00 (20130101) Original (OR) Class
A01N 53/00 (20130101)
A01N 53/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10092676 Amoroso et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
U.S. Army Medical Research and Development Command (USAMRDC)
Armed Forces Institute of Regenerative Medicine (AFIRM)
U.S. Army Medical Research and Materiel Command (USAMRMC)
APPLICANT(S) University of Pittsburgh Of the Commonwealth System of Higher Education (Pittsburgh, Pennsylvania)
ASSIGNEE(S) University of Pittsburgh Of the Commonwealth System of Higher Education (Pittsburgh, Pennsylvania)
INVENTOR(S) Nicholas J. Amoroso (Pittsburgh, Pennsylvania);  Stephen Francis Badylak (West Lafayette, Indiana);  Yi Hong (Pittsburgh, Pennsylvania);  Alexander Huber (Pittsburgh, Pennsylvania);  Keisuke Takanari (Pittsburgh, Pennsylvania);  William R. Wagner (Gibsonia, Pennsylvania)
ABSTRACT A biohybrid scaffold is provided that is useful in clinical applications for abdominal wall reconstruction, pelvic floor repair, breast reconstruction, as well as other soft tissue repairs. Methods of making and using the biohybrid scaffold are provided.
FILED Friday, July 22, 2016
APPL NO 15/216878
ART UNIT 1653 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Methods or Apparatus for Sterilising Materials or Objects in General; Disinfection, Sterilisation, or Deodorisation of Air; Chemical Aspects of Bandages, Dressings, Absorbent Pads, or Surgical Articles; Materials for Bandages, Dressings, Absorbent Pads, or Surgical Articles
A61L 27/18 (20130101) Original (OR) Class
A61L 27/18 (20130101)
A61L 27/18 (20130101)
A61L 27/48 (20130101)
A61L 27/58 (20130101)
A61L 27/3633 (20130101)
A61L 2400/18 (20130101)
A61L 2430/34 (20130101)

Compositions of Macromolecular Compounds
C08L 67/04 (20130101)
C08L 75/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10092679 Ahn et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
U.S. Army Medical Research and Materiel Command (USAMRMC)
Telemedicine and Advanced Technology Research Center (TATRC)
APPLICANT(S) Wake Forest University Health Sciences (Winston-Salem, North Carolina)
ASSIGNEE(S) Wake Forest University Health Sciences (Winston-Salem, North Carolina)
INVENTOR(S) Hyunhee Ahn (Winston-Salem, North Carolina);  Young Min Ju (Winston-Salem, North Carolina);  Anthony Atala (Winston-Salem, North Carolina);  Sang Jin Lee (Winston-Salem, North Carolina)
ABSTRACT Vascular scaffolds and methods of fabricating the same are disclosed for tissue engineering of vascular constructs. By combining electrospun matrices with cell sheet technologies, vascular constructs with more mature cell layers can be obtained for reconstruction of blood vessels, heart valves and the like. A engineered smooth muscle cell sheet, wrapped around an electrospun vascular scaffold, is able to provide a mature SMC layer that expresses strong cell-to-cell junction markers and contractile proteins. In addition, preconditioning of the cell sheet covered vascular scaffold maintained cell viability and infiltration into the scaffold.
FILED Monday, October 20, 2014
APPL NO 14/518352
ART UNIT 1651 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Filters Implantable into Blood Vessels; Prostheses; Devices Providing Patency To, or Preventing Collapsing Of, Tubular Structures of the Body, e.g Stents; Orthopaedic, Nursing or Contraceptive Devices; Fomentation; Treatment or Protection of Eyes or Ears; Bandages, Dressings or Absorbent Pads; First-aid Kits
A61F 2/06 (20130101)
A61F 2/07 (20130101)
A61F 2/062 (20130101)
A61F 2210/0076 (20130101)
A61F 2240/001 (20130101)

Methods or Apparatus for Sterilising Materials or Objects in General; Disinfection, Sterilisation, or Deodorisation of Air; Chemical Aspects of Bandages, Dressings, Absorbent Pads, or Surgical Articles; Materials for Bandages, Dressings, Absorbent Pads, or Surgical Articles
A61L 27/26 (20130101)
A61L 27/26 (20130101)
A61L 27/26 (20130101)
A61L 27/507 (20130101) Original (OR) Class
A61L 27/3808 (20130101)
A61L 27/3826 (20130101)

Compositions of Macromolecular Compounds
C08L 67/04 (20130101)
C08L 89/06 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 5/0691 (20130101)
C12N 2533/40 (20130101)
C12N 2533/54 (20130101)

Mechanical Methods or Apparatus in the Manufacture of Artificial Filaments, Threads, Fibres, Bristles or Ribbons
D01D 5/0007 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10092927 George et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Office of Scientific Research (AFOSR)
National Science Foundation (NSF)
APPLICANT(S) Steven M. George (Boulder, Colorado);  Arrelaine Allen Dameron (Boulder, Colorado);  Nicole Marie Adamczyk Keaner (Madison, Wisconsin);  Byunghoon Yoon (Boulder, Colorado)
ASSIGNEE(S) The Regents of the University of Colorado, a Body Corporate (Denver, Colorado)
INVENTOR(S) Steven M. George (Boulder, Colorado);  Arrelaine Allen Dameron (Boulder, Colorado);  Nicole Marie Adamczyk Keaner (Madison, Wisconsin);  Byunghoon Yoon (Boulder, Colorado)
ABSTRACT Ultrathin layers of organic polymers or organic-inorganic hybrid polymers are deposited onto a substrate using molecular layer deposition methods. The process uses vapor phase materials which contain a first functional group and react only monofunctionally at the surface to add a unit to the polymer chain. The vapor phase reactant in addition has a second functional group, which is different from the first functional group, or a blocked, masked or protected functional group, or else has a precursor to such a functional group.
FILED Tuesday, November 13, 2007
APPL NO 12/513831
ART UNIT 1712 — Coating, Etching, Cleaning, Single Crystal Growth
CURRENT CPC
Processes for Applying Fluent Materials to Surfaces, in General
B05D 1/60 (20130101) Original (OR) Class
B05D 7/52 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10092954 Sherman et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
U.S. Army Tank-Automotive and Armaments Command (TACOM)
APPLICANT(S) Powdermet, Inc. (Euclid, Ohio)
ASSIGNEE(S) Powdermet, Inc. (Euclid, Ohio)
INVENTOR(S) Andrew J. Sherman (Kirtland Hills, Ohio);  Brian Doud (Cleveland Heights, Ohio)
ABSTRACT A syntactic metal foam composite that is substantially fully dense except for syntactic porosity is formed from a mixture of ceramic microballoons and matrix forming metal. The ceramic microballoons have a uniaxial crush strength and a much higher omniaxial crush strength. The mixture is continuously constrained while it is consolidated. The constraining force is less than the omniaxial crush strength. The substantially fully dense syntactic metal foam composite is then constrained and deformation worked at a substantially constant volume. This deformation causes at least work hardening and grain refinement in the matrix metal. The resulting deformed syntactic metal foam composite has an energy absorption capacity that is at least 1.5 to 2 or 3 times or more the energy absorption capacity of the precursor substantially fully dense syntactic metal foam composite.
FILED Friday, June 26, 2015
APPL NO 14/752166
ART UNIT 1733 — Metallurgy, Metal Working, Inorganic Chemistry, Catalyst, Electrophotography, Photolithography
CURRENT CPC
Working or Processing of Sheet Metal or Metal Tubes, Rods or Profiles Without Essentially Removing Material; Punching Metal
B21D 31/00 (20130101)

Working Metallic Powder; Manufacture of Articles From Metallic Powder; Making Metallic Powder
B22F 3/1112 (20130101) Original (OR) Class

Layered Products, i.e Products Built-up of Strata of Flat or Non-flat, e.g Cellular or Honeycomb, Form
B32B 5/16 (20130101)
B32B 5/18 (20130101)
B32B 5/20 (20130101)

Alloys
C22C 32/0036 (20130101)
C22C 32/0078 (20130101)
C22C 49/00 (20130101)
C22C 49/06 (20130101)
C22C 49/11 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10093737 Zang
FUNDED BY
Department of Defense (DOD)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
APPLICANT(S) ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY (Bronx, New York)
ASSIGNEE(S) Albert Einstein College of Medicine, Inc. (Bronx, New York)
INVENTOR(S) Xingxing Zang (New York, New York)
ABSTRACT Provided are methods of treating an autoimmune disease in a subject, or of suppressing transplant rejection in a subject, or of treating a cancer in a subject, as well as compositions therefor.
FILED Friday, February 07, 2014
APPL NO 14/770120
ART UNIT 1642 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Peptides
C07K 16/2827 (20130101) Original (OR) Class
C07K 2317/21 (20130101)
C07K 2317/24 (20130101)
C07K 2319/30 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10093901 Scott et al.
FUNDED BY
Department of Defense (DOD)
Uniformed Services University of the Health Sciences (USUHS)
Henry M Jackson Foundation for the Advancement of Military Medicine, Inc (HJF)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. (Bethesda, Maryland)
ASSIGNEE(S) THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. (Bethesda, Maryland)
INVENTOR(S) David W. Scott (Bethesda, Maryland);  Yong Chan Kim (Rockville, Maryland)
ABSTRACT The present invention generally relates to the production of antigen-specific T regulatory cells (Tregs). Such cells can be used in therapy to minimize undesirable immune responses such as those observed in autoimmunity and hemophilia and other diseases as well as in the response to protein therapy for genetic diseases. Methods for producing antigen specific Tregs and conditions for preferential expansion of functionally stable, specific Tregs are also provided.
FILED Friday, May 09, 2014
APPL NO 14/889962
ART UNIT 1644 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 35/17 (20130101)
A61K 39/0008 (20130101)
A61K 2039/57 (20130101)
A61K 2039/572 (20130101)
A61K 2039/5156 (20130101)
A61K 2039/5158 (20130101)

Peptides
C07K 14/7051 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 5/0637 (20130101) Original (OR) Class
C12N 2502/11 (20130101)
C12N 2510/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10093938 Ikushima et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
Department of the Navy (DON)
APPLICANT(S) The Johns Hopkins University (Baltimore, Maryland)
ASSIGNEE(S) The Johns Hopkins University (Baltimore, Maryland)
INVENTOR(S) Shigehito Ikushima (Towson, Maryland);  Jef Boeke (New York, New York)
ABSTRACT A system for controlling gene expression in yeast comprises a repressible gene expression plasmid that has a regulator binding sequence for camR and a target gene sequence. The system also includes a transcription enhancer expression plasmid; wherein said transcriptional activator protein binds to the regulator binding sequence in the absence of a transcriptional inhibitor. The system is used in a method for controlling expression of the target gene through the use of camphor. The target gene is expressed in the absence of camphor but unexpressed if camphor is added to a solution of cells containing the plasmids.
FILED Thursday, February 19, 2015
APPL NO 15/118508
ART UNIT 1636 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/63 (20130101)
C12N 15/81 (20130101) Original (OR) Class
C12N 15/635 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10093967 Walter et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
Army Research Office (CCDC ARO)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) The Regents of The University of Michigan (Ann Arbor, Michigan)
ASSIGNEE(S) THE REGENTS OF THE UNIVERSITY OF MICHIGAN (Ann Arbor, Michigan)
INVENTOR(S) Nils Walter (Ann Arbor, Michigan);  Alexander Johnson-Buck (Brighton, Massachusetts);  Mario Blanco (Pasadena, California);  Arlie Rinaldi (Pasadena, California)
ABSTRACT Provided herein is technology relating to detecting and identifying nucleic acids and particularly, but not exclusively, to compositions, methods, kits, and systems for detecting, identifying, and quantifying target nucleic acids with high confidence at single-molecule resolution.
FILED Monday, January 05, 2015
APPL NO 14/589467
ART UNIT 1634 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6816 (20130101)
C12Q 1/6816 (20130101)
C12Q 1/6837 (20130101) Original (OR) Class
C12Q 1/6837 (20130101)
C12Q 2537/125 (20130101)
C12Q 2537/125 (20130101)
C12Q 2565/107 (20130101)
C12Q 2565/107 (20130101)
C12Q 2565/519 (20130101)
C12Q 2565/519 (20130101)
C12Q 2565/601 (20130101)
C12Q 2565/601 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10094279 Kupratis et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
APPLICANT(S) UNITED TECHNOLOGIES CORPORATION (Hartford, Connecticut)
ASSIGNEE(S) United Technologies Corporation (Farmington, Connecticut)
INVENTOR(S) Daniel B. Kupratis (Wallingford, Connecticut);  Francis R Moon (Granby, Connecticut)
ABSTRACT The engine (10) includes a low spool (16) disposed aft of an air inlet (12) and a high spool (34) disposed aft of the low spool (16). An intake reverse-duct (44) is disposed radially outward of the high spool (34) and reverses direction of low pressure compressed air from the low spool (16) into a forward-flow high pressure compressor (40) of the high spool (34). A discharge reverse-manifold (48) directs flow of an exhaust gas stream (50} from a forward-flow low pressure turbine (20) into a rearward-flow direction and into at least one pulse detonation firing tube (54). An annular bypass air duct (72) directs cooling air along the engine (10)—The at least, one firing tube is positioned radially outward of the high spool (34), overlies the high spool (34) and is also positioned within the bypass air duct (72).
FILED Tuesday, January 29, 2013
APPL NO 14/764186
ART UNIT 3741 — Thermal & Combustion Technology, Motive & Fluid Power Systems
CURRENT CPC
Gas-turbine Plants; Air Intakes for Jet-propulsion Plants; Controlling Fuel Supply in Air-breathing Jet-propulsion Plants
F02C 3/14 (20130101)
F02C 3/107 (20130101)
F02C 3/145 (20130101) Original (OR) Class
F02C 5/02 (20130101)
F02C 7/06 (20130101)
F02C 7/36 (20130101)

Jet-propulsion Plants
F02K 3/06 (20130101)
F02K 3/11 (20130101)

Indexing Scheme for Aspects Relating to Non-positive-displacement Machines or Engines, Gas-turbines or Jet-propulsion Plants
F05D 2250/31 (20130101)
F05D 2250/311 (20130101)
F05D 2260/16 (20130101)

Cremation Furnaces; Consuming Waste Products by Combustion
F23G 7/065 (20130101)

Generating Combustion Products of High Pressure or High Velocity, e.g Gas-turbine Combustion Chambers
F23R 7/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10094289 Lovett et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Materiel Command (AFMC)
Air Force Research Laboratory (AFRL)
APPLICANT(S) United Technologies Corporation (Hartford, Connecticut)
ASSIGNEE(S) United Technologies Corporation (Farmington, Connecticut)
INVENTOR(S) Jeffery A. Lovett (Tolland, Connecticut);  Benjamin D. Bellows (Glastonbury, Connecticut)
ABSTRACT A fuel injection system for a gas turbine engine includes a fuel nozzle with a fuel injection aperture to inject a fuel jet and a multiple of airflow passages in the fuel nozzle to communicate a multiple of air streams to interact with the fuel jet.
FILED Monday, July 08, 2013
APPL NO 13/936876
ART UNIT 3741 — Thermal & Combustion Technology, Motive & Fluid Power Systems
CURRENT CPC
Gas-turbine Plants; Air Intakes for Jet-propulsion Plants; Controlling Fuel Supply in Air-breathing Jet-propulsion Plants
F02C 7/22 (20130101) Original (OR) Class

Jet-propulsion Plants
F02K 3/10 (20130101)

Indexing Scheme for Aspects Relating to Non-positive-displacement Machines or Engines, Gas-turbines or Jet-propulsion Plants
F05D 2240/36 (20130101)

Generating Combustion Products of High Pressure or High Velocity, e.g Gas-turbine Combustion Chambers
F23R 3/12 (20130101)
F23R 3/20 (20130101)
F23R 3/28 (20130101)
F23R 3/60 (20130101)
F23R 3/283 (20130101)
F23R 3/286 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10094292 Ainslie et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
APPLICANT(S) Walter Ernest Ainslie (Ramona, California);  Andre M. Ajami (Spring Valley, California);  Mujtaba T. Saifuddin (Corona, California)
ASSIGNEE(S) Hamilton Sundstrand Corporation (Windsor Locks, Connecticut)
INVENTOR(S) Walter Ernest Ainslie (Ramona, California);  Andre M. Ajami (Spring Valley, California);  Mujtaba T. Saifuddin (Corona, California)
ABSTRACT A method for controlling fuel flow to a gas turbine engine during starting includes monitoring acceleration of the gas turbine engine to determine actual acceleration value, and calculating a fuel flow rate for a setpoint acceleration using the actual acceleration value as a factor. The method further includes commanding the calculated fuel flow for the setpoint acceleration to the gas turbine engine.
FILED Friday, March 02, 2012
APPL NO 13/410752
ART UNIT 3741 — Thermal & Combustion Technology, Motive & Fluid Power Systems
CURRENT CPC
Gas-turbine Plants; Air Intakes for Jet-propulsion Plants; Controlling Fuel Supply in Air-breathing Jet-propulsion Plants
F02C 7/26 (20130101) Original (OR) Class
F02C 9/26 (20130101)

Indexing Scheme for Aspects Relating to Non-positive-displacement Machines or Engines, Gas-turbines or Jet-propulsion Plants
F05D 2220/50 (20130101)

Climate Change Mitigation Technologies Related to Transportation
Y02T 50/671 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10094560 Doyle et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
APPLICANT(S) Leidos, Inc. (Reston, Virginia);  Defense Life Sciences, Inc. (Alexandria, Virginia)
ASSIGNEE(S) Leidos, Inc. (Reston, Virginia);  Defense Life Sciences, Inc. (Alexandria, Virginia)
INVENTOR(S) Geoffrey Louis Doyle (Charlestown, Maryland);  Jerry B. Warner (Alexandria, Virginia);  Kunihiro Nakamoto (Chicago, Illinois)
ABSTRACT A system for waste processing includes a feeder for receiving a waste stream of carbonaceous materials, multiple independently controllable augers, a reactor and an incinerator. The reactor receives a waste stream from the feeder and using a controllable heating element assembly converts the carbonaceous materials in the waste stream to syngas. The incinerator uses the syngas from the reactor to incinerate separately received black water waste from a storage tank.
FILED Thursday, July 16, 2015
APPL NO 14/801048
ART UNIT 3743 — Thermal & Combustion Technology, Motive & Fluid Power Systems
CURRENT CPC
Production of Producer Gas, Water-gas, Synthesis Gas From Solid Carbonaceous Material, or Mixtures Containing These Gases; Carburetting Air or Other Gases
C10J 3/007 (20130101)
C10J 2200/15 (20130101)
C10J 2300/0946 (20130101)

Cremation Furnaces; Consuming Waste Products by Combustion
F23G 5/12 (20130101)
F23G 5/0276 (20130101) Original (OR) Class
F23G 5/444 (20130101)
F23G 5/446 (20130101)
F23G 2203/70 (20130101)
F23G 2900/50001 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10094641 Thouless et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Office of Naval Research (ONR)
APPLICANT(S) The Regents of The University of Michigan (Ann Arbor, Michigan)
ASSIGNEE(S) The Regents of The University of Michigan (Ann Arbor, Michigan)
INVENTOR(S) Michael Thouless (Ann Arbor, Michigan);  Ellen M. Arruda (Ann Arbor, Michigan);  Tanaz Rahimzadeh (Ann Arbor, Michigan);  Levon Cimonian (Kentwood, Michigan);  Marie Rice (Ann Arbor, Michigan)
ABSTRACT A tuning and mitigation system and method for mitigating a blast or impact event having an elastic layer having an acoustic impedance chosen to tune stress waves resulting from the blast or impact to one or more specific tuned frequencies, and a dissipative layer made of a viscoelastic material having a critical damping frequency that matches at least one or more specific tuned frequencies.
FILED Monday, April 09, 2018
APPL NO 15/948505
ART UNIT 3641 — Aeronautics, Agriculture, Fishing, Trapping, Vermin Destroying, Plant and Animal Husbandry, Weaponry, Nuclear Systems, and License and Review
CURRENT CPC
Armour; Armoured Turrets; Armoured or Armed Vehicles; Means of Attack or Defence, e.g Camouflage, in General
F41H 1/04 (20130101)
F41H 5/04 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10094646 Albright et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S) The Boeing Company (Chicago, Illinois)
ASSIGNEE(S) The Boeing Company (Chicago, Illinois)
INVENTOR(S) Justin G. Albright (La Mirada, California);  Aaron J. Kutzmann (Long Beach, California)
ABSTRACT A rocket comprises at least one propulsion unit including a pivotable rocket motor, a spring-assisted one-time deployment mechanism, and a release mechanism. The pivotable rocket motor is pivotable between a stowed position and a deployed position. The spring-assisted one-time deployment mechanism moves the rocket motor from the stowed position to the deployed position when the deployment mechanism is released by the release mechanism. Outer geometry of the rocket is changed as the rocket motor is moved to the deployed position.
FILED Monday, April 13, 2015
APPL NO 14/685585
ART UNIT 3648 — Aeronautics, Agriculture, Fishing, Trapping, Vermin Destroying, Plant and Animal Husbandry, Weaponry, Nuclear Systems, and License and Review
CURRENT CPC
Equipment for Fitting in or to Aircraft; Flying Suits; Parachutes; Arrangements or Mounting of Power Plants or Propulsion Transmissions in Aircraft
B64D 1/02 (20130101)

Jet-propulsion Plants
F02K 9/976 (20130101)

Indexing Scheme for Aspects Relating to Non-positive-displacement Machines or Engines, Gas-turbines or Jet-propulsion Plants
F05D 2260/311 (20130101)

Explosive Charges, e.g for Blasting, Fireworks, Ammunition
F42B 15/10 (20130101)
F42B 15/36 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10094866 Davis
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Naval Surface Warfare Center (NSWC)
APPLICANT(S) The United States of America as represented by the Secretary of the Navy (Washington, District of Columbia)
ASSIGNEE(S) The United States of America, as represented by the Secretary of the Navy (Washington, District of Columbia)
INVENTOR(S) Brent E. Davis (Bloomington, Indiana)
ABSTRACT The methods and apparatus described herein are designed and configured to allow one user to test cable continuity using a wire-configurable directional connector. The methods and apparatus may transmit a first and second voltage pulse through a first and second wire of a cable under test, respectively, having a wire-configurable directional connector attached. Both voltage pulses travel through the wire-configurable directional connector. The first voltage pulse selectively leaves at least one of the second wire and a third wire of the cable under test and the second voltage pulse selectively leaves the third wire. The methods and apparatus may store a pre-determined pattern of a returning voltage pulse specific to the cable under test, and determine a state of the first, second, and third wires in response to receiving the first and second voltage pulses.
FILED Wednesday, April 01, 2015
APPL NO 14/676783
ART UNIT 2858 — Printing/Measuring and Testing
CURRENT CPC
Measuring Electric Variables; Measuring Magnetic Variables
G01R 1/04 (20130101)
G01R 1/0416 (20130101)
G01R 3/00 (20130101)
G01R 31/11 (20130101)
G01R 31/021 (20130101)
G01R 31/026 (20130101) Original (OR) Class

Technical Subjects Covered by Former US Classification
Y10T 29/49171 (20150115)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10094928 Josset et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
APPLICANT(S) The Government of the United States of America, as represented by the Secretary of the Navy (Washington, District of Columbia)
ASSIGNEE(S) The Govemment of the United States ofAmerica, as represented by the Secretary of the Navy (Washington, District of Columbia)
INVENTOR(S) Damien Josset (Covington, Louisiana);  Weilin Hou (Slidell, Louisiana)
ABSTRACT Embodiments relate to characterizing underwater turbulence. Initially, multispectral laser light (MLL) is generated and then converted to output laser light (OLL). The OLL is received at a polarization rotator that causes the OLL to be emitted in one of multiple modes of polarization. Next, the OLL is directed toward a target medium, where the OLL causes backscattered light to be emitted from the target medium. While using the polarization rotator to switch between the multiple modes of polarization, Stokes parameters of the backscattered light are detected and then used to characterize the underwater turbulence of the target medium.
FILED Tuesday, February 21, 2017
APPL NO 15/438717
ART UNIT 2886 — Optics
CURRENT CPC
Radio Direction-finding; Radio Navigation; Determining Distance or Velocity by Use of Radio Waves; Locating or Presence-detecting by Use of the Reflection or Reradiation of Radio Waves; Analogous Arrangements Using Other Waves
G01S 7/499 (20130101)
G01S 17/95 (20130101) Original (OR) Class

Technologies for Adaptation to Climate Change
Y02A 90/19 (20180101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10094978 Wu et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
APPLICANT(S) The Government of the United States of America, as represented by the Secretary of the Navy (Arlington, Virginia)
ASSIGNEE(S) The United States of America, as represented by the Secretary of the Navy (Washington, District of Columbia)
INVENTOR(S) Dong Ho Wu (Olney, Maryland);  Benjamin Graber (Washington, District of Columbia)
ABSTRACT Systems and method are provided for producing portable, high power, broadband terahertz emitters based on arrayed terahertz photoconductive antennas. After such an arrayed structure is made, the phase of terahertz signals that are produced by each photoconductive antenna can be adjusted, and the terahertz signals can be added such that the signals are added constructively. Terahertz emitters based on terahertz photoconductive antenna arrays are advantageously small in size and scalable, allowing for terahertz power to be increased by adding more photoconductive antenna arrays.
FILED Thursday, June 23, 2016
APPL NO 15/191299
ART UNIT 2884 — Optics
CURRENT CPC
Optical Elements, Systems, or Apparatus
G02B 6/10 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10094988 Sandhu
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S) Gurtej Sandhu (Boise, Idaho)
ASSIGNEE(S) Micron Technology, Inc. (Boise, Idaho)
INVENTOR(S) Gurtej Sandhu (Boise, Idaho)
ABSTRACT The disclosed embodiments relate to an integrated circuit structure and methods of forming them in which photonic devices are formed on the back end of fabricating a CMOS semiconductor structure containing electronic devices. Doped regions associated with the photonic devices are formed using microwave annealing for dopant activation.
FILED Friday, August 31, 2012
APPL NO 13/600779
ART UNIT 2828 — Semiconductors/Memory
CURRENT CPC
Optical Elements, Systems, or Apparatus
G02B 6/42 (20130101) Original (OR) Class
G02B 6/122 (20130101)
G02B 2006/12169 (20130101)

Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 21/324 (20130101)
H01L 27/0617 (20130101)
H01L 31/1864 (20130101)
H01L 31/02327 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10095089 Po et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Research Laboratory (AFRL)
APPLICANT(S) RAYTHEON COMPANY (Waltham, Massachusetts)
ASSIGNEE(S) RAYTHEON COMPANY (Waltham, Massachusetts)
INVENTOR(S) Li Chiao Po (El Segundo, California);  Ray McVey (El Segundo, California)
ABSTRACT A lens mount assembly is configured to support a lens assembly having a lens ring and at least one lens secured to the lens ring. The lens mount assembly includes a ring mount having an annular body with at least two retaining arms that project from the annular body, a flexure configured to be secured to the ring mount, and at least two bellows. Each bellows is configured to be secured to a respective retaining arm of the at least two retaining arms of the ring mount. The at least two bellows further are configured to engage the flexure.
FILED Tuesday, May 17, 2016
APPL NO 15/156865
ART UNIT 2662 — Image Analysis; Applications; Pattern Recognition; Color and compression; Enhancement and Transformation
CURRENT CPC
Equipment for Fitting in or to Aircraft; Flying Suits; Parachutes; Arrangements or Mounting of Power Plants or Propulsion Transmissions in Aircraft
B64D 47/08 (20130101)

Optical Elements, Systems, or Apparatus
G02B 7/004 (20130101)
G02B 7/021 (20130101)
G02B 7/023 (20130101)
G02B 7/026 (20130101)
G02B 7/028 (20130101)
G02B 7/1825 (20130101)
G02B 13/008 (20130101)

Apparatus or Arrangements for Taking Photographs or for Projecting or Viewing Them; Apparatus or Arrangements Employing Analogous Techniques Using Waves Other Than Optical Waves; Accessories Therefor
G03B 17/12 (20130101) Original (OR) Class
G03B 17/565 (20130101)

Pictorial Communication, e.g Television
H04N 5/2252 (20130101)
H04N 5/2254 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10095193 Irizarry
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Naval Surface Warfare Center (NSWC)
APPLICANT(S) The United States of America as represented by the Secretary of the Navy (Washington, District of Columbia)
ASSIGNEE(S) The United States of America, as represented by the Secretary of the Navy (Washington, District of Columbia)
INVENTOR(S) George L. Irizarry (Bloomington, Indiana)
ABSTRACT Exemplary apparatuses and methods are provided which provide a safety system that automatically controls charge and discharge of high voltage (HV) capacitors upon application or removal of HV power to a HV system (e.g., a surveillance radar) that includes different timing and sequencing for turn-on/turn operations. In one embodiment, an apparatus and method automatically discharges high voltage (HV) capacitors when HV power is deactivated. Another aspect of an embodiment of the invention automatically deactivates a HV capacitor shunt when the HV system's main HV power is applied or activated. Additionally, an exemplary apparatus requires no human interaction when shunting the HV capacitors, increasing electrical system safety.
FILED Monday, October 05, 2015
APPL NO 14/874892
ART UNIT 2836 — Electrical Circuits and Systems
CURRENT CPC
Control or Regulating Systems in General; Functional Elements of Such Systems; Monitoring or Testing Arrangements for Such Systems or Elements
G05B 9/02 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10095198 Ross et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
APPLICANT(S) The United States of America, as represented by the Secretary of the Navy (Washington, District of Columbia)
ASSIGNEE(S) The United States of America, as represented by the Secretary of the Navy (Washington, District of Columbia)
INVENTOR(S) Isaac Michael Ross (Monterey, California);  Mark Karpenko (Salinas, California);  Ronald J. Proulx (Waban, Massachusetts)
ABSTRACT The disclosure provides a closed-loop controller for a controlled system comprising a comparison element generating an error e, a compensator generating a control uN value based on the error e, and a control allocator determining a manipulated parameter uM value based on the control uN. The control allocator typically utilizes a control effectiveness function and determines uM value by selecting one or more specific system x0 signals from the system state xi or system input yj values or system parameters values pk reported, defining a plurality of distributed xD around each specific system x0 signal, and minimizing an error function E(zi), where the error function E(zi) is based on errors which arise from use of the plurality of distributed xD in the control effectiveness function rather than one or more specific system x0 signals.
FILED Thursday, July 06, 2017
APPL NO 15/643135
ART UNIT 2121 — AI & Simulation/Modeling
CURRENT CPC
Control or Regulating Systems in General; Functional Elements of Such Systems; Monitoring or Testing Arrangements for Such Systems or Elements
G05B 13/04 (20130101)
G05B 13/042 (20130101)
G05B 13/045 (20130101) Original (OR) Class
G05B 13/048 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10095248 Ruffa
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
APPLICANT(S) Anthony A Ruffa (Hope Valley, Rhode Island)
ASSIGNEE(S) The United States of America as represented by the Secretary of the Navy (Washington, District of Columbia)
INVENTOR(S) Anthony A Ruffa (Hope Valley, Rhode Island)
ABSTRACT A method for isolating vibrations from a source on a structure includes modeling the structure as a beam having a portion for isolation. A sensor is positioned proximate to the source, and at least one actuator is positioned on the structure between the source and the portion for isolation. A controller receives signals from the sensor and calculates vibrational inputs for each actuator that will isolate the structure portion. Driving signals are provided to each actuator by the controller in response to the calculated vibrational inputs, and each actuator is vibrated accordingly, isolating the structure portion from the source. This method can be implemented in multiple configurations to isolate the structure portion.
FILED Monday, November 07, 2016
APPL NO 15/344754
ART UNIT 2121 — AI & Simulation/Modeling
CURRENT CPC
Methods or Apparatus for Generating or Transmitting Mechanical Vibrations of Infrasonic, Sonic, or Ultrasonic Frequency, for Performing Mechanical Work in General
B06B 1/0207 (20130101)

Structural Elements; Building Materials
E04C 3/02 (20130101)

Control or Regulating Systems in General; Functional Elements of Such Systems; Monitoring or Testing Arrangements for Such Systems or Elements
G05B 17/02 (20130101)

Systems for Controlling or Regulating Non-electric Variables
G05D 19/02 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10095262 Valley et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
The Aerospace Corporation (AEROSPACE)
Federally Funded Research and Development Center (FFRDC)
Operated by The Aerospace Corporation (AEROSPACE) at El Segundo, CA
APPLICANT(S) The Aerospace Corporation (El Segundo, California)
ASSIGNEE(S) The Aerospace Corporation (El Segundo, California)
INVENTOR(S) George C. Valley (Los Angeles, California);  Thomas Justin Shaw (Reston, Virginia)
ABSTRACT Under one aspect, a method for performing a linear algebra operation includes imposing matrix elements onto a chirped optical carrier; inputting into a multi-mode optic the matrix elements imposed on the chirped optical carrier; outputting by the multi-mode optic a speckle pattern based on the matrix elements imposed on the optical carrier; and performing a linear algebra operation on the matrix elements based on the speckle pattern. The matrix elements can be from matrix A and a vector b, and the multi-mode optic can optically transform each of matrix A and vector b by a speckle transformation S, so as to output a speckle pattern including elements of a matrix SA of dimension p,n and matrix elements of a vector Sb of dimension p. The linear algebra operation can include generating {tilde over (x)}=(SA)Sb, wherein † indicates a pseudo-inverse operation.
FILED Monday, December 12, 2016
APPL NO 15/376500
ART UNIT 2182 — Computer Architecture and I/O
CURRENT CPC
Optical Computing Devices;
G06E 1/00 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10095494 Meister et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Research Laboratory (AFRL)
APPLICANT(S) Reservoir Labs, Inc. (New York, New York)
ASSIGNEE(S) Reservoir Labs, Inc. (New York, New York)
INVENTOR(S) Benoit J. Meister (New York, New York);  Muthu M. Baskaran (Bayonne, New Jersey);  Richard A. Lethin (New York, New York)
ABSTRACT A system can generate and impose constraints on a compiler/scheduler so as to specifically minimize the footprints of one or more program variables. The constraints can be based on scopes of the variables and/or on dependence distances between statements specifying operations that use the one or more program variables.
FILED Friday, August 28, 2015
APPL NO 14/839539
ART UNIT 2192 — Interprocess Communication and Software Development
CURRENT CPC
Electric Digital Data Processing
G06F 8/4434 (20130101)
G06F 8/4441 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10095837 Corey et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
Department of the Navy (DON)
APPLICANT(S) Medtronic, Inc. (Minneapolis, Minnesota)
ASSIGNEE(S) Medtronic, Inc. (Minneapolis, Minnesota)
INVENTOR(S) Robert A. Corey (Arden Hills, Minnesota);  Gregory J. Loxtercamp (Edina, Minnesota);  Heather Diane Orser (Farmington, Minnesota);  Scott R. Stanslaski (Shoreview, Minnesota);  Jadin C. Jackson (Roseville, Minnesota)
ABSTRACT Techniques are described for real-time phase detection. For the phase detection, a signal is correlated with a frequency component of a frequency band whose phase is being detected, and the correlation includes predominantly decreasing weighting of past portions of the signals.
FILED Wednesday, November 18, 2015
APPL NO 14/945139
ART UNIT 2829 — Semiconductors/Memory
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/048 (20130101)
A61B 5/686 (20130101)
A61B 5/04014 (20130101)
A61B 5/4088 (20130101)
A61B 5/4094 (20130101)
A61B 5/4836 (20130101)
A61B 5/4839 (20130101)
A61B 5/7246 (20130101)
A61B 5/7257 (20130101)

Electric Digital Data Processing
G06F 19/3406 (20130101) Original (OR) Class

Healthcare Informatics, i.e Information and Communication Technology [ICT] Specially Adapted for the Handling or Processing of Medical or Healthcare Data
G16H 40/63 (20180101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10096097 Fleizach et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Space and Naval Warfare Systems Center (SPAWAR)
APPLICANT(S) SPAWAR Systems Center Pacific (San Diego, California)
ASSIGNEE(S) The United States of America as represented by the Secretary of the Navy (Washington, District of Columbia)
INVENTOR(S) Gregory Knowles Fleizach (San Diego, California);  Brian Matthew Sperlongano (North Kingstown, Rhode Island);  Kevin Donald Casey (Alexandria, Virginia)
ABSTRACT A method for highlighting edges of interest in an image comprising the following steps: calculating edge intensity of edges in the image using gradient operators; applying a transformation to emphasize mid-level edges and deemphasize strong edges; and if a given transformed edge is greater than a threshold value, highlighting the corresponding edge in an edge-highlighted image.
FILED Monday, August 01, 2016
APPL NO 15/225621
ART UNIT 2665 — Image Analysis; Applications; Pattern Recognition; Color and compression; Enhancement and Transformation
CURRENT CPC
Image Data Processing or Generation, in General
G06T 5/002 (20130101)
G06T 5/003 (20130101)
G06T 5/20 (20130101) Original (OR) Class
G06T 7/0085 (20130101)
G06T 7/0095 (20130101)
G06T 2207/20192 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10096148 Case et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
The Aerospace Corporation (AEROSPACE)
Federally Funded Research and Development Center (FFRDC)
Operated by The Aerospace Corporation (AEROSPACE) at El Segundo, CA
APPLICANT(S) The Aerospace Corporation (El Segundo, California)
ASSIGNEE(S) The Aerospace Corporation (El Segundo, California)
INVENTOR(S) Joseph T. Case (El Segundo, California);  Shant Kenderian (El Segundo, California);  Eric C. Johnson (El Segundo, California)
ABSTRACT A portable x-ray computed tomography (CT) system may utilize algebraic reconstruction techniques (ART) to produce 3D volume images from tens of shots or less. The system may be deployed as desired where x-ray source and detector positions are not known beforehand. A fast, accurate matrix may be formed relating voxels to detector pixels via a modified ray tracing algorithm, eliminating artifacts caused by approaches using rough approximations. Masking or recombination may be performed to remove detector pixels that are not part of a region of interest (ROI) or lump the pixels together as one unknown, significantly reducing matrix size, and hence, computation time. The positions and orientations of the x-ray source and detector may be treated as unknowns and refined to optimize a volume image metric. For example, the optimized metric could be image contrast, image sparsity, or total variation.
FILED Wednesday, April 26, 2017
APPL NO 15/497280
ART UNIT 2667 — Image Analysis; Applications; Pattern Recognition; Color and compression; Enhancement and Transformation
CURRENT CPC
Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 23/046 (20130101)
G01N 2223/401 (20130101)
G01N 2223/419 (20130101)

Image Data Processing or Generation, in General
G06T 11/006 (20130101)
G06T 11/008 (20130101)
G06T 15/08 (20130101) Original (OR) Class
G06T 2207/10081 (20130101)
G06T 2211/424 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10096348 Lynch et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
Department of the Navy (DON)
APPLICANT(S) Purdue Research Foundation (West Lafayette, Indiana)
ASSIGNEE(S) Purdue Research Foundation (West Lafayette, Indiana)
INVENTOR(S) John K. Lynch (West Lafayette, Indiana);  Pedro P. Irazoqui (West Lafayette, Indiana)
ABSTRACT An electronic memory array includes a plurality of memory domains, a current controller, and a selector device. Each memory domain includes a plurality of bit cells. The current controller includes a current controller output electrically connectable to said plurality of memory domains and is configured to control a bit cell current. The selector device is electrically connected to the current controller and the plurality of memory domains. The selector device is configured to selectively electrically connect the current controller output to only a select one of said memory domains, such that the current controller controls only the bit cell current of the bit cells of the select memory domain.
FILED Monday, May 16, 2016
APPL NO 15/155905
ART UNIT 2824 — Semiconductors/Memory
CURRENT CPC
Static Stores
G11C 7/08 (20130101)
G11C 7/12 (20130101) Original (OR) Class
G11C 7/14 (20130101)
G11C 7/065 (20130101)
G11C 7/106 (20130101)
G11C 7/1051 (20130101)
G11C 11/419 (20130101)
G11C 11/565 (20130101)
G11C 11/4091 (20130101)
G11C 11/4094 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10096385 Thibeault et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S) HRL Laboratories, LLC (Malibu, California)
ASSIGNEE(S) HRL Laboratories, LLC (Malibu, California)
INVENTOR(S) Corey M. Thibeault (Encino, California);  Narayan Srinivasa (Portland, Oregon)
ABSTRACT Described is a system for controlling epidural spinal cord stimulation. Using an Unscented Kalman Filter (UKF), the system receives sensed physiological signals from a subject and, based on the sensed physiological signals, estimating an unobservable state of a target area on the subject. A central pattern generator is then used to generate a stimulation pattern based on the unobservable state. The stimulation pattern is applied to the target area (e.g., spinal cord) of the subject using an electrode array. Receiving feedback, the UKF continuously updates a model of the spinal cord, which results in adjustment of the stimulation pattern as necessary.
FILED Monday, July 25, 2016
APPL NO 15/219162
ART UNIT 3762 — Refrigeration, Vaporization, Ventilation, and Combustion
CURRENT CPC
Electrotherapy; Magnetotherapy; Radiation Therapy; Ultrasound Therapy
A61N 1/3787 (20130101)
A61N 1/36067 (20130101)
A61N 1/36071 (20130101)

Electric Digital Data Processing
G06F 19/3437 (20130101)

Healthcare Informatics, i.e Information and Communication Technology [ICT] Specially Adapted for the Handling or Processing of Medical or Healthcare Data
G16H 50/50 (20180101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10096729 Rappe et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Materiel Command (AFMC)
Air Force Office of Scientific Research (AFOSR)
Department of the Navy (DON)
Office of Naval Research (ONR)
Department of Energy (DOE)
Office of Science (DOE-SC)
Basic Energy Sciences (BES)
APPLICANT(S) The Trustees of The University of Pennsylvania (Philadelphia, Pennsylvania)
ASSIGNEE(S) The Trustees of The University of Pennsylvania (Philadelphia, Pennsylvania)
INVENTOR(S) Andrew M. Rappe (Penn Valley, Pennsylvania);  Steve M. Young (Alexandria, Virginia);  Fan Zheng (Philadelphia, Pennsylvania)
ABSTRACT The present invention provides materials with high bulk photovoltaic effect response. The present invention also provides for products comprising the high bulk photovoltaic effect materials of the present invention.
FILED Friday, January 23, 2015
APPL NO 15/112708
ART UNIT 1736 — Metallurgy, Metal Working, Inorganic Chemistry, Catalyst, Electrophotography, Photolithography
CURRENT CPC
Compounds of Alkali Metals, i.e Lithium, Sodium, Potassium, Rubidium, Caesium, or Francium
C01D 15/02 (20130101)

Compounds of the Metals Beryllium, Magnesium, Aluminium, Calcium, Strontium, Barium, Radium, Thorium, or of the Rare-earth Metals
C01F 5/00 (20130101)

Compounds Containing Metals Not Covered by Subclasses C01D or C01F
C01G 21/02 (20130101)

Indexing Scheme Relating to Structural and Physical Aspects of Solid Inorganic Compounds
C01P 2006/40 (20130101)

Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 31/032 (20130101) Original (OR) Class
H01L 31/068 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10096733 Kagan et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Office of Naval Research (ONR)
Multidisciplinary University Research Initiative (MURI)
Department of Energy (DOE)
Office of Science (DOE-SC)
Basic Energy Sciences (BES)
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Chemical, Bioengineering, Environmental and Transport Systems (CBET)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Mathematical Sciences (DMS)
APPLICANT(S) THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (Philadelphia, Pennsylvania)
ASSIGNEE(S) The Trustees of the University of Pennsylvania (Philadelphia, Pennsylvania)
INVENTOR(S) Cherie R. Kagan (Bala-Cynwyd, Pennsylvania);  Aaron T. Fafarman (Philadelphia, Pennsylvania);  Ji-Hyuk Choi (Philadelphia, Pennsylvania);  Weon-Kyu Koh (Los Alamos, New Mexico);  David K. Kim (Lincoln, Massachusetts);  Soong Ju Oh (Philadelphia, Pennsylvania);  Yuming Lai (Philadelphia, Pennsylvania);  Sung-Hoon Hong (Daejeon, South Korea);  Sangameshwar Rao Saudari (Fishkill, New York);  Christopher B. Murray (Bala Cynwyd, Pennsylvania)
ABSTRACT Methods of preparing a dispersion of colloidal nanocrystals (NCs) for use as NC thin films are disclosed. A dispersion of NCs capped with ligands may be mixed with a solution containing chalcogenocyanate (xCN)-based ligands. The mixture may be separated into a supernatant and a flocculate. The flocculate may be dispersed with a solvent to form a subsequent dispersion of NCs capped with xCN-based ligands.
FILED Tuesday, May 10, 2016
APPL NO 15/150816
ART UNIT 1715 — Coating, Etching, Cleaning, Single Crystal Growth
CURRENT CPC
Specific Uses or Applications of Nanostructures; Measurement or Analysis of Nanostructures; Manufacture or Treatment of Nanostructures
B82Y 10/00 (20130101)
B82Y 20/00 (20130101)
B82Y 40/00 (20130101)

Cables; Conductors; Insulators; Selection of Materials for Their Conductive, Insulating or Dielectric Properties
H01B 1/06 (20130101)

Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 29/18 (20130101)
H01L 29/22 (20130101)
H01L 29/24 (20130101)
H01L 29/45 (20130101)
H01L 29/127 (20130101)
H01L 29/413 (20130101)
H01L 29/0665 (20130101)
H01L 29/2203 (20130101)
H01L 29/4908 (20130101)
H01L 29/66969 (20130101)
H01L 29/78603 (20130101)
H01L 29/78681 (20130101)
H01L 31/07 (20130101) Original (OR) Class
H01L 31/18 (20130101)
H01L 31/0324 (20130101)

Reduction of Greenhouse Gas [GHG] Emissions, Related to Energy Generation, Transmission or Distribution
Y02E 10/50 (20130101)

Technical Subjects Covered by Former USPC Cross-reference Art Collections [XRACs] and Digests
Y10S 977/891 (20130101)
Y10S 977/938 (20130101)
Y10S 977/954 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10096734 Kagan et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Office of Naval Research (ONR)
Multidisciplinary University Research Initiative (MURI)
Department of Energy (DOE)
Office of Science (DOE-SC)
Basic Energy Sciences (BES)
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Chemical, Bioengineering, Environmental and Transport Systems (CBET)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Mathematical Sciences (DMS)
APPLICANT(S) THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (Philadelphia, Pennsylvania)
ASSIGNEE(S) The Trustees of the University of Pennsylvania (Philadelphia, Pennsylvania)
INVENTOR(S) Cherie R. Kagan (Bala-Cynwyd, Pennsylvania);  Aaron T. Fafarman (Philadelphia, Pennsylvania);  Ji-Hyuk Choi (Philadelphia, Pennsylvania);  Weon-Kyu Koh (Los Alamos, New Mexico);  David K. Kim (Lincoln, Massachusetts);  Soong Ju Oh (Philadelphia, Pennsylvania);  Yuming Lai (Philadelphia, Pennsylvania);  Sung-Hoon Hong (Daejeon, South Korea);  Sangameshwar Rao Saudari (Fishkill, New York);  Christopher B. Murray (Bala Cynwyd, Pennsylvania)
ABSTRACT Methods of forming colloidal nanocrystal (NC)-based thin film devicesare disclosed. The methods include the steps of depositing a dispersion of NCs on a substrate to form a NC thin-film, wherein at least a portion of the NCs is capped with chalcogenocyanate (xCN)-based ligands; and doping the NC thin-film with a metal.
FILED Tuesday, May 10, 2016
APPL NO 15/150824
ART UNIT 1715 — Coating, Etching, Cleaning, Single Crystal Growth
CURRENT CPC
Specific Uses or Applications of Nanostructures; Measurement or Analysis of Nanostructures; Manufacture or Treatment of Nanostructures
B82Y 10/00 (20130101)
B82Y 20/00 (20130101)
B82Y 40/00 (20130101)

Cables; Conductors; Insulators; Selection of Materials for Their Conductive, Insulating or Dielectric Properties
H01B 1/06 (20130101)

Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 29/18 (20130101)
H01L 29/22 (20130101)
H01L 29/24 (20130101)
H01L 29/45 (20130101)
H01L 29/127 (20130101)
H01L 29/413 (20130101)
H01L 29/0665 (20130101)
H01L 29/2203 (20130101)
H01L 29/4908 (20130101)
H01L 29/66969 (20130101)
H01L 29/78603 (20130101)
H01L 29/78681 (20130101)
H01L 31/07 (20130101) Original (OR) Class
H01L 31/18 (20130101)
H01L 31/0324 (20130101)

Reduction of Greenhouse Gas [GHG] Emissions, Related to Energy Generation, Transmission or Distribution
Y02E 10/50 (20130101)

Technical Subjects Covered by Former USPC Cross-reference Art Collections [XRACs] and Digests
Y10S 977/891 (20130101)
Y10S 977/938 (20130101)
Y10S 977/954 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10096742 Shatalov et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
APPLICANT(S) Sensor Electronic Technology, Inc. (Columbia, South Carolina)
ASSIGNEE(S) Sensor Electronic Technology, Inc. (Columbia, South Carolina)
INVENTOR(S) Maxim S. Shatalov (Columbia, South Carolina);  Jianyu Deng (Lexington, South Carolina);  Alexander Dobrinsky (Loudonville, New York);  Xuhong Hu (Columbia, South Carolina);  Remigijus Gaska (Columbia, South Carolina);  Michael Shur (Latham, New York)
ABSTRACT A light emitting device having improved light extraction is provided. The light emitting device can be formed by epitaxially growing a light emitting structure on a surface of a substrate. The substrate can be scribed to form a set of angled side surfaces on the substrate. For each angled side surface in the set of angled side surfaces, a surface tangent vector to at least a portion of each angled side surface in the set of angled side surfaces forms an angle between approximately ten and approximately eighty degrees with a negative of a normal vector of the surface of the substrate. The substrate can be cleaned to clean debris from the angled side surfaces.
FILED Wednesday, December 30, 2015
APPL NO 14/984246
ART UNIT 2894 — Semiconductors/Memory
CURRENT CPC
Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 33/20 (20130101)
H01L 33/22 (20130101)
H01L 33/0095 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10096955 Higgins et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
APPLICANT(S) The United States of America, as represented by the Secretary of the Navy (Washington, District of Columbia)
ASSIGNEE(S) The United States of America as Represented by the Secretary of the Navy (Washington, District of Columbia)
INVENTOR(S) Shawn Orion Higgins (Ridgecrest, California);  Andrew K. Yuenger (Ridgecrest, California);  Stephen G. Hall (Ridgecrest, California)
ABSTRACT A high voltage radio frequency (RF) coaxial cable connector. The high voltage RF coaxial cable connector may withstand high voltages (e.g., above 200 kV) and may provide impedance matching at RF frequencies. The high voltage RF coaxial cable connector may comprise a bulkhead connector and coaxial cable connector, both of which may be adapted to electrically couple a coaxial cable to a bulkhead. As the bulkhead connector matingly engages the coaxial cable connector, a first air gap may form therebetween, having an impedance determined, at least in part, by an air gap distance between the dielectrics inserts of the bulkhead connector and the coaxial cable connector. A second air gap may also be formed between the center conductor plug portion and shield portion of a coaxial cable coupled by the coaxial cable connector. The second air gap may have approximately the same air gap distance as the first air gap.
FILED Monday, October 02, 2017
APPL NO 15/722740
ART UNIT 2831 — Electrical Circuits and Systems
CURRENT CPC
Electrically-conductive Connections; Structural Associations of a Plurality of Mutually-insulated Electrical Connecting Elements; Coupling Devices; Current Collectors
H01R 9/05 (20130101)
H01R 13/46 (20130101)
H01R 24/52 (20130101)
H01R 24/542 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10097153 Rowland et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Space and Naval Warfare Systems Center (SPAWAR)
APPLICANT(S) SPAWAR Systems Center Pacific (San Diego, California)
ASSIGNEE(S) The United States of America as represented by Secretary of the Navy (Washington, District of Columbia)
INVENTOR(S) Jason F. Rowland (San Diego, California);  Jia-Chi S. Chieh (San Diego, California)
ABSTRACT A bandstop filter is provided that includes an input port, a series bandpass resonator, a first capacitor, a bandstop resonator, a second capacitor and an output port. The combination of the first capacitor, the bandstop resonator and the second capacitor comprises a bandstop impedance magnitude and a bandstop impedance phase. The bandpass resonator impedance magnitude is substantially equal to the bandstop impedance magnitude. The bandpass resonator impedance phase is substantially 180° out of phase with the bandstop impedance phase. The series bandpass resonator, the first capacitor, the bandstop resonator and the second capacitor operate as a band stop for a predetermined frequency within the frequency band.
FILED Friday, March 10, 2017
APPL NO 15/455299
ART UNIT 2842 — Electrical Circuits and Systems
CURRENT CPC
Impedance Networks, e.g Resonant Circuits; Resonators
H03H 7/07 (20130101)
H03H 7/12 (20130101) Original (OR) Class
H03H 7/0115 (20130101)
H03H 2007/013 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10097199 Kushner et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
APPLICANT(S) BAE SYSTEMS Information and Electronic Systems Integration Inc. (Nashua, New Hampshire)
ASSIGNEE(S) BAE Systems Information and Electronic Systems Integration Inc. (Nashua, New Hampshire)
INVENTOR(S) Lawrence J. Kushner (Andover, Massachusetts);  Mark E. Stuenkel (Goffstown, New Hampshire);  Steven E. Turner (Nashua, New Hampshire)
ABSTRACT A digital to analog converter (DAC) circuit is disclosed which employs isolation providing cascode devices to reduce data dependent signal distortion. A DAC circuit configured according to an embodiment includes a current source associated with each bit of a digital word that is to be converted. Each current source is coupled to a current switch that is controlled by the associated bit. The DAC also includes a cascode device coupled to each of the current switches through a feed line. The DAC further includes a summing junction configured to generate an analog output signal corresponding to the digital word based on a sum of currents provided by the current sources, through the current switches and the feed lines. The cascode devices provide impedance matching and isolation between the feed lines and the summing junction to reduce signal reflections between the current switches and the summing junction to improve conversion performance.
FILED Monday, February 12, 2018
APPL NO 15/893895
ART UNIT 2845 — Electrical Circuits and Systems
CURRENT CPC
Electric Digital Data Processing
G06F 9/223 (20130101)

Amplifiers
H03F 3/45179 (20130101)

Coding; Decoding; Code Conversion in General
H03M 1/742 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10097221 Gupta et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
APPLICANT(S) Hypres, Inc. (Elmsford, New York)
ASSIGNEE(S) Hypres, Inc. (Emsford, New York)
INVENTOR(S) Deepnarayan Gupta (Briarcliff Manor, New York);  Amol Inamdar (Elmsford, New York)
ABSTRACT A radio frequency receiver subject to a large in-band interferor employs active cancellation with coarse and at least one fine cancellation signal, each with a respective radio frequency combiner, in order to increase the effective dynamic range of the receiver for weak signals of interest. One or both can be digitally synthesized. This is particularly applicable for co-site interference, whereby the interfering transmit signal is directly accessible. A similar system and method may also be applied to external interferors such as those produced by deliberate or unintentional jamming signals, or by strong multipath signals. An adaptive algorithm may be used for dynamic delay and gain matching. In a preferred embodiment, a hybrid technology hybrid temperature system incorporates both superconducting and semiconducting components to achieve enhanced broadband performance.
FILED Monday, December 04, 2017
APPL NO 15/831209
ART UNIT 2647 — Telecommunications: Analog Radio Telephone; Satellite and Power Control; Transceivers, Measuring and Testing; Bluetooth; Receivers and Transmitters; Equipment Details
CURRENT CPC
Transmission
H04B 1/10 (20130101) Original (OR) Class
H04B 1/109 (20130101)
H04B 1/525 (20130101)
H04B 7/15585 (20130101)

Transmission of Digital Information, e.g Telegraphic Communication
H04L 27/01 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10097258 Wakayama et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Space and Naval Warfare Systems Center (SPAWAR)
APPLICANT(S) SPAWAR Systems Center Pacific (San Diego, California)
ASSIGNEE(S) The United States of America as represented by Secretary of the Navy (Washington, District of Columbia)
INVENTOR(S) Cherry Y. Wakayama (San Diego, California);  Peter J. Yoo (San Diego, California);  Zelda B. Zabinsky (Seattle, Washington)
ABSTRACT Delivery of a plurality of messages by a satellite is scheduled taking energy into account. An amount of time needed to deliver each of the plurality of messages received from a plurality of ground sources and intended for a plurality of ground recipients at respective different destinations is estimated based on the size of each of the messages. Each different destination has an associated contact time window during which the satellite will be in range of the ground recipients at that destination. An amount of energy that will be available from a power source for delivering the messages during each contact window is determined. Delivery of the plurality of messages to the ground recipients is scheduled such that a total time for delivery of the messages is minimized.
FILED Thursday, April 06, 2017
APPL NO 15/480634
ART UNIT 2472 — Multiplex and VoIP
CURRENT CPC
Circuit Arrangements or Systems for Supplying or Distributing Electric Power; Systems for Storing Electric Energy
H02J 7/35 (20130101)

Transmission
H04B 7/18513 (20130101) Original (OR) Class
H04B 7/18519 (20130101)

Wireless Communication Networks
H04W 72/10 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10097383 Bulzacchelli et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
National Security Agency (NSA)
APPLICANT(S) International Business Machines Corporation (Armonk, New York)
ASSIGNEE(S) INTERNATIONAL BUSINESS MACHINES CORPORATION (Armonk, New York)
INVENTOR(S) John Bulzacchelli (Somers, New York);  Timothy Dickson (Danbury, Connecticut);  Mounir Meghelli (Tarrytown, New York);  Jonathan Proesel (Mount Vernon, New York);  Guanghua Shu (San Carlos, California)
ABSTRACT A method and system of equalizing in a decision feedback equalizer is provided. A plurality of adder circuits receives a digital code representing a previously decided symbol from an output of a prior path of a plurality of paths. A decision-making slicer circuit receives an input voltage and a first clock signal. The plurality of adder circuits receives a second clock signal and injects an offset current proportional to the digital code representing the previously decided symbol into a current injection input of the decision-making slicer circuit, at a first edge of the second clock signal. There is a predetermined skew between the first clock and the second clock to control a timing between the injection of the offset current of the plurality of adder circuits and the initiation of a decision-making phase of the decision-making slicer circuit.
FILED Wednesday, August 02, 2017
APPL NO 15/667079
ART UNIT 2633 — Digital Communications
CURRENT CPC
Transmission of Digital Information, e.g Telegraphic Communication
H04L 25/03057 (20130101) Original (OR) Class
H04L 2025/03668 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10098051 Mosko et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Research Laboratory (AFRL)
APPLICANT(S) CISCO TECHNOLOGY, INC. (San Jose, California)
ASSIGNEE(S) Cisco Technology, Inc. (San Jose, California)
INVENTOR(S) Marc E. Mosko (Santa Cruz, California);  Jose J. Garcia-Luna-Aceves (San Mateo, California)
ABSTRACT One embodiment provides a mobile wireless network that includes a plurality of wireless nodes and a controller node which manages a weighted network graph for the plurality of wireless nodes. A local wireless node sends a route-request message associated with at least one destination node to the controller node, receives a path to the destination node, and routes a packet to the destination node based on the received path. The path is computed based on the weighted network graph. One embodiment provides a system for routing in a mobile wireless network that comprises a plurality of wireless nodes. The system receives a route-request message associated with at least one destination node from a source node, computes a path between the source node and the destination node based on a weighted network graph for the plurality of wireless nodes, and transmits the computed path to at least the destination node.
FILED Wednesday, January 22, 2014
APPL NO 14/161410
ART UNIT 2473 — Multiplex and VoIP
CURRENT CPC
Transmission of Digital Information, e.g Telegraphic Communication
H04L 45/02 (20130101)
H04L 45/16 (20130101)
H04L 45/42 (20130101)
H04L 45/64 (20130101)

Wireless Communication Networks
H04W 28/10 (20130101)
H04W 40/02 (20130101) Original (OR) Class
H04W 40/24 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Energy (DOE) 

US 10093067 Kunc et al.
FUNDED BY
Department of Energy (DOE)
Office of Science (DOE-SC)
Oak Ridge National Laboratory (ORNL)
Federally Funded Research and Development Center (FFRDC)
Operated by UT-Battelle, LLC (UTB) at Oak Ridge, TN
APPLICANT(S) UT-BATTELLE, LLC (Oak Ridge, Tennessee)
ASSIGNEE(S) UT-BATTELLE, LLC (Oak Ridge, Tennessee)
INVENTOR(S) Vlastimil Kunc (Concord, Tennessee);  Randall F. Lind (Loudon, Tennessee);  Lonnie J. Love (Knoxville, Tennessee)
ABSTRACT A manufactured component, method and apparatus for advanced manufacturing that includes a polymeric working material formed into a mandrel with a carbon fiber overlay formed in a continuation of the process. The mandrel build and the carbon fiber overlay of the component preferably take place at atmospheric temperatures.
FILED Wednesday, November 05, 2014
APPL NO 14/533951
ART UNIT 1742 — Tires, Adhesive Bonding, Glass/Paper making, Plastics Shaping & Molding
CURRENT CPC
Shaping or Joining of Plastics; Shaping of Material in a Plastic State, Not Otherwise Provided For; After-treatment of the Shaped Products, e.g Repairing
B29C 33/52 (20130101)
B29C 33/448 (20130101)
B29C 67/0055 (20130101)
B29C 70/38 (20130101) Original (OR) Class

Indexing Scheme Associated With Subclasses B29B, B29C or B29D, Relating to Moulding Materials or to Materials for Reinforcements, Fillers or Preformed Parts, e.g Inserts
B29K 2101/12 (20130101)

Additive Manufacturing, i.e Manufacturing of Three-dimensional [3-D] Objects by Additive Deposition, Additive Agglomeration or Additive Layering, e.g by 3-d Printing, Stereolithography or Selective Laser Sintering
B33Y 10/00 (20141201)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10093072 Vlassiouk et al.
FUNDED BY
Department of Energy (DOE)
Office of Science (DOE-SC)
Oak Ridge National Laboratory (ORNL)
Federally Funded Research and Development Center (FFRDC)
Operated by UT-Battelle, LLC (UTB) at Oak Ridge, TN
APPLICANT(S) UT-Battelle, LLC (Oak Ridge, Tennessee)
ASSIGNEE(S) UT-Battelle, LLC (Oak Ridge, Tennessee)
INVENTOR(S) Ivan V. Vlassiouk (Oak Ridge, Tennessee);  Ilia N. Ivanov (Knoxville, Tennessee);  Panagiotis G. Datskos (Knoxville, Tennessee)
ABSTRACT Graphene reinforced materials and related methods of manufacture are provided. The graphene reinforced materials include graphene sheet or scroll, graphene-polymer sheet or scroll, and graphene-carbon sheet or scroll, each having material properties that are attractive across a broad range of applications and industries. The graphene reinforced materials generally include monolayer or multilayer graphene that is synthesized by annealing a catalyst substrate within a CVD chamber, introducing a hydrocarbon gas as a carbon source with the CVD chamber to form a layer of graphene on the catalyst substrate, detaching the catalyst substrate from the layer of graphene, and rolling the layer of graphene onto itself to form a scroll, optionally with the addition of a polymer layer or carbonized layer on the graphene layer.
FILED Tuesday, March 18, 2014
APPL NO 14/217759
ART UNIT 1783 — Miscellaneous Articles, Stock Material
CURRENT CPC
Layered Products, i.e Products Built-up of Strata of Flat or Non-flat, e.g Cellular or Honeycomb, Form
B32B 1/00 (20130101) Original (OR) Class
B32B 15/08 (20130101)
B32B 18/00 (20130101)
B32B 2255/10 (20130101)
B32B 2255/20 (20130101)

Non-metallic Elements; Compounds Thereof;
C01B 32/186 (20170801)
C01B 32/194 (20170801)

Lime, Magnesia; Slag; Cements; Compositions Thereof, e.g Mortars, Concrete or Like Building Materials; Artificial Stone; Ceramics; Refractories; Treatment of Natural Stone
C04B 35/522 (20130101)
C04B 35/62218 (20130101)
C04B 2235/94 (20130101)
C04B 2235/96 (20130101)
C04B 2237/363 (20130101)

Technical Subjects Covered by Former US Classification
Y10T 156/1038 (20150115)
Y10T 428/30 (20150115)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10093136 Gobinath et al.
FUNDED BY
Department of Energy (DOE)
Office of Energy Efficiency and Renewable Energy (EERE)
APPLICANT(S) The Goodyear Tire and Rubber Company (Akron, Ohio)
ASSIGNEE(S) The Goodyear Tire and Rubber Company (Akron, Ohio)
INVENTOR(S) Thulasiram Gobinath (Hudson, Ohio);  Patrick David Marks (Uniontown, Ohio);  Arun Kumar Byatarayanapura Gopala (Copley, Ohio);  Jungmee Kang (Macedonia, Ohio);  Robin Lamgaday (Wadsworth, Ohio)
ABSTRACT An air maintenance tire assembly is provided in which an elongate groove is located within a first sidewall of a tire. The groove forms an elongate channel within the first sidewall and an elongate groove access passage extends from the elongate channel to an access opening located at an outward surface of the first sidewall. An air pumping tube inserts through the groove access passage and is positioned within the groove channel. A cover strip attaches to the first sidewall to enclose the access opening of the groove access passage. The cover strip is positioned along the first sidewall at a higher distance from the bead region of the first sidewall than the groove channel to avoid contact with a wheel rim flange when the tire is mounted to a wheel rim.
FILED Friday, October 30, 2015
APPL NO 14/927683
ART UNIT 1747 — Tires, Adhesive Bonding, Glass/Paper making, Plastics Shaping & Molding
CURRENT CPC
Vehicle Wheels; Castors; Axles for Wheels or Castors; Increasing Wheel Adhesion
B60B 21/04 (20130101)

Vehicle Tyres Tyre Inflation; Tyre Changing or Repairing; Repairing, or Connecting Valves To, Inflatable Elastic Bodies in General; Devices or Arrangements Related to Tyres
B60C 11/00 (20130101)
B60C 13/02 (20130101)
B60C 15/00 (20130101)
B60C 23/004 (20130101) Original (OR) Class
B60C 23/12 (20130101)
B60C 29/04 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10093299 Sujan et al.
FUNDED BY
Department of Energy (DOE)
Office of Energy Efficiency and Renewable Energy (EERE)
APPLICANT(S) Cummins Inc. (Columbus, Indiana)
ASSIGNEE(S) Cummins Inc. (Columbus, Indiana)
INVENTOR(S) Vivek Anand Sujan (Columbus, Indiana);  Phani Vajapeyazula (Columbus, Indiana);  Kenneth Follen (Greenwood, Indiana);  An Wu (Columbus, Indiana);  Barty L. Moffett (Seymour, Indiana);  Howard Robert Frost (Columbus, Indiana);  Suk-Min Moon (Greenwood, Indiana);  Jaidev Khatri (Jaipur, India);  Wesley M. Mays (Coppell, Texas)
ABSTRACT A vehicle may include a controller configured to control the vehicle to operate in an active control mode or a passive control mode. In the passive control mode, the controller may provide a feedback indicator on a human machine interface. In the active control mode, the controller may provide a control command to an engine control unit.
FILED Thursday, February 19, 2015
APPL NO 14/625951
ART UNIT 3659 — Material and Article Handling
CURRENT CPC
Conjoint Control of Vehicle Sub-units of Different Type or Different Function; Control Systems Specially Adapted for Hybrid Vehicles; Road Vehicle Drive Control Systems for Purposes Not Related to the Control of a Particular Sub-unit
B60W 10/06 (20130101) Original (OR) Class
B60W 10/10 (20130101)
B60W 2510/06 (20130101)
B60W 2520/00 (20130101)
B60W 2540/00 (20130101)
B60W 2550/12 (20130101)
B60W 2550/14 (20130101)
B60W 2710/06 (20130101)
B60W 2710/10 (20130101)

Controlling Combustion Engines
F02D 29/02 (20130101)
F02D 41/1401 (20130101)
F02D 2041/142 (20130101)
F02D 2041/228 (20130101)
F02D 2200/604 (20130101)
F02D 2200/0625 (20130101)
F02D 2200/702 (20130101)

Measuring Distances, Levels or Bearings; Surveying; Navigation; Gyroscopic Instruments; Photogrammetry or Videogrammetry
G01C 21/3469 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10093303 Grider et al.
FUNDED BY
Department of Energy (DOE)
APPLICANT(S) Duane M. Grider (Farmington Hills, Michigan);  Bruce Carvell Blakemore (Plymouth, Michigan)
ASSIGNEE(S) Ford Global Technologies, LLC (Dearborn, Michigan)
INVENTOR(S) Duane M. Grider (Farmington Hills, Michigan);  Bruce Carvell Blakemore (Plymouth, Michigan)
ABSTRACT A vehicle may include an engine and electric machine each configured to generate motive power for the vehicle, a battery configured to store energy for the electric machine, and a tank configured to store fuel for the engine. The vehicle may further include one or more controllers configured to determine a vehicle drive range based on an amount of fuel in the tank and an available charge depletion energy in the battery.
FILED Tuesday, August 17, 2010
APPL NO 12/858112
ART UNIT 3668 — Computerized Vehicle Controls and Navigation, Radio Wave, Optical and Acoustic Wave Communication, Robotics, and Nuclear Systems
CURRENT CPC
Conjoint Control of Vehicle Sub-units of Different Type or Different Function; Control Systems Specially Adapted for Hybrid Vehicles; Road Vehicle Drive Control Systems for Purposes Not Related to the Control of a Particular Sub-unit
B60W 10/06 (20130101)
B60W 10/08 (20130101)
B60W 20/00 (20130101)
B60W 20/11 (20160101) Original (OR) Class
B60W 2050/146 (20130101)
B60W 2510/244 (20130101)
B60W 2560/02 (20130101)

Climate Change Mitigation Technologies Related to Transportation
Y02T 10/6269 (20130101)
Y02T 10/6286 (20130101)
Y02T 90/14 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10094017 Pocius et al.
FUNDED BY
Department of Energy (DOE)
Advanced Research Projects Agency - Energy (ARPA-E)
APPLICANT(S) SLT TECHNOLOGIES, INC. (Los Angeles, California)
ASSIGNEE(S) SLT TECHNOLOGIES, INC. (Los Angeles, California)
INVENTOR(S) Douglas W. Pocius (Santa Barbara, California);  Derrick S. Kamber (Goleta, California);  Mark P. D'Evelyn (Santa Barbara, California);  Jonathan D. Cook (Santa Barbara, California)
ABSTRACT A process of preparing polycrystalline group III nitride chunks comprising the steps of (a) placing a group III metal inside a source chamber; (b) flowing a halogen-containing gas over the group III metal to form a group III metal halide; (c) contacting the group III metal halide with a nitrogen-containing gas in a deposition chamber containing a foil, the foil comprising at least one of Mo, W, Ta, Pd, Pt, Ir, or Re; (d) forming a polycrystalline group III nitride layer on the foil within the deposition chamber; (e) removing the polycrystalline group III nitride layer from the foil; and (f) comminuting the polycrystalline group III nitride layer to form the polycrystalline group III nitride chunks, wherein the removing and the comminuting are performed in any order or simultaneously.
FILED Friday, January 29, 2016
APPL NO 15/011266
ART UNIT 1713 — Coating, Etching, Cleaning, Single Crystal Growth
CURRENT CPC
Non-metallic Elements; Compounds Thereof;
C01B 21/0632 (20130101)

Indexing Scheme Relating to Structural and Physical Aspects of Solid Inorganic Compounds
C01P 2004/60 (20130101)
C01P 2004/90 (20130101)
C01P 2006/80 (20130101)

Coating Metallic Material; Coating Material With Metallic Material; Surface Treatment of Metallic Material by Diffusion into the Surface, by Chemical Conversion or Substitution; Coating by Vacuum Evaporation, by Sputtering, by Ion Implantation or by Chemical Vapour Deposition, in General
C23C 16/01 (20130101)
C23C 16/303 (20130101) Original (OR) Class
C23C 16/4401 (20130101)

Single-crystal-growth; Unidirectional Solidification of Eutectic Material or Unidirectional Demixing of Eutectoid Material; Refining by Zone-melting of Material; Production of a Homogeneous Polycrystalline Material With Defined Structure; Single Crystals or Homogeneous Polycrystalline Material With Defined Structure; After-treatment of Single Crystals or a Homogeneous Polycrystalline Material With Defined Structure; Apparatus Therefor
C30B 7/105 (20130101)
C30B 29/406 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10094306 Shaver et al.
FUNDED BY
Department of Energy (DOE)
Office of Energy Efficiency and Renewable Energy (EERE)
APPLICANT(S) Purdue Research Foundation (West Lafayette, Indiana)
ASSIGNEE(S) Purdue Research Foundation (West Lafayette, Indiana)
INVENTOR(S) Gregory M. Shaver (Lafayette, Indiana);  Lyle E. Kocher (Whiteland, Indiana);  Carrie Hall (Chicago, Illinois);  Daniel Van Alstine (Lafayette, Indiana);  Mark Magee (Columbus, Indiana)
ABSTRACT Advanced combustion modes, such as PCCI, operate near the system stability limits. In PCCI, the combustion event begins without a direct combustion trigger in contrast to traditional spark-ignited gasoline engines and direct-injected diesel engines. The lack of a direct combustion trigger encourages the usage of model-based controls to provide robust control of the combustion phasing. The nonlinear relationships between the control inputs and the combustion system response often limit the effectiveness of traditional, non-model-based controllers. Accurate knowledge of the system states and inputs is helpful for implementation of an effective nonlinear controller. A nonlinear controller is developed and implemented to control the engine combustion timing during diesel PCCI operation by targeting desired values of the in-cylinder oxygen concentration, pressure, and temperature during early fuel injection.
FILED Thursday, December 12, 2013
APPL NO 14/651521
ART UNIT 3747 — Thermal & Combustion Technology, Motive & Fluid Power Systems
CURRENT CPC
Internal-combustion Piston Engines; Combustion Engines in General
F02B 1/12 (20130101)

Controlling Combustion Engines
F02D 13/0226 (20130101)
F02D 13/0265 (20130101)
F02D 35/02 (20130101) Original (OR) Class
F02D 41/0007 (20130101)
F02D 41/0062 (20130101)
F02D 41/0072 (20130101)
F02D 41/401 (20130101)
F02D 41/1401 (20130101)
F02D 41/1447 (20130101)
F02D 41/1458 (20130101)
F02D 41/3035 (20130101)
F02D 2041/1415 (20130101)
F02D 2041/1416 (20130101)
F02D 2041/1433 (20130101)
F02D 2200/0402 (20130101)
F02D 2200/0406 (20130101)
F02D 2200/0411 (20130101)
F02D 2200/0414 (20130101)

Supplying Combustion Engines in General With Combustible Mixtures or Constituents Thereof
F02M 26/05 (20160201)
F02M 26/10 (20160201)
F02M 26/23 (20160201)

Climate Change Mitigation Technologies Related to Transportation
Y02T 10/18 (20130101)
Y02T 10/44 (20130101)
Y02T 10/47 (20130101)
Y02T 10/128 (20130101)
Y02T 10/144 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10094874 Tangyunyong et al.
FUNDED BY
Department of Energy (DOE)
National Nuclear Security Administration (NNSA)
Sandia National Laboratories (SNL)
Federally Funded Research and Development Center (FFRDC)
Operated by National Technology and Engineering Solutions of Sandia, LLC (NTESS) at Albuquerque, NM
APPLICANT(S) Sandia Corporation (Albuquerque, New Mexico)
ASSIGNEE(S) National Technology and Engineering Solutions of Sandia, LLC (Albuquerque, New Mexico)
INVENTOR(S) Paiboon Tangyunyong (Albuquerque, New Mexico);  Edward I. Cole, Jr. (Albuquerque, New Mexico);  Guillermo M. Loubriel (Albuquerque, New Mexico);  Joshua Beutler (Albuquerque, New Mexico)
ABSTRACT A visualization method for screening electronic devices is provided. In accordance with the disclosed method, a probe is applied to a grid of multiple points on the circuit, and an output produced by the circuit in response to the stimulus waveform is monitored for each of multiple grid points where the probe is applied. A power spectrum analysis (PSA) produces a power spectrum amplitude, in each of one or more frequency bins, on the monitored output for each of the multiple grid points. The PSA provides a respective pixel value for each of the multiple grid points. An image is displayed, in which image portions representing the multiple grid points are displayed with the respective pixel values.
FILED Wednesday, July 13, 2016
APPL NO 15/208931
ART UNIT 2868 — Printing/Measuring and Testing
CURRENT CPC
Measuring Electric Variables; Measuring Magnetic Variables
G01R 27/28 (20130101)
G01R 31/303 (20130101)
G01R 31/307 (20130101) Original (OR) Class
G01R 31/311 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10095207 Ji et al.
FUNDED BY
Department of Energy (DOE)
Office of Energy Efficiency and Renewable Energy (EERE)
APPLICANT(S) Kun Ji (Plainsboro, New Jersey);  Yan Lu (West Windsor, New Jersey);  Zhen Song (Plainsboro, New Jersey)
ASSIGNEE(S) SIEMENS CORPORATION (Iselin, New Jersey)
INVENTOR(S) Kun Ji (Plainsboro, New Jersey);  Yan Lu (West Windsor, New Jersey);  Zhen Song (Plainsboro, New Jersey)
ABSTRACT A method of controlling energy consumption in a building includes receiving occupancy data including at least one of occupant request data and occupant schedule data, receiving weather data including at least one of current weather measurement data and weather forecast data, generating an output control signal based on the occupancy data and the weather data, and transmitting the output control signal to a building automation system (BAS) of the building. The occupant request data includes a current request, and the occupant schedule data includes a predicted occupant schedule. The output control signal adjusts a building control device in a zone in the building.
FILED Monday, February 11, 2013
APPL NO 13/763870
ART UNIT 2127 — AI & Simulation/Modeling
CURRENT CPC
Air-conditioning; Air-humidification; Ventilation; Use of Air Currents for Screening
F24F 11/30 (20180101)
F24F 11/62 (20180101)
F24F 11/65 (20180101)
F24F 2120/10 (20180101)
F24F 2130/00 (20180101)
F24F 2130/10 (20180101)

Control or Regulating Systems in General; Functional Elements of Such Systems; Monitoring or Testing Arrangements for Such Systems or Elements
G05B 15/02 (20130101)
G05B 19/02 (20130101) Original (OR) Class
G05B 2219/2642 (20130101)

Systems for Controlling or Regulating Non-electric Variables
G05D 23/1923 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10095421 Roberts
FUNDED BY
Department of Energy (DOE)
National Nuclear Security Administration (NNSA)
Lawrence Livermore National Laboratory (LLNL)
Federally Funded Research and Development Center (FFRDC)
Operated by Lawrence Livermore National Security LLC (LLNS) at Livermore, CA
APPLICANT(S) Advanced Micro Devices, Inc. (Sunnyvale, California)
ASSIGNEE(S) Advanced Micro Devices, Inc. (Santa Clara, California)
INVENTOR(S) David A. Roberts (Cambridge, Massachusetts)
ABSTRACT Systems, apparatuses, and methods for implementing a hybrid memory module bridge network and buffers are disclosed. A system includes one or more host processors and multiple memory modules. Each memory module includes a relatively low pin count, high-bandwidth serial link to one or more other memory modules to perform inter-memory data transfers without consuming host-memory bandwidth. In one embodiment, a first memory module acts as a cache and a second memory module acts as the main memory for the system. The traffic between the host and the first memory module utilizes a first interface, and the cache traffic between the first and second memory modules utilizes a second interface. Cache line fill and writeback transfers between the first and second memory modules occur in parallel with timing-critical cache demand accesses from the host, in a latency-tolerant and buffered manner, without interfering with the cache demand accesses.
FILED Friday, October 21, 2016
APPL NO 15/331582
ART UNIT 2132 — Memory Access and Control
CURRENT CPC
Electric Digital Data Processing
G06F 3/0611 (20130101) Original (OR) Class
G06F 3/0659 (20130101)
G06F 3/0685 (20130101)

Static Stores
G11C 7/1072 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10096536 Washburn et al.
FUNDED BY
Department of Energy (DOE)
National Nuclear Security Administration (NNSA)
Sandia National Laboratories (SNL)
Federally Funded Research and Development Center (FFRDC)
Operated by National Technology and Engineering Solutions of Sandia, LLC (NTESS) at Albuquerque, NM
APPLICANT(S) National Technology and Engineering Solutions of Sandia, LLC (Albuquerque, New Mexico);  Qorvo US, Inc. (Greensboro, North Carolina)
ASSIGNEE(S) National Technology and Engineering Solutions of Sandia, LLC (Albuquerque, New Mexico)
INVENTOR(S) Cody M. Washburn (Albuquerque, New Mexico);  Timothy N. Lambert (Albuquerque, New Mexico);  David R. Wheeler (Albuquerque, New Mexico);  Christopher T. Rodenbeck (Alexandria, Virginia);  Tarak A. Railkar (Plano, Texas)
ABSTRACT Various technologies presented herein relate to forming one or more heat dissipating structures (e.g., heat spreaders and/or heat sinks) on a substrate, wherein the substrate forms part of an electronic component. The heat dissipating structures are formed from graphene, with advantage being taken of the high thermal conductivity of graphene. The graphene (e.g., in flake form) is attached to a diazonium molecule, and further, the diazonium molecule is utilized to attach the graphene to material forming the substrate. A surface of the substrate is treated to comprise oxide-containing regions and also oxide-free regions having underlying silicon exposed. The diazonium molecule attaches to the oxide-free regions, wherein the diazonium molecule bonds (e.g., covalently) to the exposed silicon. Attachment of the diazonium plus graphene molecule is optionally repeated to enable formation of a heat dissipating structure of a required height.
FILED Thursday, June 08, 2017
APPL NO 15/618000
ART UNIT 2812 — Semiconductors/Memory
CURRENT CPC
Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 21/02115 (20130101)
H01L 21/02282 (20130101)
H01L 21/02318 (20130101)
H01L 23/3737 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10096675 Stockman
FUNDED BY
Department of Energy (DOE)
APPLICANT(S) Georgia State University Research Foundation (Atlanta, Georgia)
ASSIGNEE(S) Georgia State University Research Foundation (Atlanta, Georgia)
INVENTOR(S) Mark Stockman (Atlanta, Georgia)
ABSTRACT A processor includes a transistor pair of a first transistor and a second transistor. The first transistor of the transistor pair is coupled to a Spaser and configured to output a drive current to the Spaser to pump the Spaser. Responsive to the drive current, the Spaser outputs surface plasmon polaritons (SPPs) which are fed to a plasmonic interconnect wire. The plasmonic interconnect wire propagates the SPPs. Further, the SPPs propagated on the plasmonic interconnect wire are detected by a phototransistor. Responsive to detecting the SPPs, the phototransistor generates an output current that is fed to a gate terminal of the second transistor to charge the second transistor.
FILED Friday, April 11, 2014
APPL NO 14/777769
ART UNIT 2877 — Optics
CURRENT CPC
Specific Uses or Applications of Nanostructures; Measurement or Analysis of Nanostructures; Manufacture or Treatment of Nanostructures
B82Y 20/00 (20130101)

Optical Elements, Systems, or Apparatus
G02B 6/1226 (20130101)

Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 23/5283 (20130101)
H01L 27/092 (20130101)
H01L 29/78 (20130101)
H01L 29/165 (20130101)
H01L 29/0847 (20130101) Original (OR) Class
H01L 31/1136 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10096729 Rappe et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Materiel Command (AFMC)
Air Force Office of Scientific Research (AFOSR)
Department of the Navy (DON)
Office of Naval Research (ONR)
Department of Energy (DOE)
Office of Science (DOE-SC)
Basic Energy Sciences (BES)
APPLICANT(S) The Trustees of The University of Pennsylvania (Philadelphia, Pennsylvania)
ASSIGNEE(S) The Trustees of The University of Pennsylvania (Philadelphia, Pennsylvania)
INVENTOR(S) Andrew M. Rappe (Penn Valley, Pennsylvania);  Steve M. Young (Alexandria, Virginia);  Fan Zheng (Philadelphia, Pennsylvania)
ABSTRACT The present invention provides materials with high bulk photovoltaic effect response. The present invention also provides for products comprising the high bulk photovoltaic effect materials of the present invention.
FILED Friday, January 23, 2015
APPL NO 15/112708
ART UNIT 1736 — Metallurgy, Metal Working, Inorganic Chemistry, Catalyst, Electrophotography, Photolithography
CURRENT CPC
Compounds of Alkali Metals, i.e Lithium, Sodium, Potassium, Rubidium, Caesium, or Francium
C01D 15/02 (20130101)

Compounds of the Metals Beryllium, Magnesium, Aluminium, Calcium, Strontium, Barium, Radium, Thorium, or of the Rare-earth Metals
C01F 5/00 (20130101)

Compounds Containing Metals Not Covered by Subclasses C01D or C01F
C01G 21/02 (20130101)

Indexing Scheme Relating to Structural and Physical Aspects of Solid Inorganic Compounds
C01P 2006/40 (20130101)

Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 31/032 (20130101) Original (OR) Class
H01L 31/068 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10096733 Kagan et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Office of Naval Research (ONR)
Multidisciplinary University Research Initiative (MURI)
Department of Energy (DOE)
Office of Science (DOE-SC)
Basic Energy Sciences (BES)
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Chemical, Bioengineering, Environmental and Transport Systems (CBET)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Mathematical Sciences (DMS)
APPLICANT(S) THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (Philadelphia, Pennsylvania)
ASSIGNEE(S) The Trustees of the University of Pennsylvania (Philadelphia, Pennsylvania)
INVENTOR(S) Cherie R. Kagan (Bala-Cynwyd, Pennsylvania);  Aaron T. Fafarman (Philadelphia, Pennsylvania);  Ji-Hyuk Choi (Philadelphia, Pennsylvania);  Weon-Kyu Koh (Los Alamos, New Mexico);  David K. Kim (Lincoln, Massachusetts);  Soong Ju Oh (Philadelphia, Pennsylvania);  Yuming Lai (Philadelphia, Pennsylvania);  Sung-Hoon Hong (Daejeon, South Korea);  Sangameshwar Rao Saudari (Fishkill, New York);  Christopher B. Murray (Bala Cynwyd, Pennsylvania)
ABSTRACT Methods of preparing a dispersion of colloidal nanocrystals (NCs) for use as NC thin films are disclosed. A dispersion of NCs capped with ligands may be mixed with a solution containing chalcogenocyanate (xCN)-based ligands. The mixture may be separated into a supernatant and a flocculate. The flocculate may be dispersed with a solvent to form a subsequent dispersion of NCs capped with xCN-based ligands.
FILED Tuesday, May 10, 2016
APPL NO 15/150816
ART UNIT 1715 — Coating, Etching, Cleaning, Single Crystal Growth
CURRENT CPC
Specific Uses or Applications of Nanostructures; Measurement or Analysis of Nanostructures; Manufacture or Treatment of Nanostructures
B82Y 10/00 (20130101)
B82Y 20/00 (20130101)
B82Y 40/00 (20130101)

Cables; Conductors; Insulators; Selection of Materials for Their Conductive, Insulating or Dielectric Properties
H01B 1/06 (20130101)

Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 29/18 (20130101)
H01L 29/22 (20130101)
H01L 29/24 (20130101)
H01L 29/45 (20130101)
H01L 29/127 (20130101)
H01L 29/413 (20130101)
H01L 29/0665 (20130101)
H01L 29/2203 (20130101)
H01L 29/4908 (20130101)
H01L 29/66969 (20130101)
H01L 29/78603 (20130101)
H01L 29/78681 (20130101)
H01L 31/07 (20130101) Original (OR) Class
H01L 31/18 (20130101)
H01L 31/0324 (20130101)

Reduction of Greenhouse Gas [GHG] Emissions, Related to Energy Generation, Transmission or Distribution
Y02E 10/50 (20130101)

Technical Subjects Covered by Former USPC Cross-reference Art Collections [XRACs] and Digests
Y10S 977/891 (20130101)
Y10S 977/938 (20130101)
Y10S 977/954 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10096734 Kagan et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Office of Naval Research (ONR)
Multidisciplinary University Research Initiative (MURI)
Department of Energy (DOE)
Office of Science (DOE-SC)
Basic Energy Sciences (BES)
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Chemical, Bioengineering, Environmental and Transport Systems (CBET)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Mathematical Sciences (DMS)
APPLICANT(S) THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (Philadelphia, Pennsylvania)
ASSIGNEE(S) The Trustees of the University of Pennsylvania (Philadelphia, Pennsylvania)
INVENTOR(S) Cherie R. Kagan (Bala-Cynwyd, Pennsylvania);  Aaron T. Fafarman (Philadelphia, Pennsylvania);  Ji-Hyuk Choi (Philadelphia, Pennsylvania);  Weon-Kyu Koh (Los Alamos, New Mexico);  David K. Kim (Lincoln, Massachusetts);  Soong Ju Oh (Philadelphia, Pennsylvania);  Yuming Lai (Philadelphia, Pennsylvania);  Sung-Hoon Hong (Daejeon, South Korea);  Sangameshwar Rao Saudari (Fishkill, New York);  Christopher B. Murray (Bala Cynwyd, Pennsylvania)
ABSTRACT Methods of forming colloidal nanocrystal (NC)-based thin film devicesare disclosed. The methods include the steps of depositing a dispersion of NCs on a substrate to form a NC thin-film, wherein at least a portion of the NCs is capped with chalcogenocyanate (xCN)-based ligands; and doping the NC thin-film with a metal.
FILED Tuesday, May 10, 2016
APPL NO 15/150824
ART UNIT 1715 — Coating, Etching, Cleaning, Single Crystal Growth
CURRENT CPC
Specific Uses or Applications of Nanostructures; Measurement or Analysis of Nanostructures; Manufacture or Treatment of Nanostructures
B82Y 10/00 (20130101)
B82Y 20/00 (20130101)
B82Y 40/00 (20130101)

Cables; Conductors; Insulators; Selection of Materials for Their Conductive, Insulating or Dielectric Properties
H01B 1/06 (20130101)

Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 29/18 (20130101)
H01L 29/22 (20130101)
H01L 29/24 (20130101)
H01L 29/45 (20130101)
H01L 29/127 (20130101)
H01L 29/413 (20130101)
H01L 29/0665 (20130101)
H01L 29/2203 (20130101)
H01L 29/4908 (20130101)
H01L 29/66969 (20130101)
H01L 29/78603 (20130101)
H01L 29/78681 (20130101)
H01L 31/07 (20130101) Original (OR) Class
H01L 31/18 (20130101)
H01L 31/0324 (20130101)

Reduction of Greenhouse Gas [GHG] Emissions, Related to Energy Generation, Transmission or Distribution
Y02E 10/50 (20130101)

Technical Subjects Covered by Former USPC Cross-reference Art Collections [XRACs] and Digests
Y10S 977/891 (20130101)
Y10S 977/938 (20130101)
Y10S 977/954 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10096799 Basil et al.
FUNDED BY
Department of Energy (DOE)
Office of Energy Efficiency and Renewable Energy (EERE)
APPLICANT(S) Vitro S.A.B. de C.V. (Cheswick, Pennsylvania)
ASSIGNEE(S) Vitro, S.A.B. de C.V. (Nuevo Leon, Mexico)
INVENTOR(S) John D. Basil (Pittsburgh, Pennsylvania);  Abhinav Bhandari (Cranberry, Pennsylvania);  Harry Buhay (Allison Park, Pennsylvania);  Mehran Arbab (Pittsburgh, Pennsylvania);  Gary J. Marietti (Cheswick, Pennsylvania)
ABSTRACT An organic light emitting diode includes a substrate having a surface modification layer. The surface modification layer includes a first film and a second film. The first film has a coefficient of expansion that is greater than the coefficient of expansion for the second film. The second film has ridges and troughs. A method of making a surface modification layer. A first film is formed over a substrate. The coated substrate is heated to expand the first film to a second surface area. A second film is formed over the expanded first film. The substrate coated with the first and second films is cooled to form ridges and troughs in the second film.
FILED Wednesday, March 08, 2017
APPL NO 15/453477
ART UNIT 2895 — Semiconductors/Memory
CURRENT CPC
Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 51/56 (20130101)
H01L 51/5268 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10096999 She et al.
FUNDED BY
Department of Energy (DOE)
Advanced Research Projects Agency - Energy (ARPA-E)
APPLICANT(S) General Electric Company (Schenectady, New York)
ASSIGNEE(S) GENERAL ELECTRIC COMPANY (Schenectady, New York)
INVENTOR(S) Xu She (Niskayuna, New York);  James William Bray (Niskayuna, New York);  Timothy John Sommerer (Ballston Spa, New York);  Rahul Shantilal Chokhawala (Niskayuna, New York)
ABSTRACT A var compensator circuit is provided. The var compensator circuit includes a gas tube switch and a reactive impedance. The gas tube switch is configured to be coupled to a transmission line. The transmission line is configured to deliver real power and reactive power to a load at an alternating current (AC) line voltage. The reactive impedance is configured to be coupled to the transmission line at the AC line voltage through the gas tube switch. The reactive impedance is configured to modify the reactive power configured to be delivered to the load.
FILED Thursday, June 30, 2016
APPL NO 15/199367
ART UNIT 2838 — Electrical Circuits and Systems
CURRENT CPC
Control or Regulating Systems in General; Functional Elements of Such Systems; Monitoring or Testing Arrangements for Such Systems or Elements
G05B 19/05 (20130101)
G05B 2219/15097 (20130101)

Circuit Arrangements or Systems for Supplying or Distributing Electric Power; Systems for Storing Electric Energy
H02J 3/18 (20130101) Original (OR) Class
H02J 3/1842 (20130101)
H02J 3/1864 (20130101)

Apparatus for Conversion Between AC and AC, Between AC and DC, or Between DC and DC, and for Use With Mains or Similar Power Supply Systems; Conversion of DC or AC Input Power into Surge Output Power; Control or Regulation Thereof
H02M 1/0061 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10097000 Mitra et al.
FUNDED BY
Department of Energy (DOE)
Office of Electricity (DOE-OE)
APPLICANT(S) Board of Trustees of Michigan State University (East Lansing, Michigan)
ASSIGNEE(S) Board of Trustees of Michigan State University (East Lansing, Michigan)
INVENTOR(S) Joydeep Mitra (Okemos, Michigan);  Mohammed Ben-Idris (East Lansing, Michigan);  Niannian Cai (East Lansing, Michigan)
ABSTRACT The analysis tool employs a computer-implemented algorithm that uses homotopy-based approaches to map the solution from the exit point to the controlling unstable equilibrium point (UEP). The computational time is reduced significantly by using an approximate exit point rather than computing an accurate exit point as it is required in finding the controlling UEPs using traditional transient stability direct methods. In addition, this method eliminates the necessity of computing the minimum gradient point (MGP) which is a key element in using Newton methods. These properties provide an advantage to homotopy-based approaches over traditional iterative methods in terms of both speed of computation and reliability of finding solutions.
FILED Tuesday, August 11, 2015
APPL NO 14/823531
ART UNIT 2123 — AI & Simulation/Modeling
CURRENT CPC
Circuit Arrangements or Systems for Supplying or Distributing Electric Power; Systems for Storing Electric Energy
H02J 3/24 (20130101) Original (OR) Class
H02J 2003/001 (20130101)

Reduction of Greenhouse Gas [GHG] Emissions, Related to Energy Generation, Transmission or Distribution
Y02E 60/74 (20130101)

Systems Integrating Technologies Related to Power Network Operation, Communication or Information Technologies for Improving the Electrical Power Generation, Transmission, Distribution, Management or Usage, i.e Smart Grids
Y04S 10/30 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10097090 Ferencz et al.
FUNDED BY
Department of Energy (DOE)
APPLICANT(S) International Business Machines Corporation (Armonk, New York)
ASSIGNEE(S) International Business Machines Corporation (Armonk, New York)
INVENTOR(S) Andrew Ferencz (Southborough, Massachusetts);  Todd E. Takken (Brewster, New York);  Paul W. Coteus (Yorktown, New York);  Xin Zhang (Yorktown Heights, New York)
ABSTRACT A power-delivery system may comprise a load device and a direct-current converter configured to deliver current to the load device when the direct-current converter is in an on state. The power-deliver system may comprise a voltage-measurement system configured to measure, at a beginning of each measurement cycle in a cyclic measurement pattern, a voltage at the load device. The power-deliver system may comprise a power controller configure to receive, at the beginning of each measurement cycle, the measurement of the voltage, and to perform, at the beginning of a control cycle in a cyclic control pattern, a voltage-control decision in response to a change in the measurement of the voltage being below a voltage-change threshold. The voltage-control decision may comprise whether to switch the state of the first direct-current converter. The cyclic control pattern may operate at a first frequency, and the measurement pattern may operate at a second frequency.
FILED Thursday, November 30, 2017
APPL NO 15/826793
ART UNIT 2838 — Electrical Circuits and Systems
CURRENT CPC
Apparatus for Conversion Between AC and AC, Between AC and DC, or Between DC and DC, and for Use With Mains or Similar Power Supply Systems; Conversion of DC or AC Input Power into Surge Output Power; Control or Regulation Thereof
H02M 1/08 (20130101)
H02M 1/36 (20130101)
H02M 3/158 (20130101) Original (OR) Class
H02M 2001/0003 (20130101)

Control or Regulation of Electric Motors, Electric Generators or Dynamo-electric Converters; Controlling Transformers, Reactors or Choke Coils
H02P 9/30 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10097091 Huang et al.
FUNDED BY
Department of Energy (DOE)
Exascale Computing Project (ECP)
PathForward Project (PATHFORWARD)
National Nuclear Security Administration (NNSA)
Lawrence Livermore National Laboratory (LLNL)
Federally Funded Research and Development Center (FFRDC)
Operated by Lawrence Livermore National Security LLC (LLNS) at Livermore, CA
APPLICANT(S) Advanced Micro Devices, Inc. (Santa Clara, California)
ASSIGNEE(S) ADVANCED MICRO DEVICES, INC. (Santa Clara, California)
INVENTOR(S) Wei Huang (Frisco, Texas);  Yasuko Eckert (Redmond, Washington);  Xudong An (Richardson, Texas);  Muhammad Shoaib Bin Altaf (Austin, Texas);  Jieming Yin (Bellevue, Washington)
ABSTRACT The described embodiments include an apparatus that controls voltages for an integrated circuit chip having a set of circuits. The apparatus includes a switching voltage regulator separate from the integrated circuit chip and two or more low dropout (LDO) regulators fabricated on the integrated circuit chip. The switching voltage regulator provides an output voltage that is received as an input voltage by each of the two or more LDO regulators, and each of the two or more LDO regulators provides a local output voltage, each local output voltage received as a local input voltage by a different subset of the circuits in the set of circuits. During operation, a controller sets an operating point for each of the subsets of circuits based on a combined power efficiency for the subsets of the circuits and the LDO regulators, each operating point including a corresponding frequency and voltage.
FILED Wednesday, October 25, 2017
APPL NO 15/793951
ART UNIT 2838 — Electrical Circuits and Systems
CURRENT CPC
Systems for Regulating Electric or Magnetic Variables
G05F 1/56 (20130101)
G05F 1/468 (20130101)
G05F 1/575 (20130101)

Apparatus for Conversion Between AC and AC, Between AC and DC, or Between DC and DC, and for Use With Mains or Similar Power Supply Systems; Conversion of DC or AC Input Power into Surge Output Power; Control or Regulation Thereof
H02M 3/1582 (20130101) Original (OR) Class
H02M 2001/0022 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US RE47080 Anderson et al.
FUNDED BY
Department of Energy (DOE)
National Nuclear Security Administration (NNSA)
Lawrence Livermore National Laboratory (LLNL)
Federally Funded Research and Development Center (FFRDC)
Operated by Lawrence Livermore National Security LLC (LLNS) at Livermore, CA
APPLICANT(S) Lawrence Livermore National Security, LLC (Livermore, California)
ASSIGNEE(S) Lawrence Livermore National Security, LLC (Livermore, California)
INVENTOR(S) Brian L. Anderson (Lodi, California);  Bill W. Colston (San Ramon, California);  Christopher J. Elkin (Cranston, Rhode Island)
ABSTRACT A system for nucleic acid amplification of a sample comprises partitioning the sample into partitioned sections and performing PCR on the partitioned sections of the sample. Another embodiment of the invention provides a system for nucleic acid amplification and detection of a sample comprising partitioning the sample into partitioned sections, performing PCR on the partitioned sections of the sample, and detecting and analyzing the partitioned sections of the sample.
FILED Tuesday, January 31, 2017
APPL NO 15/421141
ART UNIT 3991 — Central Reexamination Unit (Chemical)
CURRENT CPC
Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6806 (20130101) Original (OR) Class
C12Q 1/6806 (20130101)
C12Q 2531/113 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

National Science Foundation (NSF) 

US 10092512 Johnston et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Chemistry (CHE)
APPLICANT(S) Keith P. Johnston (Austin, Texas);  Joshua Engstrom (Spotswood, New Jersey);  Jasmine Rowe (Austin, Texas);  Alan B. Watts (Plainsboro, New Jersey);  Robert O. Williams, III (Austin, Texas)
ASSIGNEE(S) BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (Austin, Texas)
INVENTOR(S) Keith P. Johnston (Austin, Texas);  Joshua Engstrom (Spotswood, New Jersey);  Jasmine Rowe (Austin, Texas);  Alan B. Watts (Plainsboro, New Jersey);  Robert O. Williams, III (Austin, Texas)
ABSTRACT The present invention includes compositions and methods for treating and delivering medicinal formulations using an inhaler. The composition includes a space filled flocculated suspension having one or more flocculated particles of one or more active agents and a hydrofluoroalkane propellant. A portion of the one or more flocculated particles is templated by the formation of hydrofluoroalkane droplets upon atomization and the templated floc compacts upon the evaporation of the hydrofluoroalkane propellant to form a porous particle for deep lung delivery.
FILED Wednesday, May 12, 2010
APPL NO 12/778795
ART UNIT 1629 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/008 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10092927 George et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Office of Scientific Research (AFOSR)
National Science Foundation (NSF)
APPLICANT(S) Steven M. George (Boulder, Colorado);  Arrelaine Allen Dameron (Boulder, Colorado);  Nicole Marie Adamczyk Keaner (Madison, Wisconsin);  Byunghoon Yoon (Boulder, Colorado)
ASSIGNEE(S) The Regents of the University of Colorado, a Body Corporate (Denver, Colorado)
INVENTOR(S) Steven M. George (Boulder, Colorado);  Arrelaine Allen Dameron (Boulder, Colorado);  Nicole Marie Adamczyk Keaner (Madison, Wisconsin);  Byunghoon Yoon (Boulder, Colorado)
ABSTRACT Ultrathin layers of organic polymers or organic-inorganic hybrid polymers are deposited onto a substrate using molecular layer deposition methods. The process uses vapor phase materials which contain a first functional group and react only monofunctionally at the surface to add a unit to the polymer chain. The vapor phase reactant in addition has a second functional group, which is different from the first functional group, or a blocked, masked or protected functional group, or else has a precursor to such a functional group.
FILED Tuesday, November 13, 2007
APPL NO 12/513831
ART UNIT 1712 — Coating, Etching, Cleaning, Single Crystal Growth
CURRENT CPC
Processes for Applying Fluent Materials to Surfaces, in General
B05D 1/60 (20130101) Original (OR) Class
B05D 7/52 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10093035 Torkelson et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Materials Research (DMR)
APPLICANT(S) Northwestern University (Evanston, Illinois)
ASSIGNEE(S) Northwestern University (Evanston, Illinois)
INVENTOR(S) John M. Torkelson (Skokie, Illinois);  Philip Brunner (South Milwaukee, Wisconsin)
ABSTRACT Methods for improved colorant dispersion in polymer materials using solid-state shear pulverization, as compared to mixing techniques of the prior art, to address concerns relating to colorant agglomeration, plating-out and the like.
FILED Friday, March 15, 2013
APPL NO 13/815799
ART UNIT 1742 — Tires, Adhesive Bonding, Glass/Paper making, Plastics Shaping & Molding
CURRENT CPC
Preparation or Pretreatment of the Material to be Shaped; Making Granules or Preforms; Recovery of Plastics or Other Constituents of Waste Material Containing Plastics
B29B 7/02 (20130101)
B29B 7/72 (20130101)
B29B 7/82 (20130101)
B29B 7/823 (20130101) Original (OR) Class
B29B 17/0408 (20130101)
B29B 2017/042 (20130101)
B29B 2017/0416 (20130101)
B29B 2017/0464 (20130101)

Shaping or Joining of Plastics; Shaping of Material in a Plastic State, Not Otherwise Provided For; After-treatment of the Shaped Products, e.g Repairing
B29C 47/788 (20130101)
B29C 47/805 (20130101)
B29C 47/825 (20130101)
B29C 47/845 (20130101)

Compositions of Macromolecular Compounds
C08L 23/12 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10093584 Singh et al.
FUNDED BY
National Science Foundation (NSF)
APPLICANT(S) Kansas State University Research Foundation (Manhattan, Kansas)
ASSIGNEE(S) Kansas State University Research Foundation (Manhattan, Kansas)
INVENTOR(S) Gurpreet Singh (Manhattan, Kansas);  Lamuel David (Knoxville, Tennessee)
ABSTRACT Polymer-derived ceramic composites are described herein. The composites are formed using hexagonal boron nitride nanosheet-functionalized silicon-based ceramic precursor polymers. The composites a matrix of a polymer-derived ceramic and hexagonal boron nitride nanosheets embedded therein. Silicon-derived ceramic precursors such as polysilazane and/or polysiloxane are used to create improved SiCN and/or SiOC ceramic composites.
FILED Wednesday, July 08, 2015
APPL NO 15/323885
ART UNIT 1729 — Fuel Cells, Battery, Flammable Gas, Solar Cells, Liquid Crystal Compositions
CURRENT CPC
Lime, Magnesia; Slag; Cements; Compositions Thereof, e.g Mortars, Concrete or Like Building Materials; Artificial Stone; Ceramics; Refractories; Treatment of Natural Stone
C04B 35/571 (20130101) Original (OR) Class
C04B 35/583 (20130101)
C04B 35/589 (20130101)
C04B 2235/386 (20130101)
C04B 2235/483 (20130101)

Working-up; General Processes of Compounding; After-treatment Not Covered by Subclasses C08B, C08C, C08F, C08G or C08H
C08J 3/24 (20130101)
C08J 2383/04 (20130101)
C08J 2383/16 (20130101)

Processes or Means, e.g Batteries, for the Direct Conversion of Chemical Energy into Electrical Energy
H01M 4/58 (20130101)
H01M 4/136 (20130101)
H01M 4/661 (20130101)
H01M 10/0525 (20130101)
H01M 2004/027 (20130101)
H01M 2220/20 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10093674 Xu
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Materials Research (DMR)
APPLICANT(S) Brandeis University (Waltham, Massachusetts)
ASSIGNEE(S) Brandeis University (Waltham, Massachusetts)
INVENTOR(S) Bing Xu (Newton, Massachusetts)
ABSTRACT Disclosed are nucleopeptide compounds that include a nucleobase, and an amino acid. Certain compounds further comprise a glycoside. The compounds may self-assemble to form supramolecular hydrogels. Also, the compounds may be used as a platform to examine specific biological functions (e.g., binding to DNA and RNA) of a dynamic supramolecular system that is able to interact with both proteins and nucleic acids. Other uses include: methods of growing cells and methods of delivering a substance to a cell.
FILED Monday, December 02, 2013
APPL NO 14/093974
ART UNIT 1675 — Organic Chemistry
CURRENT CPC
Heterocyclic Compounds
C07D 239/54 (20130101)
C07D 473/18 (20130101)
C07D 473/34 (20130101) Original (OR) Class

Acyclic, Carbocyclic or Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium or Tellurium
C07F 9/65121 (20130101)
C07F 9/65616 (20130101)

Sugars; Derivatives Thereof; Nucleosides; Nucleotides; Nucleic Acids
C07H 13/04 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10093700 Ly et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Chemistry (CHE)
APPLICANT(S) CARNEGIE MELLON UNIVERSITY (Pittsburgh, Pennsylvania)
ASSIGNEE(S) CARNEGIE MELLON UNIVERSITY (Pittsburgh, Pennsylvania)
INVENTOR(S) Danith H. Ly (Pittsburgh, Pennsylvania);  Srinivas Rapireddy (Pittsburgh, Pennsylvania);  Bichismita Sahu (Pittsburgh, Pennsylvania)
ABSTRACT The present invention relates to γ-PNA monomers according to Formula I where substituent groups R1, R2, R3, R4, R5, R6, B and P are defined as set forth in the specification. The invention also provides methodology for synthesizing compounds according to Formula I and methodology for synthesizing PNA oligomers that incorporate one or more Formula I monomers.
FILED Friday, October 23, 2015
APPL NO 14/921755
ART UNIT 1637 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 47/60 (20170801)

Acyclic or Carbocyclic Compounds
C07C 229/12 (20130101)
C07C 271/20 (20130101)

Heterocyclic Compounds
C07D 239/47 (20130101)
C07D 239/54 (20130101)
C07D 473/18 (20130101)
C07D 473/34 (20130101)

Peptides
C07K 1/04 (20130101)
C07K 1/08 (20130101)
C07K 14/003 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10093906 Kan et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Chemical, Bioengineering, Environmental and Transport Systems (CBET)
APPLICANT(S) California Institute of Technology (Pasadena, California)
ASSIGNEE(S) California Institute of Technology (Pasadena, California)
INVENTOR(S) Sek Bik Jennifer Kan (Pasadena, California);  Russell D. Lewis (Pasadena, California);  Kai Chen (Pasadena, California);  Frances H. Arnold (Pasadena, California)
ABSTRACT The present invention provides compositions and methods for catalyzing the formation of carbon-silicon bonds using heme proteins. In certain aspects, the present invention provides heme proteins, including variants and fragments thereof, that are capable of carrying out in vitro and in vivo carbene insertion reactions for the formation of carbon-silicon bonds. In other aspects, the present invention provides methods for producing an organosilicon product, the method comprising providing a silicon-containing reagent, a carbene precursor, and a heme protein; and combining the components under conditions sufficient to produce an organosilicon product. Host cells expressing the heme proteins are also provided by the present invention.
FILED Wednesday, February 01, 2017
APPL NO 15/422360
ART UNIT 1652 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Acyclic, Carbocyclic or Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium or Tellurium
C07F 7/0818 (20130101)
C07F 7/0829 (20130101)
C07F 7/0896 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 9/0042 (20130101) Original (OR) Class
C12N 9/0071 (20130101)

Enzymes
C12Y 106/02004 (20130101)
C12Y 114/14001 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10094039 Risbud Bartl et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Computer and Information Science and Engineering (CISE)
Division of Electrical and Communications Systems (ECS)
APPLICANT(S) UNIVERSITY OF UTAH RESEARCH FOUNDATION (Salt Lake City, Utah)
ASSIGNEE(S) National Science Foundation (Arlington, Virginia)
INVENTOR(S) Michael Hans Risbud Bartl (Cupertino, California);  JacQueline T. Siy (Salt Lake City, Utah)
ABSTRACT Low-temperature organometallic nucleation and crystallization-based synthesis methods for the fabrication of semiconductor and metal colloidal nanocrystals with narrow size distributions and tunable, size- and shape-dependent electronic and optical properties. Methods include (1) forming a reaction mixture in a reaction vessel under an inert atmosphere that includes at least one solvent, a cationic precursor, an anionic precursor, and at least a first surface stabilizing ligand while stirring at a temperature in a range from about 50° C. to about 130° C. and (2) growing nanocrystals in the reaction mixture for a period of time while maintaining the temperature, the stirring, and the inert-gas atmosphere.
FILED Friday, January 22, 2016
APPL NO 15/004697
ART UNIT 1713 — Coating, Etching, Cleaning, Single Crystal Growth
CURRENT CPC
Materials for Miscellaneous Applications, Not Provided for Elsewhere
C09K 11/881 (20130101)
C09K 11/883 (20130101)

Single-crystal-growth; Unidirectional Solidification of Eutectic Material or Unidirectional Demixing of Eutectoid Material; Refining by Zone-melting of Material; Production of a Homogeneous Polycrystalline Material With Defined Structure; Single Crystals or Homogeneous Polycrystalline Material With Defined Structure; After-treatment of Single Crystals or a Homogeneous Polycrystalline Material With Defined Structure; Apparatus Therefor
C30B 7/14 (20130101) Original (OR) Class
C30B 29/16 (20130101)
C30B 29/40 (20130101)
C30B 29/46 (20130101)
C30B 29/48 (20130101)
C30B 29/605 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10095724 Zhang et al.
FUNDED BY
National Science Foundation (NSF)
APPLICANT(S) Mingjin Zhang (Miami, Florida);  Naphtali Rishe (Miami Beach, Florida);  Weitong Liu (Miami, Florida);  Tao Li (Coral Gables, Florida)
ASSIGNEE(S) The Florida International University Board of Trustees (Miami, Florida)
INVENTOR(S) Mingjin Zhang (Miami, Florida);  Naphtali Rishe (Miami Beach, Florida);  Weitong Liu (Miami, Florida);  Tao Li (Coral Gables, Florida)
ABSTRACT Methods for progressive continuous range query (PCRQ) are provided. A method can include using branch-and-bound to index interest points with a tree-index and generating a nearest enter split-point for a root node in the tree-index and adding to min-heap. Next, whether min-heap has more elements and whether a next split-point in min-heap is closer than a destination can be determined. Whether a query point has reached a split-point can be investigated followed by retrieving an entry that has generated the split-point. The split-point can be then be removed from min-heap.
FILED Wednesday, August 09, 2017
APPL NO 15/672884
ART UNIT 2154 — Data Bases & File Management
CURRENT CPC
Electric Digital Data Processing
G06F 17/30327 (20130101)
G06F 17/30336 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10096733 Kagan et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Office of Naval Research (ONR)
Multidisciplinary University Research Initiative (MURI)
Department of Energy (DOE)
Office of Science (DOE-SC)
Basic Energy Sciences (BES)
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Chemical, Bioengineering, Environmental and Transport Systems (CBET)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Mathematical Sciences (DMS)
APPLICANT(S) THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (Philadelphia, Pennsylvania)
ASSIGNEE(S) The Trustees of the University of Pennsylvania (Philadelphia, Pennsylvania)
INVENTOR(S) Cherie R. Kagan (Bala-Cynwyd, Pennsylvania);  Aaron T. Fafarman (Philadelphia, Pennsylvania);  Ji-Hyuk Choi (Philadelphia, Pennsylvania);  Weon-Kyu Koh (Los Alamos, New Mexico);  David K. Kim (Lincoln, Massachusetts);  Soong Ju Oh (Philadelphia, Pennsylvania);  Yuming Lai (Philadelphia, Pennsylvania);  Sung-Hoon Hong (Daejeon, South Korea);  Sangameshwar Rao Saudari (Fishkill, New York);  Christopher B. Murray (Bala Cynwyd, Pennsylvania)
ABSTRACT Methods of preparing a dispersion of colloidal nanocrystals (NCs) for use as NC thin films are disclosed. A dispersion of NCs capped with ligands may be mixed with a solution containing chalcogenocyanate (xCN)-based ligands. The mixture may be separated into a supernatant and a flocculate. The flocculate may be dispersed with a solvent to form a subsequent dispersion of NCs capped with xCN-based ligands.
FILED Tuesday, May 10, 2016
APPL NO 15/150816
ART UNIT 1715 — Coating, Etching, Cleaning, Single Crystal Growth
CURRENT CPC
Specific Uses or Applications of Nanostructures; Measurement or Analysis of Nanostructures; Manufacture or Treatment of Nanostructures
B82Y 10/00 (20130101)
B82Y 20/00 (20130101)
B82Y 40/00 (20130101)

Cables; Conductors; Insulators; Selection of Materials for Their Conductive, Insulating or Dielectric Properties
H01B 1/06 (20130101)

Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 29/18 (20130101)
H01L 29/22 (20130101)
H01L 29/24 (20130101)
H01L 29/45 (20130101)
H01L 29/127 (20130101)
H01L 29/413 (20130101)
H01L 29/0665 (20130101)
H01L 29/2203 (20130101)
H01L 29/4908 (20130101)
H01L 29/66969 (20130101)
H01L 29/78603 (20130101)
H01L 29/78681 (20130101)
H01L 31/07 (20130101) Original (OR) Class
H01L 31/18 (20130101)
H01L 31/0324 (20130101)

Reduction of Greenhouse Gas [GHG] Emissions, Related to Energy Generation, Transmission or Distribution
Y02E 10/50 (20130101)

Technical Subjects Covered by Former USPC Cross-reference Art Collections [XRACs] and Digests
Y10S 977/891 (20130101)
Y10S 977/938 (20130101)
Y10S 977/954 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10096734 Kagan et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Office of Naval Research (ONR)
Multidisciplinary University Research Initiative (MURI)
Department of Energy (DOE)
Office of Science (DOE-SC)
Basic Energy Sciences (BES)
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Chemical, Bioengineering, Environmental and Transport Systems (CBET)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Mathematical Sciences (DMS)
APPLICANT(S) THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (Philadelphia, Pennsylvania)
ASSIGNEE(S) The Trustees of the University of Pennsylvania (Philadelphia, Pennsylvania)
INVENTOR(S) Cherie R. Kagan (Bala-Cynwyd, Pennsylvania);  Aaron T. Fafarman (Philadelphia, Pennsylvania);  Ji-Hyuk Choi (Philadelphia, Pennsylvania);  Weon-Kyu Koh (Los Alamos, New Mexico);  David K. Kim (Lincoln, Massachusetts);  Soong Ju Oh (Philadelphia, Pennsylvania);  Yuming Lai (Philadelphia, Pennsylvania);  Sung-Hoon Hong (Daejeon, South Korea);  Sangameshwar Rao Saudari (Fishkill, New York);  Christopher B. Murray (Bala Cynwyd, Pennsylvania)
ABSTRACT Methods of forming colloidal nanocrystal (NC)-based thin film devicesare disclosed. The methods include the steps of depositing a dispersion of NCs on a substrate to form a NC thin-film, wherein at least a portion of the NCs is capped with chalcogenocyanate (xCN)-based ligands; and doping the NC thin-film with a metal.
FILED Tuesday, May 10, 2016
APPL NO 15/150824
ART UNIT 1715 — Coating, Etching, Cleaning, Single Crystal Growth
CURRENT CPC
Specific Uses or Applications of Nanostructures; Measurement or Analysis of Nanostructures; Manufacture or Treatment of Nanostructures
B82Y 10/00 (20130101)
B82Y 20/00 (20130101)
B82Y 40/00 (20130101)

Cables; Conductors; Insulators; Selection of Materials for Their Conductive, Insulating or Dielectric Properties
H01B 1/06 (20130101)

Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 29/18 (20130101)
H01L 29/22 (20130101)
H01L 29/24 (20130101)
H01L 29/45 (20130101)
H01L 29/127 (20130101)
H01L 29/413 (20130101)
H01L 29/0665 (20130101)
H01L 29/2203 (20130101)
H01L 29/4908 (20130101)
H01L 29/66969 (20130101)
H01L 29/78603 (20130101)
H01L 29/78681 (20130101)
H01L 31/07 (20130101) Original (OR) Class
H01L 31/18 (20130101)
H01L 31/0324 (20130101)

Reduction of Greenhouse Gas [GHG] Emissions, Related to Energy Generation, Transmission or Distribution
Y02E 10/50 (20130101)

Technical Subjects Covered by Former USPC Cross-reference Art Collections [XRACs] and Digests
Y10S 977/891 (20130101)
Y10S 977/938 (20130101)
Y10S 977/954 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10096789 Xue
FUNDED BY
National Science Foundation (NSF)
Directorate for Computer and Information Science and Engineering (CISE)
Division of Electrical and Communications Systems (ECS)
APPLICANT(S) Jiangeng Xue (Gainesville, Florida)
ASSIGNEE(S) University of Florida Research Foundation, Inc. (Gainesville, Florida)
INVENTOR(S) Jiangeng Xue (Gainesville, Florida)
ABSTRACT Embodiments of the invention pertain to the use of alloyed semiconductor nanocrystals for use in solar cells. The use of alloyed semiconductor nanocrystals offers materials that have a flexible stoichiometry. The alloyed semiconductor may be a ternary semiconductor alloy, such as AxB1-xC or AB1-yCy, or a quaternary semiconductor alloy, such as AxByC1-x-yD, AxB1-xCyD1-y or ABxCyD1-x-y (where A, B, C, and D are different elements). In general, alloys with more than four elements can be used as well, although it can be much harder to control the synthesis and quality of such materials. Embodiments of the invention pertain to solar cells having a layer incorporating two or more organic materials such that percolated paths for one or both molecular species are created. Specific embodiments of the invention pertain to a method for fabricating nanostructured bulk heterojunction that facilitates both efficient exciton diffusion and charge transport. Embodiments of the subject invention pertain to a solar cell having an architecture that allows for efficient harvesting of solar energy. The organic solar cell architecture can incorporate a host/guest (or matrix/dopant) material system that utilizes the long diffusion lengths for triplet excitons without compromising light absorption efficiency.
FILED Friday, May 23, 2008
APPL NO 12/601371
ART UNIT 1726 — Fuel Cells, Battery, Flammable Gas, Solar Cells, Liquid Crystal Compositions
CURRENT CPC
Photomechanical Production of Textured or Patterned Surfaces, e.g for Printing, for Processing of Semiconductor Devices; Materials Therefor; Originals Therefor; Apparatus Specially Adapted Therefor;
G03F 7/0002 (20130101)

Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 51/0004 (20130101)
H01L 51/426 (20130101)
H01L 51/4213 (20130101) Original (OR) Class

Reduction of Greenhouse Gas [GHG] Emissions, Related to Energy Generation, Transmission or Distribution
Y02E 10/549 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10097044 Karalis et al.
FUNDED BY
National Science Foundation (NSF)
APPLICANT(S) Massachusetts Institute of Technology (Cambridge, Massachusetts)
ASSIGNEE(S) Massachusetts Institute of Technology (Cambridge, Massachusetts)
INVENTOR(S) Aristeidis Karalis (Boston, Massachusetts);  Andre B. Kurs (Chestnut Hill, Massachusetts);  Robert Moffatt (Reston, Virginia);  John D. Joannopoulos (Belmont, Massachusetts);  Peter H. Fisher (Cambridge, Massachusetts);  Marin Soljacic (Belmont, Massachusetts)
ABSTRACT Disclosed is an apparatus for use in wireless energy transfer, which includes a first resonator structure configured to transfer energy non-radiatively with a second resonator structure over a distance greater than a characteristic size of the second resonator structure. The non-radiative energy transfer is mediated by a coupling of a resonant field evanescent tail of the first resonator structure and a resonant field evanescent tail of the second resonator structure.
FILED Monday, June 20, 2016
APPL NO 15/186969
ART UNIT 2836 — Electrical Circuits and Systems
CURRENT CPC
Propulsion of Electrically-propelled Vehicles; Supplying Electric Power for Auxiliary Equipment of Electrically-propelled Vehicles; Electrodynamic Brake Systems for Vehicles in General; Magnetic Suspension or Levitation for Vehicles; Monitoring Operating Variables of Electrically-propelled Vehicles; Electric Safety Devices for Electrically-propelled Vehicles
B60L 11/182 (20130101)
B60L 2210/20 (20130101)

Antennas, i.e Radio Aerials
H01Q 7/00 (20130101)
H01Q 9/04 (20130101)

Circuit Arrangements or Systems for Supplying or Distributing Electric Power; Systems for Storing Electric Energy
H02J 5/005 (20130101)
H02J 7/025 (20130101)
H02J 17/00 (20130101)
H02J 50/12 (20160201) Original (OR) Class
H02J 50/80 (20160201)
H02J 50/90 (20160201)

Transmission
H04B 5/0037 (20130101)

Climate Change Mitigation Technologies Related to Transportation
Y02T 10/725 (20130101)
Y02T 10/7005 (20130101)
Y02T 10/7072 (20130101)
Y02T 90/14 (20130101)
Y02T 90/122 (20130101)
Y02T 90/127 (20130101)

Technical Subjects Covered by Former US Classification
Y10T 29/4902 (20150115)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10097168 Guthaus et al.
FUNDED BY
National Science Foundation (NSF)
APPLICANT(S) The Regents of the University of California (Oakland, California)
ASSIGNEE(S) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (Oakland, California)
INVENTOR(S) Matthew Guthaus (Santa Cruz, California);  Riadul Islam (Santa Cruz, California)
ABSTRACT Current-mode signaling for a one-to-many clock signal distribution providing significantly less dynamic power use and improved noise immunity compared to traditional VM signaling schemes.
FILED Monday, September 11, 2017
APPL NO 15/701133
ART UNIT 2842 — Electrical Circuits and Systems
CURRENT CPC
Systems for Regulating Electric or Magnetic Variables
G05F 3/262 (20130101)

Electric Digital Data Processing
G06F 1/10 (20130101)

Pulse Technique
H03K 3/356104 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 

National Aeronautics and Space Administration (NASA) 

US 10092269 Shams et al.
FUNDED BY
National Aeronautics and Space Administration (NASA)
APPLICANT(S) The United States of America as represented by the Administrator of the National Aeronautics and Space Administration (Washington, District of Columbia)
ASSIGNEE(S) The United States of America as represented by the Administrator of NASA (Washington, District of Columbia)
INVENTOR(S) Qamar A. Shams (Yorktown, Virginia);  Allan J. Zuckerwar (Williamsburg, Virginia);  Albert L. Dimarcantonio (Williamsburg, Virginia)
ABSTRACT An infrasonic stethoscope for monitoring physiological processes of a patient includes a microphone capable of detecting acoustic signals in the audible frequency bandwidth and in the infrasonic bandwidth (0.03 to 1000 Hertz), a body coupler attached to the body at a first opening in the microphone, a flexible tube attached to the body at a second opening in the microphone, and an earpiece attached to the flexible tube. The body coupler is capable of engagement with a patient to transmit sounds from the person, to the microphone and then to the earpiece.
FILED Tuesday, March 17, 2015
APPL NO 15/515670
ART UNIT 2667 — Image Analysis; Applications; Pattern Recognition; Color and compression; Enhancement and Transformation
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/117 (20130101)
A61B 5/164 (20130101)
A61B 5/02411 (20130101)
A61B 5/4362 (20130101)
A61B 7/04 (20130101) Original (OR) Class
A61B 7/023 (20130101)
A61B 7/026 (20130101)
A61B 8/488 (20130101)
A61B 8/565 (20130101)
A61B 8/0866 (20130101)
A61B 8/0883 (20130101)
A61B 8/5207 (20130101)

Loudspeakers, Microphones, Gramophone Pick-ups or Like Acoustic Electromechanical Transducers; Deaf-aid Sets; Public Address Systems
H04R 1/46 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10094794 Thompson et al.
FUNDED BY
National Aeronautics and Space Administration (NASA)
Langley Research Center (LaRC)
APPLICANT(S) The Boeing Company (Chicago, Illinois)
ASSIGNEE(S) The Boeing Company (Chicago, Illinois)
INVENTOR(S) Jeffrey G. Thompson (Tacoma, Washington);  Gary E. Georgeson (Tacoma, Washington);  Hong Hue Tat (Redmond, Washington);  Tyler M. Holmes (Seattle, Washington)
ABSTRACT Methods for identifying and quantifying wrinkles in a composite structure by processing infrared image data. The intensity and first and second time derivatives thereof at a particular time can be displayed as thermography line profiles on a graph in which the horizontal axis represents the pixel number across the field of view of an infrared camera. The spatial derivatives of the foregoing thermography line profiles can also be calculated and displayed as a graph. The maximum amplitude (i.e., height) of an out-of-plane wrinkle can be determined using a correlation/calibration curve that is constructed by correlating infrared image data with optical measurement data. In addition, the wavelength and maximum amplitude of an in-plane wrinkle can be measured directly from the thermography line profiles.
FILED Friday, December 09, 2016
APPL NO 15/374014
ART UNIT 2884 — Optics
CURRENT CPC
Measurement of Intensity, Velocity, Spectral Content, Polarisation, Phase or Pulse Characteristics of Infra-Red, Visible or Ultra-violet Light; Colorimetry; Radiation Pyrometry
G01J 5/025 (20130101)
G01J 5/0896 (20130101)
G01J 2005/0048 (20130101)
G01J 2005/0077 (20130101)
G01J 2005/0081 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 25/72 (20130101) Original (OR) Class

Recognition of Data; Presentation of Data; Record Carriers; Handling Record Carriers
G06K 9/6267 (20130101)

Image Data Processing or Generation, in General
G06T 2207/30248 (20130101)

Pictorial Communication, e.g Television
H04N 5/33 (20130101)
H04N 5/2256 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10094877 Corrochano
FUNDED BY
National Aeronautics and Space Administration (NASA)
APPLICANT(S) NASA SOLUTIONS, LLC (Lake Zurich, Illinois)
ASSIGNEE(S) NASA SOLUTIONS, LLC (Lake Zurich, Illinois)
INVENTOR(S) Denis Corrochano (Algonquin, Illinois)
ABSTRACT A method and apparatus for determining a presence, color and/or brightness of a plurality of components in a printed circuit board, where the components are biased either with constant current or with a current pulse.
FILED Tuesday, August 15, 2017
APPL NO 15/677694
ART UNIT 2886 — Optics
CURRENT CPC
Measurement of Intensity, Velocity, Spectral Content, Polarisation, Phase or Pulse Characteristics of Infra-Red, Visible or Ultra-violet Light; Colorimetry; Radiation Pyrometry
G01J 1/44 (20130101)
G01J 1/0204 (20130101)
G01J 1/0228 (20130101)
G01J 1/0492 (20130101)
G01J 1/4204 (20130101)
G01J 3/51 (20130101)
G01J 3/0264 (20130101)
G01J 3/505 (20130101)
G01J 3/513 (20130101)
G01J 2001/4252 (20130101)

Measuring Electric Variables; Measuring Magnetic Variables
G01R 31/31728 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10095041 Ramos-Izquierdo et al.
FUNDED BY
National Aeronautics and Space Administration (NASA)
APPLICANT(S) The United States of America as represented by the Administrator of the National Aeronautics and Space Administration (Washington, District of Columbia)
ASSIGNEE(S) The United States of America as represented by the Administrator of the National Aeronautics and Space Administration (Washington, District of Columbia)
INVENTOR(S) Luis A. Ramos-Izquierdo (Washington, District of Columbia);  Xiaoli Sun (Bethesda, Maryland)
ABSTRACT A laser beam expander has at least two negative lenses with adjustable collimation. The amount of required motion can be reduced by an order of magnitude over single negative lens approaches by splitting the input lens in two and adjusting the small remaining air gap between the lenses. The change in collimation may be accomplished by heating/cooling (i.e., thermal), mechanical motion (e.g., motors), electro-optical means (e.g., applying or reducing an electric current), any combination thereof, or any other suitable mechanism.
FILED Monday, June 13, 2016
APPL NO 15/180245
ART UNIT 2872 — Optics
CURRENT CPC
Optical Elements, Systems, or Apparatus
G02B 7/021 (20130101)
G02B 7/023 (20130101)
G02B 7/028 (20130101)
G02B 27/30 (20130101)
G02B 27/0955 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10096472 Choi et al.
FUNDED BY
National Aeronautics and Space Administration (NASA)
APPLICANT(S) The United States of America as represented by the Administrator of the National Aeronautics and Space Administration (Washington, District of Columbia)
ASSIGNEE(S) The United States of America as represented by the Administrator of NASA (Washington, District of Columbia)
INVENTOR(S) Sang Hyouk Choi (Poquoson, Virginia);  Adam J. Duzik (Yorktown, Virginia)
ABSTRACT Various embodiments may provide a low temperature (i.e., less than 850° C.) method of Silicon-Germanium (SiGe) on sapphire (Al2O3) (SiGe/sapphire) growth that may produce a single crystal film with less thermal loading effort to the substrate than conventional high temperature (i.e., temperatures above 850° C.) methods. The various embodiments may alleviate the thermal loading requirement of the substrate, which in conventional high temperature (i.e., temperatures above 850° C.) methods had surface temperatures within the range of 850° C.-900° C. The various embodiments may provide a new thermal loading requirement of the sapphire substrate for growing single crystal SiGe on the sapphire substrate in the range of about 450° C. to about 500° C.
FILED Wednesday, December 21, 2016
APPL NO 15/386592
ART UNIT 2816 — Semiconductors/Memory
CURRENT CPC
Single-crystal-growth; Unidirectional Solidification of Eutectic Material or Unidirectional Demixing of Eutectoid Material; Refining by Zone-melting of Material; Production of a Homogeneous Polycrystalline Material With Defined Structure; Single Crystals or Homogeneous Polycrystalline Material With Defined Structure; After-treatment of Single Crystals or a Homogeneous Polycrystalline Material With Defined Structure; Apparatus Therefor
C30B 23/08 (20130101)
C30B 23/063 (20130101)
C30B 29/20 (20130101)
C30B 29/52 (20130101)

Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 21/0242 (20130101)
H01L 21/02532 (20130101) Original (OR) Class
H01L 21/02598 (20130101)
H01L 29/161 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Agriculture (USDA) 

US 10092622 Lu et al.
FUNDED BY
Department of Agriculture (USDA)
Agricultural Research Service (ARS)
Cooperative State Research, Education, and Extension Service (CSREES)
APPLICANT(S) Mississippi State University Research and Technology Corporation (Mississippi State, Mississippi)
ASSIGNEE(S) MISSISSIPPI STATE UNIVERSITY (Starkville, Mississippi)
INVENTOR(S) Shien Lu (Starkville, Mississippi);  James L. Smith (College Station, Texas);  Frank Austin (Starkville, Mississippi);  Ganyu Gu (Melfa, Virginia)
ABSTRACT The present invention is directed to novel antifungal glycopeptide compounds and salts thereof produced by a strain of Burkholderia contaminans useful for preventing or treating fungal infection or disease in animals and plants and the bacterial strain that produces the compounds.
FILED Wednesday, July 22, 2015
APPL NO 14/806121
ART UNIT 1676 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/12 (20130101)
A61K 38/16 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10093925 Vander Meer et al.
FUNDED BY
Department of Agriculture (USDA)
APPLICANT(S) The United States of America, as represented by the Secretary of Agriculture (Washington, District of Columbia)
ASSIGNEE(S) The United States of America, as represented by The Secretary of Agriculture (Washington, District of Columbia)
INVENTOR(S) Robert K. Vander Meer (Newberry, Florida);  Man-Yeon Choi (Gainesville, Florida)
ABSTRACT Disclosed is a dsRNA construct that relates to a method to control Lepidopteran moths via double-stranded RNA interference of the PBAN/Pyrokinin gene.
FILED Monday, February 27, 2017
APPL NO 15/442873
ART UNIT 1662 — Plants
CURRENT CPC
Preservation of Bodies of Humans or Animals or Plants or Parts Thereof; Biocides, e.g as Disinfectants, as Pesticides or as Herbicides; Pest Repellants or Attractants; Plant Growth Regulators
A01N 57/16 (20130101)
A01N 63/02 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/113 (20130101) Original (OR) Class
C12N 15/1136 (20130101)
C12N 15/8286 (20130101)
C12N 2310/14 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10093928 Vander Meer et al.
FUNDED BY
Department of Agriculture (USDA)
APPLICANT(S) Robert K. Vander Meer (Newberry, Florida);  Man Yeon Choi (Gainesville, Florida);  Frederic Paul Schmitt (Saint Didier de Formans, France);  Cecile Denise Dorme (Lyons, France);  Angela Becker (Dusseldorf, Germany)
ASSIGNEE(S) The United States of America, as represented by The Secretary of Agriculture (Washington, District of Columbia);  Bayer Cropscience AG (Monheim, Germany)
INVENTOR(S) Robert K. Vander Meer (Newberry, Florida);  Man Yeon Choi (Gainesville, Florida);  Frederic Paul Schmitt (Saint Didier de Formans, France);  Cecile Denise Dorme (Lyons, France);  Angela Becker (Dusseldorf, Germany)
ABSTRACT Disclosed is a dsRNA construct that relates to a method to control insect pests of the genus Helicoverpa or Heliothis double-stranded RNA interference of the PBAN/Pyrokinin gene.
FILED Wednesday, December 14, 2011
APPL NO 13/993751
ART UNIT 1662 — Plants
CURRENT CPC
Preservation of Bodies of Humans or Animals or Plants or Parts Thereof; Biocides, e.g as Disinfectants, as Pesticides or as Herbicides; Pest Repellants or Attractants; Plant Growth Regulators
A01N 57/16 (20130101)
A01N 63/02 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/1136 (20130101) Original (OR) Class
C12N 15/8286 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10093945 Gundersen-Rindal et al.
FUNDED BY
Department of Agriculture (USDA)
APPLICANT(S) The United States of America, as Represented by the Secretary of Agriculture (Washington, District of Columbia)
ASSIGNEE(S) The United States of America, as represented by The Secretary of Agriculture (Washington, District of Columbia)
INVENTOR(S) Dawn E. Gundersen-Rindal (Silver Spring, Maryland);  Saikat Kumar B. Ghosh (Columbia, Maryland)
ABSTRACT The present invention relates to the field of double-stranded RNA (dsRNA)-mediated gene silencing in insect species. More particularly, the present invention relates to genetic constructs designed for the expression of dsRNA corresponding to novel target genes in the insect pest Lymantria dispar, commonly known as the gypsy moth. The present invention also provides methodologies for introducing dsRNA into target insects to induce RNA interference. These constructs are particularly useful in RNAi-mediated control of the gypsy moth.
FILED Friday, November 13, 2015
APPL NO 14/940861
ART UNIT 1662 — Plants
CURRENT CPC
Preservation of Bodies of Humans or Animals or Plants or Parts Thereof; Biocides, e.g as Disinfectants, as Pesticides or as Herbicides; Pest Repellants or Attractants; Plant Growth Regulators
A01N 37/46 (20130101)
A01N 57/16 (20130101)
A01N 63/00 (20130101)
A01N 63/02 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/113 (20130101)
C12N 15/1137 (20130101)
C12N 15/8286 (20130101) Original (OR) Class
C12N 2310/14 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Veterans Affairs (DVA) 

US 10092196 Narayan et al.
FUNDED BY
Department of Veterans Affairs (DVA)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (Oakland, California)
ASSIGNEE(S) The Regents of the University of California (Oakland, California);  The United States of America as Represented by the Department of Veterans Affairs (Washington, District of Columbia)
INVENTOR(S) Sanjiv M. Narayan (La Jolla, California);  Wouter-Jan Rappel (San Diego, California)
ABSTRACT A method of analyzing a complex rhythm disorder in a human heart includes accessing signals from a plurality of sensors disposed spatially in relation to the heart, where the signals are associated with activations of the heart, and identifying a region of the heart having an activation trail that is rotational or radially emanating, where the activation trail is indicative of the complex rhythm disorder and is based on activation times associated with the activations of the heart.
FILED Friday, September 09, 2016
APPL NO 15/261013
ART UNIT 3762 — Refrigeration, Vaporization, Ventilation, and Combustion
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/02 (20130101)
A61B 5/04 (20130101)
A61B 5/042 (20130101)
A61B 5/044 (20130101)
A61B 5/046 (20130101)
A61B 5/0245 (20130101)
A61B 5/0402 (20130101)
A61B 5/0422 (20130101)
A61B 5/0452 (20130101)
A61B 5/0464 (20130101)
A61B 5/726 (20130101)
A61B 5/02405 (20130101) Original (OR) Class
A61B 5/02416 (20130101)
A61B 5/04007 (20130101)
A61B 5/04011 (20130101)
A61B 5/04012 (20130101)
A61B 5/04525 (20130101)
A61B 5/4836 (20130101)
A61B 5/6857 (20130101)
A61B 5/6858 (20130101)
A61B 5/6859 (20130101)
A61B 5/7203 (20130101)
A61B 5/7405 (20130101)
A61B 7/04 (20130101)
A61B 8/0883 (20130101)
A61B 18/1206 (20130101)
A61B 18/1492 (20130101)
A61B 2018/00214 (20130101)
A61B 2018/00351 (20130101)
A61B 2018/00357 (20130101)
A61B 2018/00375 (20130101)
A61B 2018/00839 (20130101)
A61B 2018/1435 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10092526 Chen et al.
FUNDED BY
Department of Veterans Affairs (DVA)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) University of Pittsburgh Of the Commonwealth System of Higher Education (Pittsburgh, Pennsylvania);  The United States of America as represented by the Department of Veterans Affairs (Washington, District of Columbia)
ASSIGNEE(S) University of Pittsburgh Of the Commonwealth System of Higher Education (Pittsburgh, Pennsylvania);  The United States of America as represented by the Department of Veterans Affairs (Washington, District of Columbia)
INVENTOR(S) Beibei Chen (Wexford, Pennsylvania);  Rama Mallampalli (Sewickley, Pennsylvania)
ABSTRACT A method for treating a respiratory injury or disease comprising: administering to a patient in need of treatment a pharmaceutical composition comprising a compound of general Formula I: or salt, ester, solvate, hydrate, or prodrug thereof; wherein: x is an integer from 1 to 10; A and B are each, independently, C3-7cycloalkyl, C3-7cycloalkyl-C1-6alkyl, C3-7heterocycloalkyl, C3-7heterocycloalkyl-C1-6alkyl, C6-10aryl, C6-10aryl-C1-6alkyl, C3-9heteroaryl, or C3-9heteroaryl-C1-6alkyl; and n and p are each, independently, integers from 1 to 10; and a pharmaceutically acceptable carrier, excipient, or diluent.
FILED Friday, November 17, 2017
APPL NO 15/816963
ART UNIT 1629 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/007 (20130101)
A61K 31/137 (20130101) Original (OR) Class
A61K 31/341 (20130101)
A61K 31/381 (20130101)
A61K 31/427 (20130101)
A61K 31/444 (20130101)
A61K 31/506 (20130101)
A61K 31/4025 (20130101)
A61K 31/4155 (20130101)
A61K 31/4178 (20130101)
A61K 31/4545 (20130101)
A61K 31/5377 (20130101)
A61K 45/06 (20130101)

Acyclic or Carbocyclic Compounds
C07C 211/27 (20130101)

Heterocyclic Compounds
C07D 295/135 (20130101)
C07D 401/12 (20130101)
C07D 403/12 (20130101)
C07D 407/12 (20130101)
C07D 409/12 (20130101)
C07D 417/12 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10093706 Antony et al.
FUNDED BY
Department of Veterans Affairs (DVA)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
National Institute of Child Health and Human Development (NICHD)
APPLICANT(S) Indiana University Research and Technology Corporation (Indianapolis, Indiana)
ASSIGNEE(S) Indiana University Research and Technology Corporation (Indianapolis, Indiana)
INVENTOR(S) Asok C. Antony (Indianapolis, Indiana);  Ying-Sheng Tang (Zionsville, Indiana)
ABSTRACT Described herein are compositions relating to engineered hnRNP-E1 variant polypeptides, nucleic acids encoding such polypeptides, engineered hnRNP-E1 compositions, and methods of use thereof. In some embodiments, the engineered hnRNP-E1 polypeptide contains a C293S substitution and retains the ability to bind to a poly(rC)- and poly(U)-rich 5′-UTR element in its cognate mRNA targets in the absence of homocysteine. In some cases, the engineered hnRNP-E1 compositions provided herein are useful to increase the translation of a subset of mRNAs or to treat certain health conditions as described herein.
FILED Monday, January 30, 2017
APPL NO 15/419655
ART UNIT 1636 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/00 (20130101)

Peptides
C07K 14/47 (20130101) Original (OR) Class
C07K 2319/85 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 7/00 (20130101)
C12N 15/11 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10093746 Kaplan
FUNDED BY
Department of Veterans Affairs (DVA)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) THE TRUSTEES OF THE UNIVERSiTY OF PENNSYLVANIA (Philadelphia, Pennsylvania);  The United States of America as represented by the Department of Veterans Affairs (Washington, District of Columbia)
ASSIGNEE(S) The Trustees of the University of Pennsylvania (Philadelphia, Pennsylvania);  The United States of America as represented by the Department of Veterans Affairs (Washington, District of Columbia)
INVENTOR(S) David Kaplan (Media, Pennsylvania)
ABSTRACT The present invention relates to compositions and methods of isolated polynucleotides that encode or polypeptides comprising glypican-3 (GPC3). The invention also includes a chimeric antigen receptor (CAR) wherein the CAR is able to target GPC3. The invention further includes methods of treating a subject or diagnosing and treating diseases, disorders or conditions associated with dysregulated glypican-3.
FILED Thursday, September 03, 2015
APPL NO 15/508317
ART UNIT 1643 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 35/17 (20130101)
A61K 2035/124 (20130101)

Peptides
C07K 14/7051 (20130101)
C07K 16/303 (20130101) Original (OR) Class
C07K 2317/21 (20130101)
C07K 2317/24 (20130101)
C07K 2317/54 (20130101)
C07K 2317/55 (20130101)
C07K 2317/569 (20130101)
C07K 2317/622 (20130101)
C07K 2319/02 (20130101)
C07K 2319/03 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/57438 (20130101)
G01N 2333/705 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Homeland Security (DHS) 

US 10096456 Berkout et al.
FUNDED BY
Department of Homeland Security (DHS)
APPLICANT(S) Smiths Detection Inc. (Edgewood, Maryland)
ASSIGNEE(S) SMITHS DETECTION INC. (Edgewood, Maryland)
INVENTOR(S) Vadym Berkout (Rockville, Maryland);  Thomas D. Saul (Edgewood, Maryland)
ABSTRACT A low temperature plasma probe, a mass spectrometry system, and a method for using a low temperature plasma probe are described. In an embodiment, a low temperature plasma probe includes an intake capillary that provides an ion flow from a sample surface to a mass spectrometer; at least one low temperature plasma tube that provides low temperature plasma gas; at least one heated gas tube that provides heated gas to the sample surface, where the heated gas enhances desorption and ionization of a sample on the sample surface.
FILED Friday, July 29, 2016
APPL NO 15/223200
ART UNIT 2881 — Optics
CURRENT CPC
Electric Discharge Tubes or Discharge Lamps
H01J 49/26 (20130101)
H01J 49/0027 (20130101)
H01J 49/062 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10096880 Zhu et al.
FUNDED BY
Department of Homeland Security (DHS)
Science and Technology Directorate (DHS-ST)
APPLICANT(S) Duke University (Durham, North Carolina)
ASSIGNEE(S) Duke University (Durham, North Carolina)
INVENTOR(S) Ruoyu Zhu (Durham, North Carolina);  Daniel Marks (Durham, North Carolina)
ABSTRACT Rapid radio frequency (RF) microwave devices and methods are disclosed. According to an aspect, a waveguide includes a body having first and second components that are attachable together to form an interior having a surface. Further, the waveguide includes a conductive material formed on the interior surface and shaped to convey electromagnetic waves.
FILED Thursday, September 01, 2016
APPL NO 15/255091
ART UNIT 2842 — Electrical Circuits and Systems
CURRENT CPC
Waveguides; Resonators, Lines, or Other Devices of the Waveguide Type
H01P 3/12 (20130101) Original (OR) Class
H01P 11/002 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Small Business Administration (SBA) 

US 10091985 Tempelman et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Small Business Administration (SBA)
Small Business Innovation Research (SBIR)
APPLICANT(S) Linda A. Tempelman (Lincoln, Massachusetts);  Klearchos K. Papas (Maple Grove, Minnesota);  Simon G. Stone (Arlington, Massachusetts);  William Earl Scott, III (Saint Paul, Minnesota);  Thomas M. Suszynski (Maple Plain, Minnesota);  Shuichiro Matsumoto (Uwajima Ehime, Japan);  Joana Ferrer Fabrega (Girona, Spain);  Michael D. Rizzari (Saint Paul, Minnesota)
ASSIGNEE(S) GINER, INC. (Newton, Massachusetts)
INVENTOR(S) Linda A. Tempelman (Lincoln, Massachusetts);  Klearchos K. Papas (Maple Grove, Minnesota);  Simon G. Stone (Arlington, Massachusetts);  William Earl Scott, III (Saint Paul, Minnesota);  Thomas M. Suszynski (Maple Plain, Minnesota);  Shuichiro Matsumoto (Uwajima Ehime, Japan);  Joana Ferrer Fabrega (Girona, Spain);  Michael D. Rizzari (Saint Paul, Minnesota)
ABSTRACT Method and system for organ preservation. According to one aspect, an organ may be preserved by being perfused with an in situ generated preserving gas. The organ may be, for example, a human or porcine pancreas, and perfusion of the pancreas may be anterograde, retrograde, ductal, anterograde/ductal, or retrograde/ductal. The preserving gas used to perfuse the organ may be dissolved in a liquid and then administered to the organ as a gas/liquid solution or may be mixed with one or more other gases and then administered to the organ as a gas/gas mixture. The preserving gas may be, for example, oxygen gas generated in situ using an electrochemical oxygen concentrator. According to another aspect, an organ preservation system may include an electrochemical oxygen concentrator having a water vapor feed, as well as auxiliary equipment to control and measure delivery pressure, flow, temperature and humidity.
FILED Friday, June 18, 2010
APPL NO 12/803083
ART UNIT 1657 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Preservation of Bodies of Humans or Animals or Plants or Parts Thereof; Biocides, e.g as Disinfectants, as Pesticides or as Herbicides; Pest Repellants or Attractants; Plant Growth Regulators
A01N 1/0226 (20130101)
A01N 1/0247 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 10092003 Widder et al.
FUNDED BY
Department of Defense (DOD)
Office of the Secretary of Defense (OSD)
Small Business Administration (SBA)
Small Business Innovation Research (SBIR)
APPLICANT(S) Novel Textiles and Treatments LLC (New York, New York)
ASSIGNEE(S) Novel Textiles and Treatments LLC (New York, New York)
INVENTOR(S) Laurie Widder (New York, New York);  Gary Innocenti, Sr. (Mahwah, New Jersey)
ABSTRACT Insect control devices and associated methods are generally described. In some embodiments, the insect control device includes one or more substrate materials impregnated or otherwise loaded with an active species (e.g., a pyrethroid). In some cases, the device may provide protection against insects over prolonged periods of time.
FILED Tuesday, May 19, 2015
APPL NO 14/716723
ART UNIT 1613 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Preservation of Bodies of Humans or Animals or Plants or Parts Thereof; Biocides, e.g as Disinfectants, as Pesticides or as Herbicides; Pest Repellants or Attractants; Plant Growth Regulators
A01N 25/18 (20130101)
A01N 25/34 (20130101)
A01N 53/00 (20130101) Original (OR) Class
A01N 53/00 (20130101)
A01N 53/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Commerce (DOC) 

US 10096817 Loveness et al.
FUNDED BY
Department of Commerce (DOC)
National Institute of Standards and Technology (NIST)
APPLICANT(S) Ghyrn E. Loveness (Mountain View, California);  Song Han (Foster City, California);  Zuqin Liu (Sunnvyale, California)
ASSIGNEE(S) Amprius, Inc. (Sunnyvale, California)
INVENTOR(S) Ghyrn E. Loveness (Mountain View, California);  Song Han (Foster City, California);  Zuqin Liu (Sunnvyale, California)
ABSTRACT Provided herein are novel template electrode materials and structures for lithium ion cells. Related methods are also provided. According to various embodiments, an electrode can include a nanostructured template, an electrochemically active material layer coating the template, and a first intermediate layer between the nanostructured template and the electrochemically active material layer. In one arrangement, the nanostructured template includes silicide nanowires. The electrochemically active material may be any of silicon, tin, germanium, carbon, metal hydrides, silicides, phosphides, and nitrides. The first intermediate layer may facilitate adhesion between the nanostructured template and the electrochemically active material layer, electronic conductivity within the electrode, and/or stress relaxation between the nanostructured template and the electrochemically active material layer.
FILED Monday, July 02, 2012
APPL NO 13/540484
ART UNIT 1726 — Fuel Cells, Battery, Flammable Gas, Solar Cells, Liquid Crystal Compositions
CURRENT CPC
Processes or Means, e.g Batteries, for the Direct Conversion of Chemical Energy into Electrical Energy
H01M 4/13 (20130101) Original (OR) Class
H01M 4/70 (20130101)
H01M 4/75 (20130101)
H01M 4/134 (20130101)
H01M 4/139 (20130101)
H01M 4/366 (20130101)
H01M 4/0492 (20130101)
H01M 4/624 (20130101)
H01M 4/628 (20130101)
H01M 4/665 (20130101)
H01M 2004/022 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

National Security Agency (NSA) 

US 10097383 Bulzacchelli et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
National Security Agency (NSA)
APPLICANT(S) International Business Machines Corporation (Armonk, New York)
ASSIGNEE(S) INTERNATIONAL BUSINESS MACHINES CORPORATION (Armonk, New York)
INVENTOR(S) John Bulzacchelli (Somers, New York);  Timothy Dickson (Danbury, Connecticut);  Mounir Meghelli (Tarrytown, New York);  Jonathan Proesel (Mount Vernon, New York);  Guanghua Shu (San Carlos, California)
ABSTRACT A method and system of equalizing in a decision feedback equalizer is provided. A plurality of adder circuits receives a digital code representing a previously decided symbol from an output of a prior path of a plurality of paths. A decision-making slicer circuit receives an input voltage and a first clock signal. The plurality of adder circuits receives a second clock signal and injects an offset current proportional to the digital code representing the previously decided symbol into a current injection input of the decision-making slicer circuit, at a first edge of the second clock signal. There is a predetermined skew between the first clock and the second clock to control a timing between the injection of the offset current of the plurality of adder circuits and the initiation of a decision-making phase of the decision-making slicer circuit.
FILED Wednesday, August 02, 2017
APPL NO 15/667079
ART UNIT 2633 — Digital Communications
CURRENT CPC
Transmission of Digital Information, e.g Telegraphic Communication
H04L 25/03057 (20130101) Original (OR) Class
H04L 2025/03668 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

U.S. Agency for International Development (USAID) 

US 10093720 Burton et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
U.S. Agency for International Development (USAID)
APPLICANT(S) International AIDS Vaccine Initiative (New York, New York);  The Scripps Research Institute (La Jolla, California);  Cornell University (Ithaca, New York)
ASSIGNEE(S) INTERNATIONAL AIDS VACCINE INITIATIVE (New York, New York);  THE SCRIPPS RESEARCH INSTITUTE (La Jolla, California);  CORNELL UNIVERSITY (Ithaca, New York)
INVENTOR(S) Dennis R. Burton (La Jolla, California);  Marit J. van Gils (La Jolla, California);  Wayne Koff (New York, New York);  Pascal R. G. Poignard (New York, New York);  Rogier W. Sanders (Ithaca, New York);  Melissa D. J. S. Simek-Lemos (New York, New York);  Devin Sok (La Jolla, California)
ABSTRACT The present invention relates to an exceptionally broad and potent neutralizing antibody which may comprise cross-clade neutralizing coverage of 83% at a median IC50 of 0.003 μg/ml, compositions containing the same and uses thereof.
FILED Friday, June 05, 2015
APPL NO 14/731621
ART UNIT 1648 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Peptides
C07K 16/1063 (20130101) Original (OR) Class
C07K 2317/21 (20130101)
C07K 2317/55 (20130101)
C07K 2317/76 (20130101)
C07K 2317/565 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Government Rights Acknowledged 

US 10097186 Epstein et al.
FUNDED BY
APPLICANT(S) Ryan J. Epstein (Denver, Colorado);  David James Clarke (Silver Spring, Maryland);  Alexander Marakov (Columbia, Maryland);  Gregory R. Boyd (Washington, District of Columbia);  Anthony Joseph Przybysz (Linthicum, Maryland);  Joel D. Strand (Ellicott City, Maryland);  David George Ferguson (Takoma Park, Maryland)
ASSIGNEE(S) NORTHROP GRUMMAN SYSTEMS CORPORATION (Falls Church, Virginia)
INVENTOR(S) Ryan J. Epstein (Denver, Colorado);  David James Clarke (Silver Spring, Maryland);  Alexander Marakov (Columbia, Maryland);  Gregory R. Boyd (Washington, District of Columbia);  Anthony Joseph Przybysz (Linthicum, Maryland);  Joel D. Strand (Ellicott City, Maryland);  David George Ferguson (Takoma Park, Maryland)
ABSTRACT Systems and methods are provided for linking two components in a superconducting circuit. A plurality of circuit elements, each comprising one of an inductor, a capacitor, and a Josephson junction, are connected in series on a path connecting the two components. A plurality of tunable oscillators are connected from the path connecting the two components. Each tunable oscillator is responsive to a control signal to tune an associated resonance frequency of the tunable oscillator within a first frequency range, within which the two components are coupled, and within a second frequency range, within which the two components are isolated.
FILED Friday, March 02, 2018
APPL NO 15/910254
ART UNIT 2844 — Electrical Circuits and Systems
CURRENT CPC
Computer Systems Based on Specific Computational Models
G06N 99/002 (20130101)

Pulse Technique
H03K 3/38 (20130101)
H03K 19/16 (20130101)
H03K 19/1958 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 

How To Use This Page 

THE FEDINVENT PATENT DETAILS PAGE

Each week, FedInvent analyzes newly granted patents and published patent applications whose origins lead back to funding by the US Federal Government. The FedInvent Patent Details page is a companion to the weekly FedInvents Patents Report.

This week's information is published in the FedInvent Patents report for Tuesday, October 09, 2018.

The FedInvent Weekly Patent Details Page contains a subset of patent information to provide a deeper dive into the week’s taxpayer-funded patents to help the reader better understand where a patent fits in the federal innovation ecosphere.

HOW IS THE INFORMATION ORGANIZED?

Patents are organized by the funding agency. Within each group, the patents are organized in numeric order. A patent funded by more than one agency will appear in the section of each of the agencies that funded the research and development that resulted in the invention. This approach gives the reader a complete view of the department or agency activity for the week.

WHAT INFORMATION WILL I FIND?

THE PANEL
There is a panel for each patent that contains the patent number and the title of the patent. When you click the panel, it opens to reveal the following information:

FUNDED BY
The agencies that funded the grants, contracts, or other research agreements that resulted in the patent. FedInvent includes as much information on the source of the funding as possible. The information is presented in a hierarchy going from the Federal Department down to the agencies, subagencies, and offices that funded the work. Here are two examples:

Department of Health and Human Services (HHS)
     National Institutes of Health (NIH)
         National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Department of Defense (DOD)
     Defense Advanced Research Projects Agency (DARPA)
         Army Research Office (ARO)

We do our best to provide detailed information about the funding. In some cases, the patent only reports limited information on the origins of the funding. FedInvents presents what it can confirm. We add the patents without the information required by the Bayh-Dole Act to our list of patents worthy of further investigation.

APPLICANT(S) and ASSIGNEES
FedInvent includes both the Applicants and the Assignees because having both provides more information about where the inventive work was done and by what organizations. Many organizations — universities, corporations, and federal agencies — standardize the Assignee/Owner information by the time a patent is granted. In the case of federal patents, many of the patents use the agency headquarters information for patent assignment.

Showing just the headquarters address would make Washington, DC the epicenter of all taxpayer-funded research and development. Providing both the applicant information and the assignee information provides a more accurate picture of where important taxpayer funded innovation is happening in America. Here are two examples from two different patents:

APPLICANT: U.S. Army Research Laboratory, Adelphi, MD
ASSIGNEE: The United States of America as represented by the Secretary of the Army Washington, DC

APPLICANT: Optech Ventures, LLC (Torrance, California)
ASSIGNEE(S): The Regents of the University of California (Oakland, California); Optech Ventures, LLC (Torrance, California)

INVENTOR(S)
The inventors appear in the same order as they appear on the patent. FedInvents presents the names in first name/last name order because they are easier to read than the last name/first name order of the names on the USPTO patent documents.

ABSTRACT
The abstract as it appears on the patent.

FILED
The date of the patent application including the day of the week.

APPL NO
This is the patent application serial number. If you’d like to learn more about how application serial numbers work you can go to the Lists Page.

ART UNIT
Patent data includes the Art Unit where a patent was examined. (The Art Unit isn’t available for published patent applications.) The Art Unit provides insight into what group of patent examiners prosecuted the patent application and the subject matter that the examiners work on. For example:

3793 — Medical Instruments, Diagnostic Equipment, and Treatment Devices

You can learn more about ART UNITS on the FedInvent Patents Weekly panel called About Tech Center or you can find information on the FedInvent Lists Page.

CURRENT CPC
Current CPC provides a list of the Cooperative Patent Classification symbols assigned to the patent. These are the CPC symbols assigned at the time the patent was granted.

The FedInvent Project is a patent classification maximalist endeavor or put another way, we believe that more you understand about patent classification the more you'll learn about the nature of the invention and the types of work that the federal government is funding.

The symbol presented in BOLD is the symbol identified as the "first" classification which is the most relevant classification on the patent. The date that follows the symbol is the date of the most recent revision to the art classed there.

  • A61B 1/149 (20130101)
  • A61B 1/71 (20130101)
  • A61B 1/105 (20130101)

The CPC symbols match the classifications found on the PDF version of the patent. Over time, the classifications on the full-text version of the patent change to reflect how USPTO organizes patent art to support its examiners. The two sets of CPCs don’t always match.

VIEW PATENT
As of June 2021, we include two ways to view a patent at USPTO. FedInvent provides a link to the Full-Text Version of the patent and a link to the PDF version of the patent.

HOW DO I FIND A SPECIFIC PATENT ON A PAGE?

You can use the Command F or Control F to find a specific patent you are interested in.

HOW DO I GET HERE?

You navigate to the details of a patent by clicking the information icon that follows a patent on the FedInvent Patents Weekly Report.

You can also reach this page using the weekly page link that looks like this:

https://wayfinder.digital/fedinvent/patents-2018/fedinvent-patents-20181009.html

Just update the date portion of the URL. Tuesdays for patents. Thursdays for pre-grant publication of patent applications.

Download a copy of the How To Use This Page

HAVE MORE QUESTIONS?

info@wayfinder.digital